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Abstract
The maintenance of genomic stability and the repair of DNA damage are essential for
the survival of all cells. Despite diverse pathways for repair of DNA lesions, different
mutations can arise, ranging from Single Nucleotide Variants (SNVs) to larger Structu-
ral Variants (SVs). The processes that play a role in the formation of these alterations
are not fully understood. In this thesis, I present two complementary approaches for
accumulating genomic variants and for identifying pathways involved in the suppression
of mutation formation using Saccharomyces cerevisiae (budding yeast) gene knockout
strains.
First, using next-generation sequencing, I studied neutral variants through a mutation
accumulation assay for up to 1800 generations. I used 47 yeast strains with known
defects in DNA replication, repair and recombination pathways. In all strains, small
insertions and deletions (indels) were more common than larger SVs (>50bp). Most
mutations occurred in repetitive sequences, implicating replication based mechanisms
and homologous recombination in the formation of genomic variants. Furthermore, the
knockout of MSH2 produced a hypermutable strain that acquired the highest number
of indels. Moreover, the knockout of the genes SWR1 and ISW1, involved in chromatin
remodeling, resulted in strains with high number of deletions. These results suggest
that defects in establishing a correct chromatin architecture may play a role in the
formation of genomic variants.
I further performed a genome-wide screen for genes that suppress deletion formation
under different drug treatments in the presence or absence of homologous repeats by
using designed constructs. As expected, deletions occurred more often between repeats,
in support of the frequent involvement of homologous recombination in the formation of
chromosome rearrangements. In addition, I identified genes whose knockout led to incre-
ased levels of deletions. Among these, IOC4 is of particular interest given that it belongs
to the same chromatin remodeling complex as ISW1, identified in the neutral mutati-
on accumulation assay. This provides further evidence that chromatin remodeling may
be involved in preventing the occurrence of SVs. Furthermore, several meiosis-related
mutants also showed increased levels of deletions, suggesting that meiosis proteins may
have additional roles in the maintenance of genomic stability during vegetative growth.
By performing additional experimental validations, I verified the higher vulnerability
of meiosis gene knockouts to acquire deletions, especially in their diploid stages.
In the last chapter, I briefly describe the results of several side projects in which I applied
computational methods learned through the above mentioned projects, to identify and
characterize genomic rearrangements in different human cancers.
In summary, I have found that genome-wide approaches can provide interesting insights
into the understanding of genomic variants in yeast and human cancers. In particular,
given the evolutionary conservation of the ISWI chromatin remodeling complex and
meiosis-related genes, the results presented here point to potentially novel functions of
these proteins in the maintenance of genomic stability.
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Zusammenfassung
Die Aufrechterhaltung der genomischen Stabilität sowie die Reparatur von DNA Schä-
den sind essentiell für das Überleben aller Zellen. Trotz unterschiedlicher Mechanismen
für die Behebung von DNA Defekten, können verschiedene Arten von Mutationen,
wie zum Beispiel Einzelnukleotid-Variationen (SNVs) oder Strukturvariationen (SVs),
auftreten. Die Prozesse, die bei deren Entstehung eine Rolle spielen sind noch nicht
komplett verstanden. In dieser Arbeit stelle ich zwei komplementäre Ansätze zur An-
reicherung von genomischen Veränderungen sowie zur Identifikation von, für die Ver-
meidung von Mutationen wichtigen, Signalwegen vor. Für beide Ansätze verwendete
ich Saccharomyces cerevisiae (Hefe) Gen-Knockout-Stämme.
Als erstes untersuchte ich, unter Verwendung von Hochdurchsatz-Sequenzierung, neu-
trale Mutationen anhand eines Mutations-Akkumulations-Experimentes über einen Zeit-
raum von bis zu 1800 Generationen. Dabei verwendete ich 47 Hefestämme, welche be-
kannte Defekte in DNA Replikations-, Reparatur-, und Rekombinationsmechanismen
haben. In allen Stämmen waren Indels (kleine Insertionen und Deletionen) häufiger als
große SVs (>50bp). Die meisten Mutationen traten in repetitiven Sequenzen auf, was
auf eine Beteiligung replikations-basierender Mechanismen sowie homologer Rekom-
bination bei der Entstehung genomischer Veränderungen deutet. Des Weiteren hatte
der Knockout von MSH2 einen hypermutablen Stamm zur Folge, welcher die meis-
ten Indels akkumulierte. Außerdem zeigten die Knockouts von SWR1 und ISW1 eine
große Anzahl von Deletionen. Beide Gene sind an Chromatin-Umstrukturierungen be-
teiligt. Diese Ergebnisse deuten darauf hin, dass Probleme beim Aufbau einer korrekten
Chromatin-Architektur eine wichtige Rolle bei der Entstehung genomischer Verände-
rungen spielen könnten.
Als zweiten Ansatz habe ich ein genomweites Screening mit Hilfe eines speziell entworfe-
nen DNA Konstruktes durchgeführt, um Gene zu identifizieren, welche die Entstehung
von Deletionen unterdrücken. Hierfür wurden verschiedene Bedingungen, wie die An-
wendung unterschiedlicher Wirkstoffe sowie die An- beziehungsweise Abwesenheit ho-
mologer Sequenzwiederholungen, getestet. Wie erwartet entstanden Deletionen häufiger
zwischen Sequenzwiederholungen, welches die häufige Beteiligung homologer Rekom-
bination bei dem Auftreten chromosomaler Veränderungen unterstreicht. Außerdem
habe ich Gene identifiziert, deren Knockout zu einem erhöhten Level von Deletionen
führte. Von diesen ist besonders IOC4 interessant, da es zum gleichen Chromatin-
Umstrukturierungs-Komplex wie ISW1 gehört, welches im Mutations-Akkumulations-
Experiment identifiziert wurde. Dies ist ein weiterer Hinweis darauf, dass die Chromatin-
Umstrukturierung eine Rolle bei der Vermeidung von SVs spielen könnte. Des Weiteren
zeigten Knockouts von in der Meiose beteiligte Genen ein verstärktes Auftreten von De-
letionen, was darauf hindeutet, dass diese neben der Meiose auch bei der Erhaltung der
genomischen Stabilität während des vegetativen Wachstums eine Rolle spielen könn-
ten. Durch weitere experimentelle Validierungen konnte ich die erhöhte Anfälligkeit für
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Deletionen bei Meiose-Gen-Knockout-Stämmen bestätigen, vor allem in ihrer diploiden
Form.
Im letzten Kapitel dieser Arbeit gehe ich schließlich kurz auf mehrere Nebenprojekte
ein, in denen ich bioinformatische Methoden, welche ich in den oben genannten Pro-
jekten gelernt hatte, angewandt habe, um genomische Veränderungen in verschiedenen
Krebsarten von Menschen zu identifizieren und zu charakterisieren.
Zusammenfassend konnte ich zeigen, dass genomweite Ansätze interessante Einblicke
in das Verständnis genomischer Veränderungen in Hefe und bei Krebserkrankungen
geben können. Insbesondere in Anbetracht der evolutionären Konservierung des ISWI
Chromatin-Umstrukturierungs-Komplexes und der in Meiose involvierten Gene weisen
die hier präsentierten Ergebnisse auf mögliche neue Funktionen dieser Proteine beim
Erhalt genomischer Stabilität hin.
viii
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Chapter 1
Introduction
1.1 Motivation and outline of this thesis
The maintenance of genome integrity is an essential process for the survival of any
organism. Throughout the life of a single cell, numerous endogenous and exogenous
agents can damage DNA [Ciccia and Elledge, 2010]. This damage can impair essential
processes, including DNA replication and transcription. If the damage is not repaired,
it can give rise to mutations or large-scale genomic aberrations, which can be passed
to the next generations. Therefore, to ensure genome stability, all organisms have
evolved diverse mechanisms, generally known as the DNA damage response (DDR), for
sensing and repairing damaged DNA and avoiding the inheritance of incorrect genetic
information [Jackson and Bartek, 2009].
Nevertheless, DNA damage is inevitable and can result in changes ranging from Single
Nucleotide Variants (SNVs) to larger Structural Variants (SVs). Many thousands of
DNA lesions occur [Lindahl and Barnes, 2000] mainly because of byproducts of the
normal cellular metabolism, as a consequence of radiation or other environmental fac-
tors, or even as intermediates of normal developmental processes such as those related
to lymphocytes and germ cell formation [Jackson and Bartek, 2009]. Most of the time,
these lesions are repaired, often causing no further damage. Defects in the mechanisms
of detection or repair of DNA damage can cause alterations that eventually lead to
uncontrolled cellular proliferation and the development of cancer and other diseases
such as developmental disorders [Branzei and Foiani, 2010; Carvalho et al., 2010].
Even though these mutations often have negative effects on the phenotype, they are the
ultimate source of variation. A major field of research in genetics is to understand how
genetic variation occurs and how the underlying sequence variants give rise to certain
phenotypic characteristics [Frazer et al., 2009]. A better comprehension of mutational
processes is important to gain insights into the evolution of specific traits, i.e. why and
how some phenotypes are adaptive, but also to understand disease processes, such as
why some individuals are more susceptible to a particular disorder.
Given recent advances in tools for detection and analysis of genetic variation, such
1
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as next-generation sequencing technologies, we are now able to explore genomes more
thoroughly than ever and to better understand the nature and impact of genetic vari-
ation. In this regard, model organisms, such as the budding yeast, Saccharomyces
cerevisiae, are particularly useful for assessing the impact of molecular pathways on
the maintenance of genome stability.
During the course of my PhD work, I was therefore interested in characterizing genetic
variation in a wide range of genetic backgrounds. Using next-generation sequencing
technologies and experimental approaches, my main aim was to improve the under-
standing of the processes involved in preserving genome integrity. For this purpose,
I made use of a set of publicly available yeast deletion mutants, the Yeast Deletion
Collection, each with a knockout of an open reading frame (ORF).
In the remainder of this chapter, I introduce basic concepts related to the content of
this thesis, including several topics on genomic variation and the use of yeast as a model
organism to study the maintenance of genomic stability.
Chapter 2 describes a mutation accumulation approach to study spontaneous mu-
tations in a set of 47 knockout strains with defects in genes related to DNA repair,
recombination, chromosome segregation and chromatin remodeling. In this approach,
strains were passed through up to 90 recurrent single-cell-to-colony bottlenecks, conse-
quently reducing the effects of selection and allowing neutral mutations to accumulate.
By sequencing the strains at several time points, I investigated different characteristics
of genomic variants, including their size, frequency, genome-wide distribution.
In Chapter 3, I describe an experimental approach using the budding yeast to study
genomic variants in a broader collection of genetic backgrounds. I designed specific
constructs to enrich for strains with defects in genes that are involved in preventing the
formation of deletions. This led to the identification of several genes that may play a
role in the maintenance of genomic stability.
These studies using the budding yeast allowed me to familiarize myself with the compu-
tational tools available for the identification and analysis of genomic sequencing data.
Therefore, during my PhD I also participated in several side projects with the main aim
of improving the understanding of SVs in human cancers. As part of these projects,
I identified and performed experimental validations of SVs. A summary of my main
contributions in these collaborations are mentioned briefly in Chapter 4.
Finally, in the last Chapter of this thesis I summarize my main results and conclusions,
and give future perspectives on potential research directions. Detailed experimental
procedures are described in Appendix A. Supplementary Figures and Tables are pro-
vided in Appendix B. A list of publications in which I was involved during my PhD
is included in Appendix C.
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1.2 Genomic variation
Even though members of the same species have essentially the same sets of genes, no
two individuals, including closely related ones, are genetically identical. Genomic varia-
tion refers to these differences between DNA sequences within and among populations.
While genomic differences between individuals tend to be small. They largely account
for variation at the phenotypic level, from molecular differences in gene expression to
distinctive characteristics in appearance, adaptation to environmental conditions, sus-
ceptibility to diseases and response to drugs [Wilson et al., 2001; Perry et al., 2007;
The Wellcome Trust Case Control Consortium, 2007; Pickrell et al., 2010].
Genomic differences between individuals can occur at distinct scales, from changes in
a single base pair (SNVs), to large genomic alterations, often called SVs. The latter
can range from around 50bp to several megabases and can include whole chromosome
gains or losses (aneuploidies). Additionally, between these two extremes, there are
small insertions and deletions (indels) of up to 50bp in size. This size cutoff is mainly
an operational definition. Earlier definitions set the size larger because sequencing
technologies were not able to detect smaller variants as efficient as they do nowadays.
The impact of genomic variants on phenotypic variation depends largely on their size
and genomic location, and substantial investigations have been made to catalog variants
in humans [The 1000 Genomes Project Consortium, 2010] as well as other organisms
such as yeast [Cherry et al., 1998] in an effort to better understand their functional
impact and effects on phenotype.
1.2.1 Single nucleotide variants (SNVs)
SNVs are the most common type of genomic variation between individuals. As an
operational definition, SNVs are called single nucleotide polymorphisms (SNPs) if the
frequency of the variant is 1% or greater in a population. As part of the 1000 Genomes
Project (1000GP), 38 million SNPs have been discovered and genotyped in human
genomes and they occur mainly as biallelic variants [The 1000 Genomes Project Con-
sortium, 2012].
The distribution of SNVs in the genome is not homogeneous. Variants in coding regions
are less frequent than in non-coding ones, mainly due to purifying selection acting
against mutations with a negative effect on the phenotype as well as the relatively
small size of the coding regions in humans. These variants in non-coding regions can
affect regulatory elements, such as transcription factor binding sites or non-coding
RNAs, or introns affecting the splicing of a gene. Additionally, SNV distribution is
also influenced by the mutation and recombination rates along the genome [Nachman,
2001].
3
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SNVs within coding regions can be synonymous if they do not change the sequence
of the protein encoded by the gene, or nonsynonymous if they have an effect on the
amino acid sequence of the protein. Nonsynonymous variants can be classified into
missense and nonsense. The first type results in a change of amino acid, whereas the
second one produces a premature stop codon at the variant site. Depending on the
base change that an SNV causes, it can be referred to as a transition, if a purine is
replaced by another purine, or if a pyrimidine is replaced by a pyrimidine. In contrast,
if a purine is substituted by a pyrimidine, or the other way around, the variant is called
a transversion. Transitions are in general more common than transversions, being the
former twice as common as the latter in humans [Zhang, 2003].
SNVs can originate from errors during DNA synthesis by the DNA polymerase or after
the mismatch repair processes. Environmentally induced DNA damage can also give
rise to point mutations, not only by external conditions such as chemicals or radiation,
but also by the cells’ own environment. On the other hand, spontaneous mutations
can occur due to the deamination of cytosine to uracil [Pfeifer, 2006]. In fact, the most
common point mutation is the deamination of 5-methylcytosine resulting a C to T
transition, which occurs predominantly at CpG islands and has been observed at high
rates in human cancers, e.g. by Alexandrov et al. [2013].
1.2.2 Small insertions and deletions (indels)
Indels are also relatively frequent in the genome, making them the second most abun-
dant type of variant in human genomes after SNVs [Mullaney et al., 2010]. However,
their identification and cataloging has been more challenging than other types of vari-
ants. The 1000GP has detected around 2 million indels in human genomes [The 1000
Genomes Project Consortium, 2012; Montgomery et al., 2013], with an average of one
every 8kb per individual. Indels are also abundant in other organisms, and they ac-
count for around 20% of all genetic variation in Caenorabditis elegans [Wicks et al.,
2001] and Drosophila melanogaster [Berger et al., 2001]. On the other hand, in yeast,
for example, where the genome is relatively stable, indels occur less frequently [Nishant
et al., 2010]. Nevertheless, they still account for a high percentage of the variation in
the yeast genome in comparison to other types of variants [Zhu et al., 2014].
Similar to the uneven distribution of SNVs in the genome, indels are also not randomly
distributed. There are some hotspots of variation with increased indel occurrence com-
pared to the chromosomal average [Mills et al., 2006]. These regions also contain higher
numbers of SNVs. A set of smaller indel hotspots within genes was also identified, and
similarly co-occurs with increased levels of SNVs [Mills et al., 2006]. There may be
several reasons for these unusual regions of high genetic variation. For example, older
segments of DNA with a longer evolutionary history have more time to accumulate mu-
tations. Additionally, higher rates of homologous recombination and a lack of selective
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pressure if the variants have little impact on the fitness of the individual can result in
increased levels of genetic variants [Montgomery et al., 2013].
Indels can arise due to slippage of the DNA polymerase during replication, especially in
regions of highly repetitive sequences. This mechanism can explain almost 75% of indels
in the human genome including the ones that occur in hotspots [Montgomery et al.,
2013]. The remaining indels are most likely the result of a fork stalling and template
switching (FoSTeS) mechanism which is associated with palindromic sequences and
which is also related to the formation of larger structural variants [Montgomery et al.,
2013].
1.2.3 Structural variants (SVs)
Larger rearrangements in the DNA sequence are termed SVs due to their overall effect
on the structure of the genome. These include variants of different sizes. They can be
unbalanced, such as deletions, duplications, insertions (both of novel sequences or of
mobile elements, MEIs), which produce gains or losses of DNA and are therefore usually
referred to as copy-number variants (CNVs). Additionally, there are also balanced large
variants such as inversions and translocations, which do not change the overall content
of DNA in the cells.
Due to their size, SVs account for a higher difference in nucleotides between individuals
compared to SNVs and indels. In fact, in humans, up to 1% of sequence differences
between two individuals are due to SVs compared to only around 0.1% for SNVs [Pang
et al., 2010]. Consequently, these larger variants can have significant impact on pheno-
typic variation and evolution [Stankiewicz and Lupski, 2010; Zhang et al., 2009a].
Several studies have undertaken the task of identifying, cataloging and assessing the
functional impact of SVs in human genomes [Pang et al., 2010; Conrad et al., 2010;
Mills et al., 2011]. It has become clear that SVs, similar to SNVs, occur more frequently
in some regions of the genome compared to others, which creates hotspots of recurrent
variation [Mills et al., 2011]. Some of these regions also contain a higher amount of
SNVs. Some factors that contribute to the clustering of mutations have been mentioned
above, but additionally, they depend on the sequence context and the local genomic
architecture [Stankiewicz and Lupski, 2002; Shaw and Lupski, 2004].
1.2.4 Mechanisms of formation of structural variants
There are diverse molecular mechanisms that can lead to structural variant formation.
The natural processes by which cells acquire genetic variation are of biological impor-
tance. For example, DNA double strand breaks (DSBs) are required for proper meiotic
recombination [Keeney and Neale, 2006] and for V(D)J recombination as part of the
adaptive immune response [Jung et al., 2006].
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Even though this variation can be beneficial, cells usually prevent DNA damage by a
careful regulation of processes that involve DNA replication, recombination and repair.
However, there may be some alterations that escape these controls and lead to the
formation of mutations, including structural variants.
SV formation mechanisms have been operationally classified into different types. Al-
though this classification is still partly in debate, to simplify this section, these mecha-
nisms will be broadly categorized into two main groups: those that involve homologous
sequences and those that are homology independent [Pâques and Haber, 1999; Hastings
et al., 2009b]. Mechanisms that are homology dependent include those that require
regions of sequence homologies that range from 50bp to 300bp, for Escherichia coli
and mammals respectively [San Filippo et al., 2008; Liskay et al., 1987]. On the other
hand, nonhomologous events can join DNA strands that are not complementary to each
other, although in some cases they make use of very short sequences (microhomologies)
to create the junctions [Pâques and Haber, 1999] (Figure 1.1).
In yeast, these homology independent mechanisms occur less often than the homology
dependent ones. In fact, most of the DSBs in wild type yeast are repaired by homologous
recombination. However, when this pathway is eliminated, other pathways are then
activated for the fast repair of broken DNA strands, even though this process may be
less efficient. Consequently, some yeast deletion mutants deficient in a repair process
can still result in viable strains without severe phenotypes [Pâques and Haber, 1999].
Homology-mediated mechanisms. Homologous recombination is an important
basis for several mechanisms that accurately repair damaged DNA using an identi-
cal sequence as a template. However, genomes contain repeated sequences that are not
in the exact same chromosomal position in the homologous chromosome nor in the sis-
ter chromatid, but rather in different loci in the same or even in another chromosome
[Hastings et al., 2009b]. This process, called non-allelic homologous recombination
(NAHR), can be responsible for the formation of deletions, translocations, duplications
and inversions and is believed to be a major source of rearrangements in cancer genomes
[Hoeijmakers, 2001] (Figure 1.1A).
Homology dependent mechanisms include single-strand annealing (SSA), double-strand
break repair (DSBR), synthesis-dependent strand annealing (SDSA) and break-induced
replication (BIR).
If a DSB occurs between two flanking repeat regions, it can be repaired by homologous
recombination in a process called single-strand annealing (SSA) [Sung and Klein, 2006]
that leads to the deletion of a single copy of the repeated sequence (Figure 1.1B). In
this case, the ends of the DSB are processed to create single stranded DNA (ssDNA)
tails that can subsequently anneal to each other. Similarly, in the DSBR model, the
broken chromosomes are also processed into ssDNA, which then invade the homologous
6
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Figure 1.1: Mechanisms of formation of structural variants. A | Non-allelic homologous recom-
bination (NAHR) can give rise to large deletions, translocations, inversions and duplications when
recombination occurs between long sequence repeats (filled squares with white arrows). B | Single-
strand annealing (SSA) depends on homologous sequences (orange squares) to repair DSBs. The
removal of the single stranded flaps and the re-ligation of the broken ends creates a deletion of
the sequence between the homologous sequences. C | Non-homologous end joining (NHEJ) is a
non-homology-mediated mechanism to repair DNA DSBs. The rejoining of the DSB ends often
leaves a repair “scar” in the form of small deletions or insertions. D | More complex mechanisms,
like micro-homology mediated break-induced replication (MMBIR) and fork stalling and template
switching (FoSTeS) can lead to the formation of simple and complex SVs with microhomologies at
the breakpoints. They occur during replication and involve one or multiple rounds of single strand
invasion into different replication forks. Modified from [Hastings et al., 2009a,b; Currall et al., 2013].
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chromosome or an ectopic location to copy genetic information. This exchange of
strands can result in a crossover with the exchange of segments of the two interacting
chromosomes [Szostak et al., 1983].
On the other hand, in some cases, the DSBR process is not associated with a crossover.
For this, the SDSA model has been proposed, in which the invading DNA strands and
the newly synthesized one are separated from the template by a helicase and returned
to the original broken molecule. This allows for the two ends to encounter and anneal
to each other [Pâques and Haber, 1999], although it is possible that changes in copy
numbers occur when the DNA template contains direct repeats [Hastings et al., 2009b].
Furthermore, if a DSB has only one end, e.g. when a replication fork breaks or collapses,
the single end can then be repaired by the process of break-induced replication (BIR)
[McEachern and Haber, 2006; Sung and Klein, 2006]. In this model, the single-stranded
end is processed to form a ssDNA tail that invades a homologous sequence, and in this
regard, it is similar to SDSA. However, it is independent of some proteins required
for SDSA, such as rad51 [Pâques and Haber, 1999]. Following the invasion, DNA is
synthesized by copying information from the donor chromosome, and DNA synthesis
continues to the end of the chromosome. If the donor is a repeated sequence located in
a different chromosomal position, it can result in non reciprocal translocations, dupli-
cations or deletions [Hastings et al., 2009b].
Non-homology-mediated mechanisms Pathways of DNA repair that use limited
or no homology also act to rejoin DNA molecules together. However, due to the lack
of a homologous template, they are more likely to introduce errors. Non-homologous
repair can be non-replicative or replicative. Among the non-replicative mechanisms,
there are non-homologous end joining (NHEJ), microhomology-mediated end joining
(MMEJ) and breakage-fusion-bridge cycles.
NHEJ is one of the major ways to repair DSBs in eukaryotic cells, including V(D)J re-
combination and damage induced by ionizing radiation [Lieber, 2010]. NHEJ is used to
rejoin DSB ends and proceeds by molecularly bringing the broken DNA ends together,
then modifying the ends to make them compatible and finally ligating them [Gu et al.,
2008; Lieber, 2010] (Figure 1.1C). The processing of the ends can lead to small deletions
and insertions (1-5bp) due to the cleavage or addition of nucleotides to the ends. On
the other hand, in MMEJ, short sequence homologies of 5-25bp are required to rejoin
the DSB ends. This mechanism also leads to deletions of sequences between the micro-
homologies [McVey and Lee, 2008]. One main difference between MMEJ and NHEJ,
is that the former is not dependent of classical repair factors required for NHEJ, such
as DNA ligase IV, Ku70 and Ku80. Therefore, MMEJ as well as a few other methods
independent of those classical factors are referred to as alternative end joining (alt-EJ)
mechanisms [Lieber, 2010].
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Breakage-fusion-bridge cycle is a mechanism implicated with the fusion of chromosome
ends and plays a role in oncogene amplification in some cancers. Chromosomes that
lack telomeres can fuse and create a dicentric chromosome. During anaphase the two
centromeres are pulled to opposite poles of the cell, causing the breakage of the dicentric
chromosome. At the same time, this process leads to the formation of new ends that
also lack the telomeres, inducing their fusion and breakage once again, establishing a
cycle until the ends are stabilized [McClintock, 1942].
DNA replication based mechanisms can also account for more complex chromosomal
rearrangements. DNA replication can lead to the formation of microhomology junc-
tions that, together with mechanisms similar to BIR, are involved in the formation of
SVs with microhomologies at the breakpoints. Such a process has been termed mi-
crohomology mediated break-induced replication (MMBIR) [Hastings et al., 2009a]. A
process that might be related to MMBIR, or is a subtype of this mechanism, is fork
stalling and template switching (FoSTeS) (Figure 1.1D). It can occur when template
switching happens between different replication forks [Zhang et al., 2009b]. Briefly,
when replication forks stall, the 3’ DNA end can change template to another ssDNA
in a nearby replication fork, leading to the formation of SVs ranging in size from a
few hundreds of base pairs to megabases. The junctions of the SVs typically show
only microhomologies of 4-14bp, indicating that homologous recombination is likely
not involved [Zhang et al., 2009b].
More recently, complex genomic rearrangements with multiple breakpoints have also
been described and the chromothripsis model has been proposed [Stephens et al., 2011;
Rausch et al., 2012a]. Chromothripsis, which was reported originally occurring in 2-3%
of cancers, has also been observed in the germline [Kloosterman et al., 2011] and involves
the acquisition of a large number of structural rearrangements in a single catastrophic
event which may include the shattering of entire chromosomes. The mechanisms by
which this is achieved are still not clear, but it may involve breakage-fusion-bridge
cycles and potentially also NHEJ and alt-EJ repair mechanisms to rejoin the DNA
ends.
1.3 Functional impact of genomic variation
Investigating the landscape of genomic variation is only one step towards understanding
the effect of the variants on gene function and on the health of an individual. Large
efforts have been made to determine the impact of mutations and the mechanisms by
which variants occur. In general, the phenotypic impact of these variants depends on
their size and their location, such that the larger the modified stretch of DNA, the
higher the chance to affect an important region and to have higher damaging potential.
Additionally, some variants occur in the germline, i.e. they are inherited from the
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parents, whereas others occur somatically, meaning that they are acquired after the
formation of the zygote.
SNVs can have a direct effect on the phenotype if they change the amino acid sequence
of a protein, if they cause a stop-gain or stop-loss or if they modify a splice site.
Additionally, they can affect regulatory elements and promoter activities.
Although approximately 0.1% of genomic variation between the genomes of two individ-
uals is due to point mutations, most of these variants are non deleterious. In humans,
it has been reported that each individual carries around 2500 nonsynonymous variants
at conserved positions [The 1000 Genomes Project Consortium, 2012]. However, some
nonsynonymous SNVs can have a milder effect if the amino acid substitution is func-
tionally similar to the original one. Additionally, most of these nonsynonymous variants
are actually common in the population (with frequencies >0.5%), and it is therefore un-
likely that they are of pathological importance [Frazer et al., 2009; The 1000 Genomes
Project Consortium, 2012]. In highly conserved loci, the majority of the variants are
present in very low frequencies, i.e. below 0.5%, because these sites of high evolutionary
conservation are usually functionally important and can have negative consequences on
the individual when disrupted [The 1000 Genomes Project Consortium, 2012].
Nevertheless, several SNVs are deleterious and are known to be responsible both for
human disorders as well as other traits that are not pathological. SNVs can affect
how an individual responds to drugs and the susceptibility to disease. Some of the best
studied examples are mutations in TP53 increasing the risk of cancer [Li and Fraumeni,
1969], or that can be directly related to the cause of an illness. Consistently, the cause
of several monogenetic disorders has been mapped to single nucleotide mutations. This
is the case of phenylketonuria [DiLella et al., 1986], Tay-Sachs disease [Myerowitz,
1997] and sickle-cell anemia [Marotta et al., 1977]. To predict the functional impact of
SNVs, several algorithms have been developed, and the predictions have proved to be
useful for characterizing the effects on the phenotype. In this regard, SIFT [Ng and
Henikoff, 2003] and PolyPhen2 [Adzhubei et al., 2010] can predict the effect of amino
acid substitutions on protein structure and function.
Furthermore, indels can affect the phenotype in similar ways as SNVs, modifying the
amino acid composition of a protein or causing frame shifts which mostly result in a
dysfunctional gene product. The functional impact of indels is also of great interest
because they can alter phenotypic traits and are the cause of several diseases. For
example, cystic fibrosis is one of the most common genetic disorders in humans and
it is caused by indels in the CFTR gene [Collins et al., 1987]. Indels not occurring
in gene coding sequences can also have severe effects. For example, insertions in the
promoter of the FMR1 gene can lead to Fragile X syndrome, but only if the size of the
trinucleotide expansion reaches a certain threshold [Warren et al., 1987].
In the case of structural variants, the effects on the phenotype can be caused by the
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direct modification of the sequence of a gene or by disruption of regulatory elements.
Additionally, positional effects can result from rearrangements that bring together ge-
nomic elements that are normally not interacting [Northcott et al., 2012a]. Copy num-
ber variants (CNVs), such as a duplication of a region, can lead to dosage effects, and
translocations can create new fusion genes.
Several larger rearrangements are known to be the cause of human diseases. Long be-
fore the advent of sequencing technologies, through the use of microscopic techniques,
many of these large rearrangements were identified and characterized, such as ane-
uploidies and fragile sites [Feuk, 2010]. More recently, many other smaller variants
have been linked to different phenotypes. These include non-pathogenic traits, such
as the copy number variation in the amylase gene (AMY1 ) [Perry et al., 2007], and
other rearrangements associated with genomic disorders such as Williams-Beuren and
Potocki-Lupski syndromes [Zhang et al., 2009a].
1.4 Structural variants in cancers genomes
Structural variants, as well as other types of somatic variations, have also been shown to
play an important role in the development of different types of tumors [Pleasance et al.,
2010a; Rausch et al., 2012a; Yang et al., 2013; Zack et al., 2013]. Cancer includes a
diverse group of diseases, of over 100 different types with distinct characteristics. These
include different risk factors, such as environmental conditions and genetic features.
Specific genomic abnormalities have been associated with particular cancers, and they
encompass a wide range of rearrangements, including SVs and SNVs [Stratton et al.,
2009]. In fact, some of the first recurrent rearrangements discovered in cancers were
large events, like the translocation between chromosomes 9 and 22 (Philadelphia translo-
cation) common in chronic myeloid leukaemia [Rowley, 1973] given that they were
visible with staining techniques and microscopes.
With the advent of new sequencing technologies, the study of cancer genomics has been
highly improved by the ability to sequence a high number of genomes in unprecedented
coverage and timing. The increasing availability of data has allowed the characteri-
zation of the genomic landscapes of a wide variety of cancer types [Pleasance et al.,
2010a; Stephens et al., 2012; Ho et al., 2013; Ojesina et al., 2014], revealing the large
variation and high complexity of cancer genomes and the processes that govern cancer
development [Berger et al., 2011].
Structural variants identified in human cancers include all simple types, like deletions,
inversions, duplications and translocations [Campbell et al., 2008; Stephens et al., 2009;
Yang et al., 2013]. It has been earlier proposed that cancers arise by an accumulation of
somatic variants and that therefore its development follows a progressive model [Strat-
ton et al., 2009]. In this model, the cells acquire consecutive mutations that can activate
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proto-oncogenes or inactivate tumor suppressor genes. Not all mutations are similarly
important for tumorigenesis, rather there are some mutations that are “drivers”, they
have an effect in tumor growth and are directly implicated in oncogenesis. Other less
important mutations are “passangers” and may have no impact on the development of
the tumor [Stratton et al., 2009].
As mentioned previously, more recent analyses of different cancer genomes have revealed
that a large number of structural variants can arise by a different mechanism involving a
one-step catastrophic event called chromothripsis [Stephens et al., 2011; Rausch et al.,
2012a]. By this process, massive rearrangements are formed, occurring in only one
or two chromosomes, in which several DNA fragments are lost and many others are
rejoined in a random way. The derived chromosome shows variation in copy number
changes that typically oscillates between two or three states [Korbel and Campbell,
2013].
The identification and annotation of structural variants in cancers has lead to the
discovery of rearrangements that affect the coding regions of genes, either by removing
part of the coding sequence or by creating the fusion of genes, such as the TMPRSS2
fusion to the ETS transcription factors ERG or ETV1 seen in prostate cancers[Tomlins
et al., 2005]. Duplications can lead to changes in the gene dosage when the repeated
units contain intact elements. High level amplifications are also characteristic of specific
cancers and can lead to overexpression of oncogenes, e.g. the amplification of MYC in
group 3 medulloblastomas [Bigner et al., 1990; Northcott et al., 2012b]. Furthermore,
SVs can also affect the expression of a gene without causing direct damage to the
coding region of that particular ORF. Such effects can be the result of changes in
the location of regulatory elements, including enhancers and isolators, which lead to
the missregulation of genes that were otherwise not regulated by these elements. An
example of this case has been shown in medulloblastoma subgroups 3 and 4, in which
by “enhancer hijacking” an enhancer element is brought to the proximity of the proto-
oncogenes GFI1 and GFI1B and leads to their activation [Northcott et al., 2014].
Even though great advances have been made in the understanding and interpretation
of the effects of SVs on the phenotype, there are still many questions that remain open.
The study of the functional impact of these large genomic variants is still ongoing and
several challenges remain to be overcome. Therefore, many cancer genomic projects are
being performed, with larger datasets (e.g. the Pan-Cancer Analysis of Whole Genomes
(PCAWG) initiative), better computational tools and more accurate matched clinical
descriptions. The detection and understanding of the influence of SVs in the genome will
probably improve by the development of new laboratory and computational techniques
[Weischenfeldt et al., 2013]. For example, the increase in sequencing read lengths will
help to understand more complex rearrangements or those occurring in repetitive areas
of the genome that are at the moment difficult to ascertain [Huddleston et al., 2014].
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1.5 Next-generation sequencing (NGS) methods and the
identification of genomic variants
Last years witnessed major improvements in the technologies used for detection and
characterization of genomic variants. Experimental and bioinformatic methods have
been developed to allow fast, reproducible, and reliable identification and analysis of
variants [Mardis, 2013]. About a decade ago, there were only a few dozen submicro-
scopic SVs detected which were discovered by microarray technologies and capillary-
based DNA sequencing (Sanger sequencing). These techniques provided useful infor-
mation and eventually led to the sequencing of the genomes of several model organisms,
including yeast and mouse, and of the first human genome.
Microarrays initially allowed the identification of copy number differences mainly by
means of array comparative genomic hybridization (array CGH) [Pinkel et al., 1998;
Conrad et al., 2010] and by SNP microarrays [Cooper et al., 2008; McCarroll et al.,
2008]. The array CGH method compares the signal ratios of two labeled samples, test
and reference, obtained when hybridizing them to a chip containing defined probes (long
oligonucleotides that align to known targets in the genome). Based on these ratios, copy
number gains and losses can be estimated. Some of these platforms contain up to 42
million probes, which allow the detection of CNVs as short as 500bp, although they
are not practical for large sets of samples [Iafrate et al., 2004; Conrad et al., 2010].
Similarly, SNP microarrays use hybridization methods with the advantage of designing
probes that are allele specific and that increase CNV detection sensitivity. Although
both methods have proved useful for the detection of CNVs, they both have certain
limitations. For example, it is not possible to accurately define the breakpoints of
events and they only allow larger and unbalance events to be detected [Alkan et al.,
2011].
At the beginning of 2005, new sequencing technologies, commonly called next-generation
sequencing technologies (NGS), became commercially available. Since then, they have
revolutionized genomics studies and in particular, biomedical research, by achieving
high-throughput and efficiency. The main improvements came from the amount of
sequence that could be produced per run, the increase in the number bases that can
be sequenced, the improved base-calling accuracy and the overall lower costs [Mardis,
2011]. Additionally, with these technological and experimental advances, bioinformat-
ics tools and methods for data analysis have also seen great progress, allowing not only
the detection of different types of rearrangements, including balanced events, but also
the mapping of breakpoints at nucleotide resolution.
Several NGS platforms were developed in the last years, including SOLiD (Life Tech-
nologies), Roche/454 and Illumina platforms. Illumina’s HiSeq2000/2500 is the most
commonly used platform to date, with the ability to generate more than 300 million
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“reads” of 100bp (the resulting sequenced fragments) per lane. All experiments using
NGS technologies in this thesis were done using the “paired-end” method and Illumina
sequencing platforms, where both ends of linear DNA fragments of similar sizes are
sequenced (Figure 1.2). Sequencing can also be done by using the “mate-pair” method,
in which the sequencing is carried out at both ends of previously circularized DNA
fragments. This circularization step of longer fragments brings together ends which
are normally distant to each other [Metzker, 2010]. Therefore, the mate-pair method
allows the spanning of larger genomic regions.
In summary, for these Illumina NGS approaches, the DNA sample to be sequenced
is used to construct a collection of DNA fragments called a library. In the case of
paired-end libraries, these fragments can be 200-500bp long. For mate-pair libraries
the fragments are much larger, ranging from 3 to 6kb. The size of these fragments are
usually referred to as “insert size”. All the fragments have universal adapters covalently
ligated in both sides. These adapters are used to PCR amplify the library products
before sequencing and they are also used to hybridize the fragments to the flowcells
[Mardis, 2013]. These flowcells are microfluidic channels that serve as a solid platform
where the amplification for sequencing occurs. The sequencing reaction is a process of
repeated steps, where in each cycle one fluorescently labeled nucleotide is incorporated.
The nucleotides are blocked from further addition of bases, but after the detection
step that identifies which base was added, a washing step cleaves the fluorescent labels
[Metzker, 2010]. Therefore, the sequencing occurs in a nucleotide-by-nucleotide process.
After the reads are generated, they can be used for de novo assembly or they can
be aligned to a reference genome. By determining differences of the sequences or the
position and the orientation of the reads with respect to the reference, different types
of genomic variants can be identified. These methods are described below and are
summarized in Figure 1.3.
Read alignment and split reads. Detection of SNVs and indels can be done di-
rectly by mapping of the sequencing reads to a reference. Computational methods have
been developed, such as SAMtools mpileup [Li et al., 2009] followed by BCFtools, to
identify positions in the genome where multiple reads disagree. Since sequencing er-
rors are in general random, if several reads disagree at the same position, it is possible
that the mismatch corresponds to an SNV. In this regard, the amount of reads that
cover each region of the genome, i.e. the sequencing coverage, is essential to correctly
identifying SNVs. The same approach is also applied for the reliable identification of
indels.
Additionally, when reads directly span a breakpoint of a variant, the mappers may not
be able to align these reads as a whole. However, some tools can map only the beginning
or the end of a read, i.e. the read is split. With this approach, all types of variants can
be identified, with the advantage of detecting the breakpoint at nucleotide resolution.
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Fragment DNA (200-500bp)
Genomic DNA
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Figure 1.2: Library preparation for paired-end sequencing with an Illumina instrument. First,
genomic DNA is sheared into fragments of about 500bp. The ends of these fragments are repaired
to create blunt-ended dsDNA. Following the end-repair, an “A” nucleotide is added to the 3’ end of
the fragments to prevent the formation of concatemers in the following ligation steps. Then specific
adapters for annealing to the sequencing flowcell are ligated to both ends of the fragments. For
multiplexed library preparations, different molecular indexes can be added, in this case depicted in
dark blue (Protocol following the paired-end Sample Preparation Guide, Illumina).
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This method is computationally challenging since short sequences can align to multiple
places in the genome. Therefore, to increase specificity, local alignment strategies can
be used, and the position of the other read of a pair is used to reduce the search space
[Ye et al., 2009]. For larger variants, another way of reducing complexity is to first
identify the SVs by other methods, and then perform the split read search [Rausch
et al., 2012b]. Similarly, higher sequencing coverage and longer reads are necessary to
have better support for the variants. Specifically, the detection and validation of indels
is more challenging compared to the detection of SNVs and SVs, especially because
they occur more frequently in repetitive regions which are harder to accurately map to
the reference genome.
Read depth. The read depth (also called sequencing coverage or depth of coverage)
refers to the amount of sequenced reads that aligns to a specific region of the genome.
These methods assume that there is a random distribution of the sequencing reads
mapping to the genome. Deviations from this distribution suggest the existence of
deletions or duplications (unbalanced SVs) [Alkan et al., 2011; Raphael, 2012]. Other
variants that do not cause a change in the read depth, like translocations and inversions,
cannot be identified by this method.
The general workflow following the alignment of the reads to a reference genome is to
divide the genome into equally sized windows (e.g. 10kb) and to determine the number
of reads mapped per window. By comparing the number of reads per window to the
genome-wide read depth average, unbalanced events can be identified. Contiguous
windows with a lower or higher than expected coverage indicate the occurrence of a
deletion or a duplication respectively. For example, in the case of diploid organisms, if
the coverage of a segment is reduced by half, it is assumed that there is a heterozygous
deletion, and if it is reduced to zero, a homozygous deletion occurred. Similarly, if a
region is duplicated, or amplified in the case that there are more than 2 copies, the
coverage will in theory increase in proportion to the number of copies.
There are several factors that can cause deviations from the simple rules described
above. Repetitive sequences in the genome and biases in the sequencing, such as GC-
rich regions, can affect the read depth. The latter occurs mainly at the PCR step of
the library preparation, where it has been shown that the PCR efficiency is lower in
GC-rich parts of the genome [Quail et al., 2012]. This particular bias, however, can
be corrected by normalizing the coverage by the GC content before making inferences
about the copy number. One additional disadvantage of identifying SVs only based on
read depth approaches is the inability to map the breakpoints at a nucleotide resolution.
Regions with gains and losses are identified typically with a breakpoint within at least
1kb.
Despite these disadvantages, read depth based methods have been successfully used
to map copy number variants in healthy and disease human genomes. For example,
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Sudmant et al. [2010] identified regions of human-specific expansions, i.e. highly am-
plified gene families, specifically in genes involved in brain development. Additionally,
several copy number analyses have been carried out in cancer genomes [Campbell et al.,
2008; Chiang et al., 2009]. There are several computational tools for the identification
of CNVs based on read depth, for instance, CNVnator [Abyzov et al., 2011], Genome
STRiP [Handsaker et al., 2011] and BIC-seq [Xi et al., 2010].
Paired-end sequencing and mapping. For paired-end mapping a paired-end or
mate-pair sequencing protocol, such as the ones described above, are required. In both
protocols the two ends of each DNA fragment are sequenced. The sequences are then
aligned to a reference genome. In general, most reads will map concordantly with an
expected distance between them equal to the fragment length (insert size). On the
other hand, if the reads align discordantly, with an abnormal distance between them,
with an unexpected orientation, or if they align to different chromosomes, they can
be considered as evidence for the occurrence of an SV [Korbel et al., 2007]. Several
computational tools have been developed for the identification of SVs based on paired-
end mapping, such as DELLY [Rausch et al., 2012b] and Genome STRiP [Handsaker
et al., 2011].
This approach has the advantage of allowing the identification of both balanced and
unbalanced rearrangements. For example, if a discordant pair of reads aligns farther
away than the mean insert size of the library, the occurrence of a deletion in the
sample genome is suggested. Additionally, if the two reads of a pair align to different
chromosomes, a translocation may have happened. Based on the orientation of the
reads, inversions can also be identified through a similar logic (Figure 1.3). Since the
length of a particular sequenced DNA fragment is not exactly known, the definition
of discordantly mapping reads is done by comparing to the empirical distribution of
fragment lengths obtained for a particular library [Korbel et al., 2009]. It is therefore
desirable that the variance of the insert size distribution is small. This can be achieved
by doing a tight size selection of the fragments around the target size during the library
preparation.
On the other hand, discordantly mapping reads can also arise by sequencing errors or
by misalignments due to, for example, repetitive sequences in the genome. To over-
come these issues, clusters of discordant pairs that support the same event are usually
required before calling an SV [Korbel et al., 2009; Rausch et al., 2012b]. Furthermore,
some algorithms do not take into account reads that map to many different positions
in the genome. One disadvantage of paired-end mapping is that the breakpoints of an
SV cannot be determined at nucleotide resolution. Only an approximation is obtained,
which can be a few base pairs to several kilobases away from the exact position.
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Figure 1.3: Methods to detect genomic variants based on next-generation sequencing data. Dif-
ferent approaches are used in combination to identify the sites where mutations occur. Paired-end
mapping uses the information of discordantly mapping reads (red arrows) to infer SVs. Read depth
methods are based on the sequence coverage (number of reads aligning to each region, gray arrows).
Split reads refer to reads where the start maps to a region and the end maps to another region (dark
green arrows). Modified from Weischenfeldt et al. [2013].
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Assembly. Assembling the whole genome of an individual from scratch, i.e. without
the use of a reference genome, is a very complex computational task, and it is even more
challenging using short sequence reads [Nagarajan and Pop, 2013]. This means that
millions of DNA sequences have to be put together into the right order to completely
build a genome. In addition to the high number of fragments, other issues like the
existence of repetitive sequences, errors in sequencing, and missing fragments, can con-
tribute to the complexity. Because of these challenges, assembling whole genomes is at
the moment very time consuming and computationally challenging. On the other hand,
de novo local assembly is useful to better understand the derivative DNA molecules
after the occurrence of complex rearrangements. The major advantage is that by as-
sembling a region affected by structural variants, the exact positions of SVs can be
determined at nucleotide resolution.
1.6 Yeast as a model organism
The baker’s yeast or budding yeast, Saccharomyces cerevisiae, has been one of the most
extensively studied organisms in molecular biology. In addition to its known traditional
and commercial uses, the budding yeast is not only an excellent model organism but it
has been used to establish completely new fields of biology, such as functional genomics
and systems biology [Botstein and Fink, 2011]. In fact, the budding yeast has initiated
and improved the molecular understanding of essential cellular processes such as DNA
repair mechanisms, recombination, cell cycle, protein networks, DNA transcription
[Pelechano et al., 2013] and many others [Barnett, 2003].
As an eukaryotic organism, S. cerevisiae has several advantages that make it suitable for
biological research. Among its important features, yeast is not pathogenic, which makes
it easy to handle in the laboratories [Sherman, 2002], and it is unicellular but still has
similar fundamental cellular processes and cell constitution as higher eukaryotic cells.
In addition, it is inexpensive to grow, can be grown on defined media facilitating the
control of environmental conditions. Furthermore, it has a fast doubling time [Sherman,
2002], saving experimental time when compared to other model systems.
Genetic studies are facilitated due to the fact that yeast can grow stably in diploid and
haploid states. In the haploid state, the effects of genetic modifications can be directly
observed, in contrast to the masking of recessive mutations in the diploid state. On the
other hand, the diploid cells can carry heterozygous mutations in essential genes. Fur-
thermore, S. cerevisiae has a very efficient homologous recombination system, making
the process of gene modification, such as knockouts and gene disruptions, efficient and
simple. For all these reasons, the budding yeast is one of the most useful organisms to
study the relation between genotype and phenotype in eukaryotic cells [Botstein and
Fink, 2011].
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Another advantage of working with yeast is the abundant biological information avail-
able. Its genome, fully sequenced and published since 1996 [Goffeau et al., 1996, 1997],
was the first eukaryotic genome to become available. It is compact, with around 12Mb
packed into 16 chromosomes. In fact, the genes comprise about 70% of the total genome
[Goffeau et al., 1996] and most of them lack introns. Furthermore, S. cerevisiae has
around 6000 well characterized genes, and only one sixth of them are essential [Giaever
et al., 2002].
Perhaps one of the most important reasons why yeast became such a successful model
system is the straightforward assessment of the relationship between gene structure
and protein function [Botstein and Fink, 2011]. Until now the function of around
85% known protein coding genes in S. cerevisiae has been described [Botstein and
Fink, 2011]. This is an advantage considering that around 31% of all potential protein
coding genes in yeast have a mammalian homolog [Botstein et al., 1997; Foury, 1997].
Additionally, approximately 17% of genes belong to orthologous gene families that are
related to diseases in humans [Botstein and Fink, 2011; Heinicke et al., 2007].
Consequently, it is not unexpected that a wealth of information that has become avail-
able on human genes was initially discovered by studying their yeast homologs. For
example, the function of candidate genes that resulted from linkage studies of hu-
man diseases could be better understood by comparing them to yeast genes with high
sequence homology [Botstein et al., 1997]. For example, genes causing nonpolyposis
colon cancer could be identified by resemblance to MSH2 and MLH1 in yeast [Strand
et al., 1993]. Similarly, genes for Werner’s syndrome (SGS1 in yeast) [Sinclair et al.,
1997] and ataxia telangiectasia (TEL1 in yeast) [Greenwell et al., 1995] could be iden-
tified. Today, a vast amount of knowledge, including what has been discovered so
far about each yeast gene, is collected in the Saccharomyces Genome Database (SGD
http://www.yeastgenome.org/) [Cherry et al., 1998]. This includes information about
gene expression and functional analysis data [Ball et al., 2001], gene ontology [Dwight
et al., 2002], the roles of gene products and their interaction with other proteins, and
also organizes published literature about each gene [Christie et al., 2004].
One of the most important contributions to the understanding of the connection be-
tween genes and proteins was the production of yeast deletion mutants for every ORF
of the genome. This became what is known as the Yeast Deletion Collection. By
systematically deleting single genes and later on subjecting these mutants to a diverse
range of experiments, many biological consequences of the lack of a gene’s function
were discovered [Botstein and Fink, 2011].
1.6.1 The Yeast Deletion Collection
As mentioned, one of the main advantages of using budding yeast as an experimental
organism is the wealth of data and strains available. In addition to the publication
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of the complete genomic sequence of S. cerevisiae around 1986, a consortium of Eu-
ropean and North American laboratories [Winzeler, 1999; Giaever and Nislow, 2014]
established the Saccharomyces Genome Deletion Project. The main goal was to create
a collection of yeast knockout (KO) mutant strains to identify, confirm and study the
function of essential genes. Additionally, it became useful for analyzing molecular com-
ponents of the cell involved in basic physiological and developmental pathways, and
their interactions.
The collection is composed of >21,000 knockout strains, with deletions in most of the
known ORFs, defined as a DNA sequence that could potentially encode a protein of
more than 100 amino acids. It comprises homozygous and heterozygous diploid strains
with deletions in around 6000 genes, including some putative ORFs and over a thousand
essential genes, and an additional set of haploid strains of both mating types for over
4700 non-essential genes [Scherens and Goffeau, 2004].
Each knockout strain contains a cassette that carries two unique “molecular barcodes”,
which are 20bp long, to allow working with the pooled collection while still being able
to identify the mutant strains. There is a great number of studies that have used these
collections to research a broad range of biological questions. Novel protocols and big
screens have been developed over the past years and have increased our understanding
of biological functions, response to stress and mechanism of drug action, of phenotypes
occurring under different physiological conditions, and of previously unknown genes
involved in essential metabolic processes [Giaever and Nislow, 2014].
1.6.2 Design of the Yeast Deletion Collection
The yeast deletion strains were constructed using a PCR-based strategy [Baudin et al.,
1993; Wach et al., 1994], in which a deletion cassette replaces each ORF (Figure 1.4).
The cassette contains the KanMX4 marker, which confers G418 resistance, and it is
required to select for the transformant strains. Additionally, it carries two unique 20bp
sequences that function as molecular barcodes or tags that are commonly referred to as
“uptag” and “downtag”. These barcodes are surrounded by universal primer sequences,
common to all the strains in the collection, making it very simple to amplify them from
a pooled culture. Furthermore, the barcodes are different enough so that it is unlikely
that PCR or sequencing errors can lead to an incorrect identification of the strains
[Pierce et al., 2007].
This cassette is integrated into the genome and replaces the target ORFs from start to
stop codon by mitotic recombination. To achieve this, the cassette is surrounded by two
sequences of 45bp directly upstream and downstream of the selected ORF [Wach et al.,
1994; Giaever et al., 2002; Pierce et al., 2007]. A total of over 50,000 oligonucleotides
were needed for the PCR-mediated construction of the deletion cassettes [Giaever et al.,
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KanMX4U1 U2 D1D2UT DT TAA......ATG
Yeast ORF
KanMX4U1 U2 D1D2UT DT TAA......ATG
Figure 1.4: The yeast deletion collection. In the deletion strains of the yeast deletion collection
each ORF has been substituted with a KanMX cassette, which integrates into the genome by
homologous recombination. The cassette confers resistance to geneticin (G418) and carries two
molecular barcodes, UT and DT, specific for each deletion strain. All UTs can be amplified with
universal primers U1 and U2, while all DTs with primers D1 and D2. (UT: uptag, DT: downtag).
Modified from Giaever and Nislow [2014].
2002]. Each deletion was then verified using a set of PCRs to amplify a sequence
spanning the left and right junctions of the deletion cassette and the genomic location.
1.6.3 Main applications of the Yeast Deletion Collections
The yeast KO strains of the yeast deletion collection have been successfully used in
many studies and in over 1000 genome-wide screens. In fact, the deletion project
became a landmark and a model to develop many other genome-wide technologies
(e.g the GFP collection [Ghaemmaghami et al., 2003]) and deletion collections in other
organisms, such as in Arabidopsis thaliana [Alonso et al., 2003] and in Escherichia coli
[Baba et al., 2006]. With no doubt, since the first results and description of the project
were published in 1999 [Winzeler, 1999], the collection became widely used, contributing
to many biological fields and having a deep impact on the yeast and genomics research
communities [Giaever and Nislow, 2014]. Some of the most important research topics
that have been addressed using the yeast KO strains are mentioned below.
Functional characterization of genes. The first studies to be published addressed
the question of the functional impact of gene deletions [Winzeler, 1999; Giaever et al.,
2002]. These studies investigated the phenotypic consequences of grown on stress con-
ditions and revealed that around 18% of the genes were essential. The researchers were
able to identify new genes required for growth in these conditions. They also found that
around 15% of the mutants had growth problems on regular rich media, indicating that
they are more vulnerable than others and present a slower growth rate when compared
to the wild type.
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With these studies it became evident that there is a low correlation between the genes
that are required for survival in one condition and the genes with increased expression
in the same condition. In fact, only less than 7% of the genes exhibited a significant
increase in mRNA levels and were required for optimal growth [Birrell et al., 2002;
Giaever et al., 2002]. This finding was surprising at that time, when there was little
understanding of all the complex events that occur post-transcriptionally and that
regulate protein expression at a translational level.
Furthermore, Giaever et al. [2002] observed the cell shape and size of the knockout
strains upon growth in different conditions. They were able to identify deletion strains
that had morphological defects compared to the ellipsoid shape of the wild type cells. As
expected, these deletion strains, comprising around 15% of the mutants, were defective
in genes related to cell growth, cell division and DNA synthesis.
These initial studies validated the suitability of the deletion collection as a valuable tool
for functional genomics experiments. Many large scale phenotypic screens have been
done so far including the assessment of cell growth and cell size (e.g. [Deutschbauer
et al., 2002; Jorgensen et al., 2002]), mating and membrane trafficking.
Identification of novel drug targets and mechanisms of action of toxic com-
pounds. Several studies have focused on identifying novel protein targets for multiple
drugs. The yeast deletion collection has been used to identify members of pathways
that are altered upon the application of different chemicals and to understand the global
functions of the targets of certain drugs, such as beomycin [Aouida et al., 2004] and
rapamycin [Chan et al., 2000].
Drug induced haploinsufficiency profiling (HIP) is one of the methods developed based
on the yeast KO collections. It takes advantage of the fact that if a heterozygous
deletion strain is sensitive to a specific drug, then the drug may act on the product of
that locus [Smith et al., 2010a]. Therefore, by screening the entire heterozygous deletion
collection, several drug targets have been identified [Giaever et al., 2004]. Additionally,
Lum et al. [2004] assessed the effects of 78 compounds on the heterozygous collection
and were able to verify the targets of previously known compounds and to propose
mechanisms of action of several of those drugs. Several of these compounds are clinically
relevant, confirming the utility of these types of screens [Lum et al., 2004].
Gene and protein interaction networks. Additional technologies based on the
yeast KO strains were also developed to study more complex gene functions. One
important development was the Synthetic Genetic Array (SGA) analysis [Tong et al.,
2001]. With this method, the impact of double mutations could be assessed in a sys-
tematic way. Crossing one mutant with an array of around 4700 other deletion mutant
strains, and evaluating the progeny generated by meiosis allowed the identification of
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the functional relationship between genes. This approach proved very useful for the
generation of interaction networks and for the production of a increasingly better map
of gene function.
Many insights have been obtained from the study of yeast interaction networks, from
the identification of novel interacting components to a better understanding of the
properties of networks and of how genes regulate themselves and other cellular processes
[Boone et al., 2007]. Earlier functional studies in the deletion mutants mentioned above
revealed that only a few genes were essential, implying that this biological system is
robust to change and that there is a buffering machinery preventing drastic variation
[Hartman et al., 2001]. Several studies have addressed this topic by using synthetic
lethality approaches, in which the combination of mutations in two genes causes a
reduced fitness or cell death, which then is an indication of the interaction between
these genes [Davierwala et al., 2005].
Evolutionary studies. The process of adaptive evolution driven by the accumu-
lation of beneficial mutations has also been studied through the use of the deletion
collections. It has been shown that mutant strains with growth defects due to the
lack of a specific gene can regain fitness to a level comparable to the wild type strain
if they are left to grow for several generations. This allows for the accumulation of
compensatory mutations that give rise to genetic divergence and consequently diverse
phenotypes across different environments [Szamecz et al., 2014].
On the other hand, these mutations arising to compensate for defects in a certain
pathway are advantageous in the particular environment in which they were positively
selected. If the growth conditions change, mutations that were beneficial at some point
can become deleterious.
The relative advantage of different alleles of a particular gene can be opposite in different
environmental conditions, an effect known as pleiotropy. By studying the collection of
deletion mutants, Qian et al. [2012] were able to identify genetic mechanisms that are
related to the pleiotropic effects of mutations. They demonstrated that hundreds of
genes expressed by yeast cells under certain growth conditions were actually harmful,
but could become useful in other conditions. These studies can be applied to higher
organisms as well, in areas such as senescence or neurodegenerative disorders, in which
the harmful effect of mutations can be seen only in later stages of life, but that might
be beneficial in earlier development [Carter and Nguyen, 2011; Qian et al., 2012].
Studies of adaptive evolution have contributed to our knowledge of how mutations be-
come fixed in the populations [Kao and Sherlock, 2008; Lang et al., 2013]. Importantly,
the dynamics of how some mutations survive even if they are not fully beneficial, while
others are lost, by for example genetic hitchhiking, closely resembles the underlying
processes that act in tumor cells during cancer progression [Nik-Zainal et al., 2012b].
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Human diseases. Since many of the fundamental processes of the cell are conserved
from S. cerevisiae to higher eukaryotes [Botstein et al., 1997], it is compelling to perform
experiments in budding yeast to understand mechanistic aspects of human cells. In
this regard, studies of DNA repair mechanisms have facilitated the discovery of genes
involved in these processes, and functional analogies between human and yeast genes
can often be made [Foury, 1997]. For example, Ooi et al. [2001] performed a screen
for identifying components of the NHEJ pathway. They were able to find a new gene,
NEJ1, which interacts with LIF1, homologous to the mammalian XRCC4 protein, an
important factor in guarding against cancer [Ooi et al., 2001].
Other important screens include the identification of genes involved in human mito-
chondrial diseases [Steinmetz et al., 2002] and a screen to identify genes and pathways
relevant for the development of Huntington’s and Parkinson’s diseases [Willingham
et al., 2003]. In the latter study, 4850 yeast strains were transformed with constructs
that expressed a mutant huntingtin fragment and α-synuclein, the major components
of the inclusion bodies that are a feature of these two diseases respectively [Willingham
et al., 2003]. It was possible to identify several yeast genes, with human orthologs, that
are relevant for these diseases.
The availability of the yeast deletion collections has been certainly a great advantage
for biological research, and will probably continue to be, especially with the availability
of cheaper and better genome sequencing technologies.
1.6.4 Uncertainties and caveats of the Yeast Deletion Collections
Despite the many advantages of yeast assays and the yeast deletion collections, there are
also a few limitations that need to be considered. While there are many shared processes
between yeast and higher eukaryotes, making the interpretation of results in some cases
easily extrapolated from one organism to another, not all cellular mechanisms can be
taken as equal. It is therefore useful to always verify the findings in other models.
Moreover, big screens are subject to a higher chance of finding false positives. It
is therefore recommended that any results should be validated by other experiments
[Scherens and Goffeau, 2004].
Furthermore, drug assays are restricted by the amount of each compound needed to
cause a response in the cell. Often very high concentrations are needed, due to reasons
such as the low permeability of the cell wall to these substances, which makes the
experiments more expensive and difficult to perform [Smith et al., 2010b].
One further potential source of error in studies using the deletion collections is the
presence of wrong annotations and the existence of a neighboring gene effect (NGE)
[Ben-Shitrit et al., 2012]. It was recently demonstrated that the phenotype in one
deletion mutant can be influenced by the effect of the deletion on a neighboring gene,
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instead of being caused only by removing the particular ORF. The NGE may account
for approximately 10% of all deleted genes, and therefore it can have some consequences
on the interpretation of gene function and genetic interactions [Ben-Shitrit et al., 2012].
Therefore, verifying results by different experiments and techniques is highly recom-
mended.
1.7 Mutation rates in the budding yeast
Mutations are the ultimate source of genetic variation. Even when the replication
and transmission of genetic material is very accurate, all cells acquire spontaneous
mutations during DNA replication or by environmental DNA damage, a process that
is biologically and evolutionary important. Most mutations are deleterious, i.e. they
affect negatively the fitness of the individuals. However, there are some that can confer
an advantage allowing for adaptive evolution [Baer et al., 2007]. The rates at which
mutations occur and the specific location where they arise are therefore important
factors in the evolution of a species and how it is able to adapt to new conditions. In
yeast, it has been estimated that there are around 10−9 single nucleotide substitutions
per base per cell division [Lynch et al., 2008], whereas chromosomal structural variants
occur less often [Nishant et al., 2010].
Several experimental studies have reported that mutation rates vary across the genome.
For example, microsatellite sequences or polynucleotide runs [Hawk et al., 2005; Ver-
strepen et al., 2005], as well as genes related to the immune response [Papavasiliou and
Schatz, 2002] have higher mutation rates than other genomic regions. Apart from this
variation within the genome, mutations rates can vary due to environmental conditions.
On one hand, the environment can be directly mutagenic, or it can also stress the cells
making them more prone to mutations. Examples of direct mutagens are ultraviolet
and ionizing radiation, alkylating agents, and crosslinking agents [Hoeijmakers, 2001].
Agents that can cause elevated mutation rates without damaging the DNA directly are
for example those that inhibit the mismatch repair process. For instance, it has been
reported that yeast growing in high cadmium concentrations show hypermutability due
to the inhibition of mismatch repair [Jin et al., 2003].
Traditionally, mutations rates were estimated using genetic reporter assays. These
experiments can unfortunately be applied only to model organisms, and their results
can be biased because only mutations having a phenotypic effect can be scored and
phenotypically silent mutations are omitted. For example, the canavanine resistance
assay Canr allows detection of different types of mutations when these inactivate the
arginine permease activity of this gene [Forsburg, 2001]. In these experiments, the wild
type cells are sensitive to the toxic arginine analogue, canavanine. Mutations in the
CAN1 gene prevent the cells to import canavanine, making then resistant to the drug.
Additionally, some methods for detecting larger rearrangements have been developed.
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For example, Chen and Kolodner [1999] measured the rates of gross chromosomal rear-
rangements by scoring the simultaneous loss of the CAN1 and URA3 markers at one
end of chromosome V.
The current knowledge of mutation rates is still incomplete due to the difficulty of
studying significant number of events [Zhu et al., 2014]. However, with novel sequencing
techniques and increasing amount of genomic data available, more general inferences of
the mutation rate and its variation across the genome have been made [Ellegren et al.,
2003; Lang and Murray, 2008, 2011].
Since mutation rates are in general very low, the estimation of events per generation is
difficult [Nishant et al., 2010]. One method to increase the number of events to a level
that is high enough to make useful inferences is through a mutation accumulation (MA)
assay. In this type of experiment the population is passed through many generations of
very sharp bottlenecks. By this method, only highly deleterious mutations, e.g. those
that hamper growth and survival, are selected against. Otherwise, there is no selective
pressure applied to the population, allowing for the accumulation of neutral mutations.
MA assays, combined with NGS technologies, have provided an experimental set up
for the study of larger amounts of mutations in a relatively unbiased way.
Several MA experiments have been performed in eukaryotic model organisms, for ex-
ample, in Arabidopsis thaliana [Ossowski et al., 2010], in the nematode Caenorhabditis
elegans [Denver et al., 2012], in Drosophila melanogaster [Haag-Liautard et al., 2007]
and also in Saccharomyces cerevisiae in the haploid [Lynch et al., 2008] and diploid [Nis-
hant et al., 2010] states. Specifically, in yeast these MA studies have revealed that its
genome is relatively stable, with few mutations accumulating over several generations
in wild type strains in both vegetative and meiosis stages [Nishant et al., 2010]. In a
MA experiment, Zhu et al. [2014] identified a total of 867 SNVs, 26 indels, 3 CNVs and
31 aneuploidies after studying 145 strains grown through more than 2000 generations
each.
One exception of the low mutation rates generally observed are the mutator strains,
i.e. strains that have increased spontaneous mutation rates. Usually these mutator
phenotypes arise by acquiring mutations in one of the numerous genes that prevent
errors to occur during replication, repair, recombination or processes that ensure the
correct chromosome segregation.
In the budding yeast there are several mutations, such as in MSH2 [Huang et al., 2003]
a mismatch repair gene, MRE11 [Chen and Kolodner, 1999] a gene involved in recom-
bination and in the replication related gen RAD27 [Chen and Kolodner, 1999] which
have been reported to exhibit mutator phenotypes. Serero et al. [2014] investigated the
genome-wide mutational spectra of MA lines of wild type and nine mutator strains.
These authors found that there are diverse processes that govern the accumulation
of mutations in the different strains. Each mutator strain had complex patterns of
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mutational spectra that included point mutations as well as structural variants and
whole chromosome gains and losses. It is very interesting and important to study the
genome-wide mutational patterns that arise in these deletion mutants because most of
these genes have conserved orthologs in humans and have been associated to genetic
diseases and higher susceptibility to certain cancers.
Apart from the limitations mentioned above, MA and reporter gene experiments have
provided estimates of mutation rates [Lynch et al., 2008] and insights into patterns of
mutations. However, due to the low amounts of mutational events, little is known about
the general mechanisms of mutation formation, of the variation of these mutations in the
genome and of the effects of gene deletions over the general occurrence of mutations.
Furthermore, most studies of mutations in the budding yeast have focused only on
point mutations. Therefore, there is little knowledge of the general rates and patterns
of structural variants and indels in the budding yeast.
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Genome-wide mutational landscapes of
yeast deletion mutants
2.1 Motivation
Even though Saccharomyces cerevisiae is one of the most studied model organisms, a
genome-wide characterization of the types, distribution, and frequency of mutations,
particularly of structural variants, is still not complete. Due to limitations in the
costs and experimental techniques available, genetic variation studies had typically
used single reporter assays, e.g. [Forsburg, 2001], or focused only on a particular part
of the genome, e.g. chrV [Chen and Kolodner, 1999]. Additional studies have identified
genes involved in the maintenance of genomic stability by analyzing specific types of
DNA sequences, such as ectopic retrotransposition of Ty1 elements [Scheifele et al.,
2009].
These assays have helped to identify key players in DNA repair pathways and the
maintenance of genomic stability. The impact of these discoveries has been particularly
influential due to the fact that yeast shares many homologies with human genes, and
several pathways are conserved. In fact, many of the genes implicated in preserving
genomic integrity are also involved in human diseases, including cancer [Yuen et al.,
2007]. However, previous work revealed that mutation rates are not uniform along
the genome, therefore focusing on specific regions does not cover the full spectrum of
mutations and the mechanisms that can lead to their formation.
As a consequence, genome-wide studies are required to better understand the causes
and consequences of genomic instability. In this regard, two very recent studies have
started to describe the large variation existing in the mutational landscapes of yeast
strains. Serero et al. [2014] used mutator strains to characterize the acquisition of muta-
tions in strains with defects in different genome maintenance processes using mutation
accumulation experiments. The study revealed a very diverse and complex mutational
spectrum for each deletion strain, indicating that the mutational processes might be
very dynamic given certain gene defects. The main limitation of this study was that
only 9 different deletion mutants were studied. In addition, Zhu et al. [2014] described
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the mutational spectrum and mutation rates in 145 yeast deletion strains. The authors
were able to identify a relatively large number of SNVs. However, their main goal was
to estimate mutation rates, rather than analyzing the context in which mutations occur
and linking the particular deficiencies of each mutant with their mutation spectrum.
One of the main findings of these studies is that different deletion mutants can have very
diverse mutational spectra [Serero et al., 2014].It is still not fully understood how dif-
ferent types of mutations arise and how often they occur under different environmental
conditions.
Thorough characterization of genomic variation is crucial to understand the relationship
between genotype and phenotype since genetic variants are known to underlie complex
diseases [Feuk et al., 2006]. Given the countless advantages of yeast as an experimental
model, as mentioned in Chapter 1.6, I chose this organism as a model to investigate
the impact of defects in main pathways of DNA repair, replication, and recombination
on genomic instability. Specifically, by using yeast deletion mutants, I was able to
characterize the mutational landscape of 47 haploid deletion mutants under no, or
very mild, selective pressure. The results from this study aim to better understand
the impact of particular defects in specific pathways and the mechanisms involved in
maintaining genome stability.
2.1.1 Contribution
The experiments in this chapter were initially started by Megumi Onishi-Seebacher,
a former postdoc in Jan Korbel’s group, who performed the mutation accumulation
assays up to bottleneck 30. I performed all the remaining bottleneck passages, as well
as the sequencing experiments and validations described in the following sections. Ad-
ditionally, I carried out all data analyses for the mutation identification and annotation
presented in this chapter.
2.2 A mutation accumulation approach for studying neu-
tral mutations in yeast
Structural variants, indels, and SNVs can arise by a diverse set of mechanisms includ-
ing errors in the processes of DNA repair, recombination and replication, or through
the insertion of transposable elements. They can arise in the presence (e.g. non-allelic
homologous recombination NAHR) or absence (non-homologous end joining NHEJ,
fork-stalling and template switching FoSTeS, microhomology-mediated break induce
replication MMBIR) of homologous sequences around the breakpoints [Hastings et al.,
2009a]. In more catastrophic forms of chromosomal rearrangements, e.g. chromothrip-
sis, as observed in different cancers types [Stephens et al., 2011; Rausch et al., 2012a]
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Figure 2.1: Mutation accumulation assay and mutation identification pipeline. A | Mutation
accumulation through recurrent single-cell-to-colony bottlenecks which consisted of multiple rounds
of randomly choosing an individual colony, streaking it out on a YPAD plate to separate it into
individual cells, letting it grow until new colonies were formed, and choosing again another colony.
Yeast deletion strains in this study were passed through a total of 90 bottlenecks in which they
accumulate mainly neutral mutations (red stars). B | Mutation identification pipeline using a set
of computational tools which are based on different algorithms for the discovery of SVs, indels and
SNVs. A more detailed explanation is described in the methods Section A.1.4. (Del: deletions,
Dup: tandem duplications, Inv: inversions, SI: short insertions).
and in the germline [Kloosterman et al., 2011], many different mechanisms might be
involved.
For this study we selected a set of 47 knockout strains from the Yeast Deletion Collec-
tion, each with a deletion of one ORF. These deleted genes belonged to a wide range of
pathways, including DNA damage checkpoints and chromatin remodeling, with many
having human homologs. The complete list of KO genes and their broad functional
categories is shown in Table B.1. We also included the wild type strain (BY4741) and
two knockout controls his1 and trp5 predicted not to have effects on genome stability.
The yeast genome has been shown to be relatively stable, acquiring low number of
mutations over several generations [Nishant et al., 2010]. Therefore, in order to obtain
a larger number of mutations for analyses, we performed a mutation accumulation
assay to increase the number of neutral mutations over time. For this, each of the
deletion strains was propagated through a series of single-cell-to-colony bottlenecks
(Figure 2.1A). This was done for a total of up to 90 bottlenecks, producing mutation
accumulation lines of around 1800 generations (given that 48h of clonal growth is 20
generations per bottleneck).
By using this approach, there is only natural selection against very damaging mutations
that can interfere with growth or survival. Therefore, we were able to study the muta-
tional landscapes of deletion mutants under no selective pressure, i.e. we characterized
the natural variation in these strains.
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Two mutation accumulation (MA) lines were propagated for each deletion strain. For
each strain, one of the two MA lines was sequenced at the beginning of the experiment
(hereafter b0, for bottleneck at time point 0). After 30 bottlenecks, i.e. around 600
generations, 22 strains were sequenced. Similarly, 93 lines were sequenced after 60
bottlenecks, including both MA lines per strain, and 21 strains were sequenced after 90
bottlenecks, for a total of 184 deletion strains. Given the relatively small yeast genome,
the sequencing was done by multiplexing up to 55 different lines per sequencing lane,
as explained in detail in Section A.1.3. All sequenced strains had around 20× coverage,
for an overall total of 3460× coverage.
2.3 Mutational landscape of yeast deletion strains
2.3.1 Mutation identification
Due to the difficulty in detecting mutations in the genome, and in particular SVs, a com-
bination of different methods was used. These included de novo assembly, read depth,
paired-end mapping [Korbel et al., 2007] and split read [Mills et al., 2006] methods
which are commonly used for the detection of genomic variants (details in Section 1.5).
Several computational tools have been developed for this purpose. Most of them focus
on predicting mutations by using only one or a few of these detection methods but they
differ in the sensitivities, specificities, length and types of variants detected.
Since there is great advantage in combining several tools for the discovery of muta-
tions, we made use of several computational approaches (Figure 2.1B) covering the
mentioned detection methods to have a more comprehensive list of variants (Further
details of methods are explained in Section A.1.4). However, to avoid a large number of
false-positives and redundant calls, merging and filtering of the detected variants was
performed as explained in Section A.1.4.
After sequencing the 47 different deletion mutants at several time points, we were
able to identify a total of 9888 variants, including deletions, short insertions, tandem
duplications and SNVs. The total number of de novo mutations (not present in the
strains at b0) are shown in Table 2.1. The most common mutations were SNVs followed
by deletions. Only a small number of tandem duplications were observed.
2.3.2 Higher accumulation of short insertions and deletions
In general, deletions were the most abundant SVs, with size ranging from 1 to 10,299bp.
However, they mainly corresponded to short events, smaller than 5bp. In fact, only
3% of identified deletions had a size larger than 50bp. The insertions detected were
also short, with sizes smaller than 20bp. The size distributions of deletions and short
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Table 2.1: Total number of de novo variants found in 47 different deletion strains after 90 bottle-
necks.
Mutation type Total
Deletions 3786
Short insertions 1348
Inversions 87
Tandem duplications 39
SNVs 4628
Total 9888
insertions are shown in Figure 2.2A. It is noticeable that a big proportion of dele-
tions and short insertions are 3bp long, likely because of the less deleterious effects of
these non-frameshift mutations. There is also an additional small peak around 300bp
that corresponds to the deletion of solo-LTR elements. These retrotransposon-derived
elements constitute around 3% of the yeast genome [Goffeau et al., 1996], and their
deletion is facilitated by surrounding small homologous sequences.
Tandem duplications corresponded to events of 20-2460bp, with a median size of 493bp.
Furthermore, the inversion sizes ranged from 52bp to 11kb. However the existence of
larger variants can not be ruled out, as the detection of larger inversions was limited
by the fact that Pindel can only identify events ranging from approximately 50-10kb.
I randomly selected a set of 35 indels for validation by PCR and Sanger sequencing.
Out of the indels, 33 loci could be amplified and sequenced. In total 28 calls were
positively validated and 5 were classified as false calls accounting for a false discovery
rate of 15%.
Figure 2.2B shows a strong positive correlation between chromosome length and number
of indels (r2=0.71, Spearman P<0.001), suggesting that at a genome-wide scale there
may not be a great variation in mutation rates among chromosomes.
The total number of deletions per MA line is shown in the Supplementary Table B.2
and Supplementary Figure B.1A. Deletion strain msh2 had the largest number of both
deletions and short insertions, which was expected given the important role of this
protein in mismatch repair (MMR) (Figure 2.3). There was a significant higher number
of deletions accumulated in msh2 than the rest of the deletion mutants (one-tailed t-
test, P=0.005), suggesting that the msh2 strain acquired a hypermutation state in
which it gained many more mutations than the rest of the strains. This was also
confirmed by the fact that this deletion mutant also acquired the highest number of
SNVs as described below.
The next 9 deletion strains with the highest number of deletions are shown in Fig-
ure 2.3A. Among these strains there was lower variation in the number of events iden-
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Figure 2.2: Sizes of de novo deletions and short insertions and their distribution per chromosome.
A | Size distribution of the overall set of de novo deletions and short insertions discovered in the
47 yeast deletion mutant strains after a total of 90 bottlenecks. B | Total number of deletions and
short insertions per chromosome.
tified (79±21, median±SD), compared to the difference between them and the msh2
strain.
Additional mutant strains with high numbers of short deletions were isw1, swr1 and
sgo1 (Figure 2.3A). These mutants are defective in chromosome segregation or chro-
matin remodeling pathways. Swr1 and Isw1 both form parts of different chromatin
remodeling complexes [Smolle et al., 2012]. These results were therefore not expected
due to the less clear connection between chromatin remodeling and the formation of
short deletions.
Similarly, since Sgo1 is a spindle checkpoint component involved in meiotic chromosome
cohesion [Indjeian et al., 2005], its link to the formation of short deletions may not
be direct. However, as it is described below, this strain became aneuploid between
b30 and b60 (Figure 2.7), and there may be a connection between aneuploidy and
genomic instability [Pavelka et al., 2010], although the order of events is still not fully
understood.
The total number of short insertions for all MA lines is shown in Supplementary Ta-
ble B.2 and Supplementary Figure B.1B. The msh2 strain was the one with the highest
amount of short insertions (Figure 2.3B). However, the total number of events was
lower than deletions, and there was not a significantly higher number of SI between
msh2 and the other mutant strains (one-tailed t-test, P=0.168). The second strain
with the highest accumulation of SI was rad27. In this case, the difference between the
first and second strains was not as striking as for deletions.
The mutant strains isw1 and sgo1, which ranked high in mutants accumulating dele-
tions, were also among the top ten strains with SI. However, different strains also
showed increased numbers of SI. These include the mutants mms4 and srs2. Mms4
is part of an endonuclease complex that cleaves branched DNA. mms4 mutants have
deficiencies in recombination and DNA repair. Together with Mus81 it is involved in
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mismatch repair and plays a role in homologous recombinational repair [Odagiri et al.,
2003]. Similarly, Srs2 is also highly involved in DNA repair and checkpoint recovery,
and its deletion leads to genome instability.
From these MA experiments one interesting finding is that there are differences in
the types and frequencies of mutations among deletion mutants, in which some strains
acquire only, or predominantly, short deletions while others mostly short insertions. For
example, swr1 mutants have mainly short deletions (one-tailed t-test, P=0.004). This
significant difference (with a significance level P<0.05) was also true for 7 other deletion
strains, rsc1, rad24, ard1, ctf4, dot1, htz1 and rad18. In contrast, the other deletion
mutants included in this study had comparable amounts of both types of indels.
2.3.3 Functional annotation of SVs and indels
I then investigated the overlap of all mutations identified with multiple genetic fea-
tures available for the yeast genome. The positions for a diverse set of genetic fea-
tures were obtained from multiple published datasets and were used to annotate the
variants detected in the yeast deletion mutants. I assessed the overlap with genes (en-
sGene from UCSC) to investigate the impact of the accumulated mutations on the
yeast genome. Additionally, to further understand potential mechanisms that are in-
volved in the formation of SVs and indels, I also performed an analysis to overlap
mutations with recombination and crossover hotspots [Mancera et al., 2008], 3’UTR
and 5’UTR [Nagalakshmi et al., 2008], nucleosome positioning based on H2AZ [Albert
et al., 2007], origin of replication sites, DSB hotspots [Pan et al., 2011], TATA elements
[Rhee and Pugh, 2012], transposable elements from the SGD, transcription start sites
(TSS) [Zhang and Dietrich, 2005] and simple repeats from the SGD.
Around 26% of the mutations overlapped genes (Figure 2.4). The deletion mutants were
classified into broad functional categories and the overlap of each category was assessed
separately. There was no significant difference in the percentage of overlap with genes
among the different functional categories (Kruskal-Wallis rank sum test, P=0.4329).
However, I observed a depletion of variants overlapping genes when compared to a
randomly generated list of mutations distributed along the genome (Wilcoxon rank-
sum test, P<0.0001).
Among the affected genes, no particular GO term was significantly enriched as assessed
by gene function analysis using the PANTHER classification system. In fact, 32.9% of
genes belonged to unknown biological processes. This is in agreement with no selection
being applied to through the accumulation of mutations.
No significant differences between the strains from different categories was found in
the percentages of overlap with the above mentioned genomic features (Kruskal-Wallis
rank sum test, P-values ranging from 0.439-0.569). On the other hand, there was a
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significantly higher number of mutations in our set overlapping 3’UTRs, 5’UTRs, DSB
hotspots, transposable elements and simple repeats, as compared to the random set
of variants (Methods Section A.1.4). There was also a significantly lower number of
mutations overlapping sites of nucleosome positioning (P<0.0001).
Additionally, 22% of the identified mutations were found to overlap simple repeats and
5% transposable elements. Given that there are different types of simple repeats in the
yeast genome, I then investigated which types of these repeats more commonly over-
lapped with mutations. Repetitive sequences such as telomeric repeats, autonomously
replicating sequences or transposon related repeats were the most frequently mutated
elements (Figure 2.4). In this regard, the presence of complete or fragmented Ty ele-
ments, retrotransposons that are very abundant in yeast, seemingly contribute to the
formation of indels and SVs, presumably by mechanisms involving HR.
2.3.4 Single nucleotide variants
By applying the filtering steps depicted in Figure 2.5A, we were able to identify a total
of 4628 SNVs following the WGS of the 47 strains. The studied strains also accumulated
different amounts of SNVs through the generations, with a significant increase in b60
and b90 compared to b30 (one-tailed t-test, P<0.001) (Figure 2.5C). The total number
of SNVs per MA line is shown in the Supplementary Table B.2.
Similar to the SVs and indels, the msh2 deletion mutant accumulated the highest
number of point mutations, confirming its hypermutable state. Other strains had a
high number of SNVs, but not a high number of indels, suggesting that the formation of
different types of mutations may be regulated by diverse mechanisms, and that different
pathways are involved. However, some strains accumulated even lower numbers of SNVs
as compared to the wild type strain, BY4741 (Supplementary Figure B.1), indicating
that not all knockouts are heavily damaging or that there are coping mechanisms that
allow the cells to maintain genome stability in spite of defects in particular pathways.
The types of nucleotide substitutions for the top 10 strains are shown in Figure 2.5D.
The msh2 mutants had a high number of G>A and G>T mutations. Other strains with
high number of SNVs included rad52, a gene essential for homologous recombination,
and two deletion strains involved in stabilizing damaged or stalled replication forks,
namely rtt107 and ctf4.
Mutation rates per base per generation in each deletion strain ranged from as low as
1.35×10−9 in slx1 to 13.19×10−9 in msh2 (median=3.33×10−9) (Figure 2.6A). As a
comparison, the wild type strain showed a mean mutation rate of 4.13×10−9. These
estimates were in agreement with previously reported genome-wide mutation rates per
base per generation [Lynch et al., 2008]. On the other hand, lower mutation rate
estimates have also been published for a wild type strain [Lang and Murray, 2008].
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However, these calculations were done by evaluating mutations in only two loci, and
both loci differed significantly, indicating that there is variation in the mutation rates
along the genome.
Considering the overall set of SNVs in all the strains, we identified G>T transversions
as the most common type of SNV (37.7%) (Figure 2.6B). The second most prevalent
change was G>A (18%). This pattern represents an overview of all the mutant strains
together. We found that this high amount of transversions (G>T) was different to
wild type strains where C>T mutations are the predominant type [Zhu et al., 2014].
However, it is important to keep in mind, that even if this is the general trend, the
pattern was not uniform among all the strains, as mentioned before for the top 10
strains.
Across the genome, somatic variants occurred mainly at G and C base pairs, corre-
sponding to mutations from G>T and C>T. By looking at the surrounding (±10bp)
sequences from each point mutation class, we could identify that 50.8% of these G>C
substitutions were followed by an A and 31% by C (Figure 2.6C). The second most
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common type of substitutions was G>A, in with the neighboring bases were mainly A
and T.
Furthermore, we performed functional annotation of SNVs using ANNOVAR [Wang
et al., 2010]. In total we found that around 64% of the SNVs were exonic, out of which
67% were nonsynonymous substitutions (Figure 2.5B), similar to the expected 75% of
nonsynonymous changes if the mutations were random. We also detected 334 SNVs
causing stop gain mutations, some in important genes involved in the maintenance of
genome stability. For example, a stop gain was observed in MLH2, a protein involved
in mismatch repair, in the ctf9 deletion strain. Additionally, mutations in MEC1
and MEC3, genes which have essential roles in DNA replication, repair and telomere
maintenance, were observed in pms1 and mus81 deletion strains. This accumulation
of mutations in strains with a knockout background makes it difficult to unravel the
specific contributions to the mutational landscape of the original deletion and newly
acquired mutations.
2.4 Aneuploidy and the accumulation of mutations
We also identified several deletion mutants that had entire chromosome gains giving
rise to aneuploid strains (an example is shown in Figure 2.7A). In total we found 15 MA
lines with 1 chromosome gain, 3 strains with 2 chromosome gains, and 2 strains with
3 chromosomes gained. Aneuploidies were detected only in strains in the 60th or 90th
bottlenecks, but not earlier (Table 2.2). Chromosome I was gained more often than
other chromosomes in most of the aneuploidy strains, which is in agreement with the
fact that this is the shortest of all chromosomes in yeast, with 230kb, and it contains
the least number of genes. However, the number of other chromosomes gained did not
correlate with their lengths.
Strains with chromosome gains had higher number of SNVs (one-tailed t-test, P=0.01)
compared to euploid strains (Figure 2.7B). In particular, ctf4 (involved in chromatin
cohesion), rtt107 (important for replication fork repair) and rad27 showed the highest
numbers of SNVs among the aneuploid strains. Although there was no significant
increase in the numbers of deletions for the aneuploid strains in general, rtt107 and sgo1
did show higher number indel events compared to the euploid strains (Figure 2.7C).
2.4.1 Validation of aneuploidies
I performed validations of aneuploidies, specifically for the gains of chromosomes I, II
and VI, by qPCR. A total of 13 chromosome gains were tested. We followed a similar
approach as described by Pavelka et al. [2010], in which for each chromosome tested,
two regions (one in each arm) were chosen to increase the confidence of the aneuploidy
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Figure 2.7: Several yeast deletion strains became aneuploid at the later bottlenecks and carried
higher number of deletions and SNVs. A | Example of whole genome read depth plots for one of the
sgo1 mutation accumulation lines at bottleneck 60 (b60) with a gain of chromosome XIV compared
to the wild type (WT) control at the beginning of the experiment (b0). This chromosome gain was
absent in the b0 sgo1 strain as well. B | Number of SNVs in the aneuploid strains. C | Number of
deletions in the aneuploid strains. (For plots B and C the grey dashed line marks the mean count
in all euploid strains and the red dashed line marks the mean count in the control wild type strain;
“_1” and “_2” refer to the two mutation accumulation lines).
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Table 2.2: Number of MA lines with chromosome gains after 60 and 90 bottlenecks. No aneuploi-
dies were observed after 30 bottlenecks.
Number of chromosomes gained Number of MA lines b60 b90
1 15 13 2
2 3 3 0
3 2 1 1
Total 20 17 3
detection. Initially, the primers from these authors were used in efficiency testing.
However, due to low efficiencies for the primers in chrII and chrVI, new primers were
designed as described in Section A.1.6. All primer sequences used are also shown in
the Supplementary Table B.4. Primer efficiencies for the tested chromosomes were
high, ranging from 93% to 97%, confirming that they were usable for the validations.
Example standard curves for chrI are shown in Figure 2.8A and B, showing a good
agreement between the Ct and the quantities of the standards (r2, Spearman P<0.001).
Similarly, good primer efficiencies were obtained for the other two chromosomes and
the selected internal reference locus SPT15 (Supplementary Figure B.2).
Aneuploidies were supported by a significant correlation between the fold change pre-
dictions obtained with the left and right arms of chrI (r2=0.956, P<0.0001) as shown
in Figure 2.8C. Similarly, there was as good correlation between both arms of chrII
(r2=0.926, P<0.0001), and of chrVI (r2=0.937, P<0.0001).
Additionally, significant correlation between the chromosome copy number predictions
based on the qPCR results and the read depth based approach (for chrI r2=0.953,
Spearman P<0.0001, Figure 2.8D) also confirmed the chromosome gains. Based on
these values, we were able to confirm aneuploidies for a total of 13 chromosome gains,
specifically for 6 samples with gain of chrI, 3 samples with gain of chrII and 4 samples
with a gain of chrVI.
2.5 Discussion
Based on next-generation sequencing technologies, I generated a catalog of genomic
variants, including deletions, short insertions, duplications and SNVs for 47 yeast dele-
tion strains. This allowed us to make inferences of the possible impact of deficiencies in
genome maintenance pathways and of broad mechanisms involved in the formation of
mutations in the yeast genome. I also estimated mutations rates and described the most
common nucleotide substitution classes arising under a neutral accumulation assay.
I showed that in spite of the long term accumulation of mutations, the total amount
of rearrangements per strain was in general low. This result was not completely unex-
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Figure 2.8: Validation of aneuploidies in chrI by qPCR. A, B | Standard curves for primer efficiency
estimation for regions in the left and right arms of chrI respectively. C | Correlation between the
fold change of the left and the right arms of chrI estimated by qPCR. There is good agreement in
the predicted fold change between both arms. D | Correlation between the predicted fold changes
based on qPCR and copy number changes detected by read depth ratios between each sample and
the wild type control at b0.
pected given the reported stability of the yeast genome. In fact, Nishant et al. [2010]
have shown that during both vegetative and meiotic growth, yeast strains remain with
very few mutations after over 1700 generations. They used wild type strains to study
the accumulation of mutations during these asexual and sexual growth phases. There-
fore, their mutation rate estimates reflect the stability of this particular strain.
Similarly, Lynch et al. [2008] observed a total of 33 single base pair substitutions, 1bp
deletion and one 3bp inversion after performing similar MA experiments in wild type
strains. Regarding larger scale variants (>10kb) they reported only 11 inversions and
4 deletions. Taken together, their results also support the idea of a very stable yeast
genome, robust to changes, at least in the wild type strain.
In this regard, our MA approach, using deletion mutants from the Yeast Deletion
Collection, proved to be a good experimental method of accumulating neutral mutations
in numbers high enough to be able to observe more general patterns of mutations. We
identified higher numbers of short deletions and insertions, which in general overlapped
with repetitive elements. Additionally, differences in the mutational landscapes of the
deletion strains were observed and although not all can be fully understood, some
patterns may reflect more directly the deficiencies in the particular pathway associated
with the deleted gene.
For example, we identified msh2 as being the deletion strain with the highest number
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of deletions, short insertions and SNVs. In addition to its role in MMR, which can
explain the large number of SNVs accumulated, Msh2 can inhibit DNA recombination
between sequences that are not 100% identical [Selva et al., 1997]. Therefore, the lack
of this protein can lead to increased numbers of deletions due to higher recombination
between direct repeats, even if they are slightly dissimilar.
The deletion of MSH2 has been shown to make the cells become hypermutable, creat-
ing mutator strains [Huang et al., 2003]. These strains have significantly higher rates
of mutation due to the deficiencies in important genome maintenance processes. Our
results are also supported by observations of human samples with mutations in the
homolog gene, MSH2. Interestingly, germline mutations of MSH2 account for a signif-
icant predisposition to cancer [Dowty et al., 2013]. They constitute one of the main
causes of Lynch syndrome [Rahner et al., 2007; Bonadona et al., 2011], an autosomal-
dominant cancer predisposition syndrome. Mutations in human MSH2 can also lead
to a hypermutation state in which the cells have an increased rates of mutations, for
example in prostate cancer [Pritchard et al., 2014]. In this state, the tumor cells also
showed signs of microsatellite instability.
The reasons for the high number of short insertions in the rad27 deletion mutant
together with the deletions in this mutant may be also explained by the roles that
Rad27 plays in the cells. This protein is involved in maintaining genome stability
by processing Okasaki fragments, base excision repair and preventing the expansion of
repeats [Reagan et al., 1995]. Consequently, strains deficient in this protein are expected
to accumulate a high number of point mutations and microsatellite instability.
However, Rad27 can also participate in restricting recombination between homologous
sequences. Interestingly, Negritto et al. [2001] have shown that the shorter the dis-
tance between homologous repeats, the more likely it is to be lost in rad27 mutants.
Therefore, deletions in this strain may be explained by deficiencies in homologous re-
combination. On the other hand, rad27 mutants can exhibit higher amounts of short
insertions and duplications flanked also by direct repeats due to its role in repairing
DSBs during replication [Tishkoff et al., 1997]. RAD27 is the homolog of the human
FEN-1 gene, and has an exonuclease role in removing “flaps” of DNA (short sections
of ssDNA) during replication. Mutations in this gene have been associated with cancer
[Zheng et al., 2007]. And finally, Rad27 can inhibit Ty1 mobility [Sundararajan et al.,
2003], likely preventing the accumulation of deletions, which as shown in this study,
overlap frequently with transposable elements.
Isw1 and Swr1 play roles in chromatin remodeling [Mizuguchi et al., 2004; Smolle
et al., 2012]. Swr1 is known to be recruited to DNA double strand breaks and has been
recently implicated in facilitating NHEJ at sites of DSBs by contributing to the mobility
of the DNA DSBs to the periphery of the nucleus, where it gets stabilized [Horigome
et al., 2014]. Being among the strains with high mutation numbers implicates that
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deficiencies in chromatin remodeling pathways are important sources of mutations.
Furthermore, the role of Sgo1 in preventing the formation of short deletions is not
completely clear, since its main role is related to accurate segregation of chromosomes
through its sensing of mitotic chromosome tension [Indjeian et al., 2005]. However, its
high number of mutations may be related to the fact that this strain became aneuploid
in the later generations, as discussed below.
Since the yeast genome is very dense, with only less than 30% being intergenic [Goffeau
et al., 1996], it is not surprising that we observed 65% of exonic mutations. Similar to
our findings, Lynch et al. [2008] also reported around 27% of mutations being intergenic.
The amount of nonsynonymous SNVs observed, close to 75%, which is the expected if
mutations were randomly distributed, is in agreement with the neutral accumulation of
mutations. This is especially true given that our mutation accumulation assay did not
involve any selection process and therefore the mutations acquired are mostly neutral,
even if they occur in exons. In fact, Giaever et al. [2002] observed that only 15% of
knockout strains had slower growth rates under normal environments, pointing out that
some genes may have more important roles only under stressful conditions.
Our results indicate that repetitive regions are more prone to have mutations, in agree-
ment with other studies Nishant et al. [2010]. These results suggest that replication
slippage and homologous recombination play an important role in the formation of
indels. Nishant et al. [2010] similarly found that the majority of variants occurred at
subtelomeric regions. In addition to the high content of repetitive sequences in these
regions, the lower gene content indicates that mutations there may have less phenotypic
impact [Nishant et al., 2010; Wellinger and Zakian, 2012]. Another possibility is that
the number of false positive variant predictions may be higher in repetitive regions due
to mapping artifacts.
The observed pattern of nucleotide substitutions (Figure 2.6B) is very similar to the
one described for small-cell lung cancer, with G>T mutations being the most prevalent
substitutions [Pleasance et al., 2010b; Lee et al., 2010; Pfeifer and Hainaut, 2003].
These mutations are usually the result of the conversion of guanine to 8-oxo-guanine, a
lesion commonly induced by oxidative agents found in tobacco [Paz-Elizur et al., 2003;
Feng et al., 2006]. Although there is obviously no direct connection between this type
of mutagenesis and the yeast deletion mutants, there are indeed some tobacco agents
that inhibit DNA repair [Feng et al., 2006] and there are some yeast deletion strains
in our set that are deficient in this pathway as well. The G>A mutations, constituting
the second most common substitutions, are probably the result of the spontaneous
deamination of cytosine [Duncan and Miller, 1980; Maki, 2002].
The results for SNV sequence context are in agreement with other studies in yeast
strains. Zhu et al. [2014] also found higher mutations rates at C and G positions.
In fact, the mutation rates at these positions were also dependent on the neighboring
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sequence. The highest mutation rates was seen for cGg and cGa environments (where
the big letters indicate the site of mutation and the small letters the preceding and
following one respectively), comparable to our observation of G mutations frequently
followed by an A.
Furthermore, I observed that some strains became aneuploid at later generations and
that these strains carried higher numbers of mutations compared to the euploid strains.
For example, the deletion of RTT107 caused whole chromosome gains together with
a high accumulation of indels and SNVs. This protein contains BRCT (BRCA1 C-
terminal) domains that function in the recruiting of signaling and repair factors upon
DNA damage [Mohammad and Yaffe, 2009]. Additionally, Rtt107 can interact with
the SMC5/5 complex which is involved in the maintenance of sister chromatid cohesion
and by this prevents errors during DNA repair. In fact, Rtt107 is recruited to the sites
of DSBs and is important for the repair through the sister chromatid recombination
pathway [Ullal et al., 2011; Leung et al., 2011]. Therefore, defects caused by the deletion
of this protein can certainly lead to both whole chromosome gains and high indel
formation rates.
Moreover, the sgo1 deletion mutant also became aneuploid at later generations and
showed a high accumulation of short deletions, consistent with its role in correct chro-
mosome segregation and in keeping with previous reports that aneuploidy can drive
genomic instability in yeast [Sheltzer et al., 2011]. Interestingly, a similar phenomenon
has been described for human cancers. The inactivation of STAG2 gene, involved in
the correct separation of sister chromatids, results in chromosomal instability [Solomon
et al., 2011] and may be related to tumorigenesis.
The direction of the relationship between aneuploidy and the accumulation of mutations
in our study is not clear yet, whether the aneuploidy was an event preceding the
accumulation of mutations or if it was the other way around. However, our results
are in agreement with earlier reports showing that aneuploidy may be responsible for
genomic instability, even though the gain or loss of a chromosome is usually detrimental
to the cells [Sheltzer et al., 2011; Zhu et al., 2012]. Nevertheless, the heterogeneity
provided by the increased instability may be beneficial in more selective environments.
As mentioned before, under neutral mutation accumulation, the total number of events
scored was higher as compared to other studies. However, our study is still limited by
the total number of mutations detected. A larger collection of mutations is required to
identify patterns like kataegis, where by studying over 100,000 events, it was possible
to identify the clustering of substitutions occurring in breast and other cancer types
[Nik-Zainal et al., 2012a; Alexandrov et al., 2013; Chen et al., 2014].
Another limitation of this project is the fact that we chose to study 47 deletion mutants
with known defects in the maintenance of genome stability. Therefore, all our results
relate to mechanisms involving those pathways, such as DNA repair by homologous
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recombination or mismatch repair. The constraint of studying a small set of strains
was in part overcome by setting up a genome-wide approach, which will be described
in the following chapter.
The results of this section indicate that neutral mutational processes are complex and
involve a combination of added effects instead of being the result of one single gene
knockout. The mutational landscapes could, in some of the cases, be attributed to
the particular deficiency caused by the knockout of a gene, such as the case of msh2
mutants. In others, the patterns of mutations may be the contribution of a deficiency
in a specific pathway plus acquiring some other slightly damaging (although not dele-
terious) mutations. These processes resemble those occurring in higher eukaryotes and
can be used to understand, for example, aspects of disease progression, evolution of
tumors or sites with higher risks of mutations.
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Chapter 3
Genome-wide screen for genes that
suppress deletion formation
3.1 Motivation
Despite the extensive work carried out in budding yeast assessing mutation rates and
the processes involved in the maintenance of genome stability, most studies have focused
on SNVs and short deletion and insertions [Lynch et al., 2008; Zhu et al., 2014], but
not larger variants. Indeed, our study on the mutation accumulation lines presented in
Chapter 2 indicated that these types of short mutations are the most abundant in the
genome, under neutral growth conditions.
Moreover, several studies have reported that the disruption of pathways involved in
DNA repair, recombination and replication can lead to an increase in the rates of SV
formation (commonly referred to as gross chromosomal rearrangements, GCR) [Myung
et al., 2001b,a; Smith et al., 2004; Motegi and Myung, 2007; Kanellis et al., 2007].
However, due to the low rates of occurrence of these types of mutations, some studies
focus on strains with defects in known pathways of genome maintenance [Myung et al.,
2001b]. Others enhance the levels of SV formation by the introduction of a PIF1
deletion, known to significantly increase the levels of GCR, in addition to the specific
KO [Myung et al., 2001a; Smith et al., 2004].
From our previous results in yeast deletion mutants under a neutral accumulation
assay, we found that mutation frequencies and types of mutations acquired could vary
depending on the specific gene defect each strain carries. These results indicate that
distinct disrupted pathways can lead to the formation of different mutation types,
probably through a combination of mechanisms. These findings motivated us to find
an independent but complementary approach to study a wider range of deletion mutants
with the aim of identifying strains that have not been previously linked to increased
levels of mutation formation.
We were interested in investigating larger structural variants. SVs may have been
missed in previous studies either because the experimental methods did not detect
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them, or because these larger variants occur in very low rates impeding their detection.
Therefore, we designed an assay in order to identify KO mutants that are more prone
to form deletions. To avoid an a priori selection of genes to be studied, the methods
and results I describe here are based on screening a pooled collection of around 5000
homozygous deletion strains, in a series of bulk experiments, where all the deletion
mutants could be tested simultaneously.
The advantages of this method, which has no biases of strain selection and which can
be performed in a pool of deletion mutants, proved useful for the identification of genes
not previously known to be involved in genome maintenance.
3.1.1 Contribution
The experimental set up presented in this chapter was designed in collaboration with
Megumi Onishi-Seebacher, a former postdoc in the group of Jan Korbel. I performed
all wet lab experiments, data analyses and validations described here.
3.2 An experimental approach for identifying and enrich-
ing for strains that acquire deletions
Using the deletion strains from the Yeast Deletion Collection, we designed an approach
to identify genes that suppress the formation of deletions. By optimizing a bulk trans-
formation assay, I inserted specifically designed constructs into most of the deletion
strains and performed experiments using the pooled collection of mutants in a high-
throughput way. I also tested the effects of several chemical agents causing direct DNA
damage or replication stress on the formation of deletions.
3.2.1 Design of a construct to detect deletions
With the main goal of identifying strains with increased genome instability, we designed
a construct in a way that allows the selection of mutant strains that acquire deletions.
The construct is used to identify strains with defects in particular pathways that are
more prone to form deletions (Figure 3.1A).
The construct carries a URA3 gene to select for positive transformation by growth
on media lacking uracil and the hygromycin phosphotransferase gene (HPH ) to confer
hygromycin resistance. More specifically, the HPH gene is interrupted by a modified
actin intron which contains the URA3 gene inside, making it longer than the original
one. Important sequences required for the splicing of the intron were kept in place,
preserving the distance between the 5’ splice site and the branchpoint [Thompson-
Jager and Domdey, 1987].
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HXT13
chromosome V
Ura -; 5FOA+; Hyg+
URA3 HPHe2HPHe1
HPHe2HPHe1
Ura+; 5FOA-; Hyg -
Ura -; 5FOA+; Hyg -
URA3HPHe1 HPHe2
A
B
URA3HPHe1 HPHe2
URA3HPHe1 HPHe2
HPHe1 HPHe2
DelRep construct
DelNoRep construct
Hyg+ construct
(1)
(2)
(3)
Integration of construct into HXT13 gene
Deletion of URA3, enabling expression of HPH
Figure 3.1: Constructs designed to detect deletions. A | The constructs contain the HPH gene that
confers resistance to hygromycin. This gene is divided into exon1 (HPHe1) and exon2 (HPHe1) by
a modified actin intron that contains the URA3 gene with its own promoter. For integration into
the yeast genome, the left and right sides of the constructs have 40bp homologous sequences up
and downstream of the HXT13 gene in chrV. Positive transformation of the constructs is selected
in Ura- medium. Upon deletions occurring in the constructs (dashed lines) the strains become
hygromycin and 5FOA (5-fluoroorotic acid) resistant. B | (1) The DelRep version of the construct
has the URA3 gene surrounded by direct repeats (grey arrows), 30bp long, belonging to a human
Alu sequence and by actin intron splice sites (orange boxes). (2) The DelNoRep version of the
construct lacks the direct repeats. (3) A Hyg+ control construct lacks the URA3 gene and has
constitutive hygromycin resistance. (Green arrow: ADH promoter, Yellow arrow: URA3 promoter).
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The rationale behind this design is that most introns in the budding yeast genome are
approximately 100bp long. There are some as short as 60bp and some as long as 600bp,
the longest ones mainly found in ribosomal genes [Spingola et al., 1999; Kupfer et al.,
2004]. Longer versions of the actin intron are either spliced in a more inefficient manner,
or are not spliced at all [Klinz and Gallwitz, 1985]. The actin intron, which is 308bp
long [Ng and Abelson, 1980], has been shown to be spliced when inserted into other
genes in the yeast genome [Yu and Gabriel, 1999; Weigand and Suess, 2007], making
it a useful tool as an artificial intron. Hygromycin resistance is only obtained upon
deletions that remove or shorten the length of this intron to a size that can be spliced.
Therefore, by screening for hygromycin resistance, we were able to detect strains with
deletions in the construct.
Since the rate of occurrence of large chromosomal rearrangements is expected to be
low, two versions of the construct were designed (Figure 3.1B). The two constructs
differ only in that one contains two direct repeats flanking the URA3 gene, in order
to increase the rate at which these mutations occur. These repeats correspond to
30bp from the human Alu element consensus sequence [Voineagu et al., 2008] to avoid
potential homologous recombination between these sequences and other regions of the
yeast genome. In the following sections I refer to these two constructs as “DelRep”
(construct with direct repeats) and “DelNoRep” (construct without direct repeats).
Additionally, the two versions of the construct are surrounded by two 40bp homolo-
gous sequences for insertion by homologous recombination into the nonessential gene
HTX13, located in the left arm of chromosome V. This locus has been used to test for
chromosomal rearrangements in other studies [Chen and Kolodner, 1999; Myung et al.,
2001b], where it was shown that the disruption of this locus has no or little impact
on the fitness of the cells. Some deletion strains may have deficiencies in homologous
recombination pathways. Therefore, they may be excluded from the final set of strains
that can be transformed with the construct, since its insertion is dependent on the HR
mechanism.
As a control, another construct with the same structure as the deletion constructs was
generated in which the hygromycin resistant gene was not interrupted by the long intron
(Figure 3.1B). Hygromycin will be expressed after insertion in the yeast strains, without
the need of rearrangements occurring in the cassette. Therefore, this control construct
(hereafter called “Hyg+” construct) confers constitutive hygromycin resistance to the
cells.
3.2.2 General experimental workflow
To be able to assess a wide range of deletion strains simultaneously and in an unbiased
fashion, we optimized a bulk transformation experiment in which we used a pool of the
yeast deletion mutants from the Yeast Deletion Collection to introduce the constructs
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described in the previous section. A general workflow of the concepts of the full experi-
ment is shown in Figure 3.2. As mentioned in Section 1.6.2, each strain in this collection
has molecular barcodes (uptag and downtag) that can be used to identify them (Fig-
ure 1.4). Therefore, the composition of this initial pool was assessed by amplifying the
barcodes of the deletion strains in a single PCR reaction and using next-generation
sequencing methods to sequence the pool of amplicons in order to detect the barcodes
(Figure 3.2A). All procedures are described in more detail in Section A.2.
Several independent bulk transformation experiments using aliquots of this original
pool were used to introduce the three different types of constructs (DelRep, DelNoRep
and Hyg+) (Figure 3.2B). I obtained a total of 20,000 transformants per construct.
Considering that there are around 5000 strains in the collection, this number of trans-
formants allowed us to cover each strain almost 4 times to have a higher probability of
being represented in the pools of transformed strains.
After performing these transformations I confirmed the insertion of the constructs by
PCRs (Figure 3.3A). I successfully amplified the uptags and downtags in 10 independent
PCRs for each transformed pool (an example is shown in Figure 3.3B) and the products
were mixed together. These PCR amplicons were then used for the sequencing of the
tags. Three replicates were performed for each construct. Based on this, I confirmed
the presence of, on average, 4852 deletion strains in the original pool, meaning that
the majority of the 5083 deletion strains from the Yeast Deletion Collection could be
detected by the PCR amplification of the tags. In the transformed pools, a mean of
76% of all strains from the original pool could be identified (Figure 3.3C). The total
number of strains identified in each transformed pool is shown in the Supplementary
Table B.7.
The strains recovered after the transformation of the different constructs were similar
in the different pools. We observed an overlap of 90% between the pools transformed
with DelRep and DelNoRep, and approximately 85% overlap between these two pools
and the Hyg+ transformed one (Figure 3.3D). Given that these sets had a large repre-
sentation of the deletion collection strains and that the overlap between them was also
very high, this gave us a set of transformed strains with which we performed all the
following experiments.
Additionally, we tested whether the amplification of both the uptags and downtags was
similar and that we could recover equal numbers and types of strains with both tags.
Indeed, we saw a high correlation between the number of reads per strain recovered
with the up and downtags for all the transformed pools (for example, for the original
pool r2=0.78, Spearman P<0.001, Supplementary Figure B.3).
With the transformed pools, we then performed several experiments to identify the
strains with increased formation of deletions. To increase the rates of mutations, the
pools were treated with different stressors after which the selection for those strains
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Bulk transformation of construct
and selection in Ura-
Stress with drug and selection
for rearrangements in Hyg
Assess the composition of pool 
after treatment
Pooled barcoded Yeast 
Deletion Collection
Assess the strain composition of 
the original pool by sequencing 
A
B
C
D
URA3HPHe1 HPHe2
Figure 3.2: Experimental workflow to identify genes that suppress the formation of deletions.
A | The experiment starts with a pool of all the homozygous deletion strains from the Yeast
Deletion Collection. The strain composition of this original pool is assessed at the beginning of the
experiment by amplifying and sequencing the barcodes. B | Using the pooled deletion strains, the
designed constructs are introduced in a bulk transformation step. C | The transformed pools of
deletion strains are then subjected to different drugs to induce the formation of rearrangements, and
the strains that acquire mutations in the construct are selected. D | Finally, the composition of the
pools after selection (containing the strains that acquired deletions) are assessed by the sequencing
of the barcodes.
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Figure 3.3: PCR validation of construct insertion and amplification of the tags. A | Verification
of the insertion of the construct into the HXT13 gene in chrV. Eight single different colonies are
shown (M: 100bp marker). B | Amplification of the uptags and downtags to assess the composition
of the pools of deletion strains was done using universal primers internal to the KanMX cassette and
at the ends of the tags. Both tags were amplified in a single PCR reaction. PCRs for ten different
pools are shown (M: 100bp marker). C | Number of strains detected after sequencing of the original
pool of deletion strains and after transformation with DelRep, DelNoRep and Hyg+ constructs.
D | Shared strains between the pools transformed with the DelRep, DelNoRep and Hyg+ constructs
before treatment (only strains present in all replicates of each construct transformation are shown).
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that acquire deletions was done on a hygromycin-containing medium (Figure 3.2C).
The composition of these final sets of strains was then assessed similarly as before, by
sequencing the barcodes and comparing them to the control (Figure 3.2D).
The stressors chosen are all known to cause either directly or indirectly DNA damage:
hydroxyurea (HU), methyl methanesulfonate (MMS), doxorubicin (Doxo) and camp-
tothecin (Campt). HU can cause replication fork arrest [Bianchi et al., 1986], which
has been linked to an increased amount of DSBs [Arnaudeau et al., 2001; Petermann
et al., 2010; Arlt et al., 2011] leading to chromosome rearrangements. MMS is a DNA
alkylating agent that can lead to DNA DSBs [Chang et al., 2002] and has been shown
to be a carcinogen [Beranek, 1990]. Doxorubicin and camptothecin are both inhibitors
of DNA topoisomerases (I and II respectively) [Liu et al., 2006; Patel et al., 1997].
Doxorubicin can also intercalate in the DNA resulting in the formation of DNA DSBs
[Patel et al., 1997].
3.2.3 Experiment design
To identify strains with increased levels of deletion formation, we grew independent
aliquots of the transformed pools with different drug treatments or without applying
any stress (YPAD control). For consistency, each transformed pool, namely the strains
containing the deletion construct with repeats, without repeats and the control with
the construct conferring constitutive Hyg resistance were all treated similarly, with the
same drug concentrations (Supplementary Table B.6), for the same time period and
plated on the same conditions.
A schematic of the experiments performed is shown in Figure 3.4. We compared the
strains that were enriched in the treated transformed samples to the respective treated
pools transformed with the Hyg+ control. To control for differences in the growth rates
of the strains under the influence of stressors we chose to use the Hyg+ control as a
baseline. In other words, all the strains carrying the Hyg+ construct have the possibility
to be discovered in the final set of strains after treatment and selection because they do
not need to acquire deletions to become hygromycin resistant. Therefore, the absence
of some strains in the final Hyg+ pool is due to either strains being too sensitive to the
drug, strains having too slow growth rates or due to random chance. Consequently, we
were able to use this pool to normalize the strains in the other pools transformed with
the DelRep or DelNoRep constructs. For all treatments and pools, I included three
replicates, and the entire experiment was performed in duplicate. The pools grown
in YPAD were used to account for the genotype effect, i.e. the specific gene KO in
these strains had an influence in the susceptibility to acquire deletions in the construct
independent of being stressed by a drug.
Before identifying the enriched strains, we assessed the correlation between different
replicates by comparing the number of reads that supported the presence of a particular
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Figure 3.4: Experimental design. A | A pool from the yeast deletion collection was used as a
starting set of strains. B | From the original pool three pools were derived. One transformed with
the deletion construct with repeats, one with the construct without repeats, and one transformed
with a construct that confers constitutive hygromycin resistance (Hyg+). C | Aliquots of the
transformed pools were used for all experiments. In each experiment the samples were treated with
specific drugs or grown on rich media (YPAD control) without any stress. D | After the treatment
or growth on YPAD, strains that acquired deletions were identified by selecting for hygromycin
resistance. E | For the strains enriched only after drug treatment, environmental effects (drugs)
were considered to have a stronger effect than the KO of a gene. The genotype (the specific
gene KO) has a stronger effect in the strains that were already enriched after growth without drug
stressor. Strains that were shared between these groups are influenced by their genotype as well as
by the environment (treatment), i.e. a synergistic effect.
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Figure 3.5: Correlation between MMS replicates for the pools transformed with DelRep and Del-
NoRep constructs. A | Correlation between the three replicates for the transformed pool with the
DelRep construct and stressed with MMS. B | Correlation between the three replicates for the
transformed pool with the DelNoRep construct and stressed with MMS. (r : Pearson correlation
coefficient).
strain. We confirmed that all replicates within a treatment were highly correlated
(Pearson correlation coefficients ranging from 0.737 to 0.999) and that we were able
to identify similar sets of strains in each replicated experiment. Figure 3.5 shows as
example the correlation between the replicates for the transformed pools stressed with
MMS. Other correlations for the pools transformed with the DelRep and DelNoRep
constructs are shown in the Supplementary Figures B.4 and B.5 respectively.
3.3 Deletions can occur in the absence of stressors
We first assessed the strains that were enriched in the pool without stressors compared
to the control pool carrying the Hyg+ construct. Only strains enriched 2-fold when
compared to the Hyg+ control and with more than 10 supporting reads, were con-
sidered. The strains enriched after growth on YPAD, represent the KO mutants that
were able to acquire deletions in the construct in the absence of a drug treatment. We
identified total of 250 strains that belonged to this group (Figure 3.6), indicating that
some KO strains had increased rates of deletion formation even in the absence of an
external stress.
When looking at the functions of the strains in this category, we could identify that
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Figure 3.6: Strains enriched at least 2 fold in the pools transformed with the DelRep and Del-
NoRep constructs after growth without any stressor. A | Strains significantly enriched in the pool
transformed with the DelRep construct, i.e. strains that acquired deletions between direct repeats.
B | Strains significantly enriched in the pool transformed with the DelNoRep construct, i.e. strains
that acquired deletions without the presence of direct repeats. C | Ten enriched strains were shared
between the DelRep and DelNoRep pools.
they belonged to a very wide range of biological processes, mainly strains with defects
in metabolic processes, synthesis and processing of cellular products. However, no
significant enrichment for a particular functional category was found.
3.4 Deletion formation between direct repeats is more
common than in the absence of repeats
The number of strains that acquired deletions in the absence of stressors was higher
in the pools transformed with the DelRep construct than in the DelNoRep construct,
implying that the formation of deletions between direct homologous repeats is more
common than in the absence of these repeats (Figure 3.6). This result was not com-
pletely surprising given the known important role of homologous recombination in the
formation of SVs. Only 10 strains were shared between the DelRep and the DelNoRep
pools, indicating that there are different mechanisms behind the formation of deletions
in the presence and absence of direct repeats.
In addition to the strains that acquired deletions in the absence of stressors, we were able
to identify a set of KO mutants that acquired deletions after the treatment with different
drugs. Similar to the pools without treatment, a higher number of enriched strains was
identified in the DelRep pool as compared to the DelNoRep pool (Figure 3.8A).
There was a high overlap between the enriched strains after each drug stressor and
the strains enriched under no treatment. In fact, on average 65.5% (SD ±11.5) of the
strains that acquired deletions in the DelNoRep construct were shared with the pool of
strains that acquired deletions without the influence of stressors. Similarly, on average
82% (SD ±5.1) of the strains that gained deletions between the direct repeats under
drug treatment were also detected in the pools grown without any stress.
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Interestingly, for strains that were detected after treatment as well as without treat-
ment, a significantly higher fold change enrichment was observed compare to those
strains that were only enriched after a specific drug treatment (Figure 3.7A), indi-
cating potential synergistic effects of the environment and the gene KO. This trend
was only seen for strains acquiring deletions between direct repeats. This suggests that
overall there are some KO strains that are more prone to gain deletions between homol-
ogous repeats, and this can occur in the absence of stressors because of the particular
deficiencies caused by the gene KO. At the same time, this effect can be amplified by
the stress caused by chemical agents. Therefore, those strains are even more likely to
form deletions in the presence of a drug stress than the strains where the genotype has
a smaller effect.
Furthermore, for the highly enriched KO strains (taking the top 25 percentile) in both
treated and untreated conditions, their fold increase under the drug stress was always
higher compared to the increase in no stress conditions (using the respective Hyg+
controls as normalizers in both cases) (Figure 3.7B). Taken together, these results are
additional support for the presence of synergistic effects suggesting that those strains
that gain deletions in the absence of any stressor are also the ones that are more prone
to form deletions when subjected to growth in stressful conditions.
I assessed the functions of the KO strains where both genotype and environmental
effects play a role in the formation of deletions (See Supplementary Table B.10 for the
complete set of strains). Remarkably, five KO genes, RDH54, MMS2, IRC20, IOC4,
were directly related to DNA repair and recombination pathways such as synthesis-
dependent strand annealing and mismatch repair. They were not uniquely detected
upon a specific drug treatment, but rather enriched after stress with several drugs.
Interestingly, Ioc4 associates with Isw1 to form the chromatin remodeling complex
Isw1p [Vary et al., 2003; Pinskaya et al., 2009; Smolle et al., 2012], one of the two
versions of the ISWI complexes. Interestingly, the isw1 mutant was the strain with
the second highest number of deletions in the mutation accumulation assay described
in Chapter 2 (Figure 2.3). Additionally, two meiosis related genes were also identified
among the highest enriched strains, namely MUM2 and GMC2.
3.5 Several strains are enriched only after growth in the
presence of stressors
A set of KO strains were only enriched after treatment with a drug. In total we were able
to detect 176 strains that were enriched upon stress, after filtering out those detected in
the absence of stressors. Independent of the drug treatment we observed always a higher
number of strains acquiring deletions between homologous repeats (Fisher’s-exact test,
P=3.5×10−5) (Figure 3.8A).
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Figure 3.7: Fold enrichment (FDR<10%) is higher for strains detected both before and after
treatment. A | Fold enrichment of strains that acquired deletions between direct repeats in the
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of strains that acquired deletions in the DelNoRep construct without direct repeats. D | Comparison
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construct. (*:P<0.01).
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The overlap between the strains detected after treatment with different drugs was on
average 45.8% (SD ±30.1) for the strains carrying the DelRep construct and 38.8%
(SD ±51.0) for the ones with the DelNoRep construct (Figure 3.8B,C). As seen from
the variation in these overlaps, there were cases with no strains shared between the
pools treated with different drugs, whereas other pools shared all the same strains. For
example, of the 16 strains highly enriched in the DelRep pools after treatment with
doxorubicin, all were also enriched after the treatment with camptothecin. A similar
trend was seen for the pools transformed with the DelNoRep construct, in which 3
out of 4 strains enriched after treatment with doxorubicin were also enriched after
camptothecin treatment.
3.5.1 Meiosis related genes are enriched among the KO strains with
deletions between direct repeats upon drug stress
The strains significantly enriched only after drug treatment are shown in the Supple-
mentary Tables B.8 and B.9 (only top 10 strains shown). The majority of the strains
that acquired deletions without direct repeats belonged to diverse biological processes,
including cellular carbohydrate metabolic processes and protein folding. No significant
Gene Ontology (GO) term was enriched among these strains.
However, among the strains that acquired deletions between homologous repeats, I
could identify several KO strains that belonged to DNA repair pathways. The top ten
strains that acquired deletions between the homologous repeats (DelRep construct) are
listed in the Supplementary Table B.9. Interestingly, also several of the top enriched
strains belonged to processes related to meiotic recombination. From the top ten strains
in every drug stressor, an overall total of 5 deletion mutants are meiosis related, with
camptothecin treatment being the one with the highest number of meiosis genes de-
tected. Some of these KO strains were also shared among the treatments, e.g. zip2
was detected after camptothecin and after HU treatments, and spo73 was detected
after camptothecin and doxorubicin treatments. Furthermore, one meiosis related gene
was also observed among the top strains with the DelNoRep construct (Supplementary
Table B.8).
By performing a GO term enrichment analysis on strains that acquired deletion between
the homologous repeats, I observed a significant enrichment for genes related to the
response to stress, DNA metabolic processes, DNA repair and strains related to meiosis
pathways (Figure 3.9). Other terms enriched include processes involved in protein post-
translational modification, such as glycosylation and acylation.
The enrichment of meiosis related genes was not expected and is of particular interest
because in this assay strains were undergoing only vegetative growth. Among the genes
enriched, MSH4 and ZIP2, both involved in meiosis, are known to co-localize, support-
ing the functional significance of their enrichment under the same growth condition.
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Figure 3.8: Number of enriched strains per treatment for the pools transformed with DelRep and
DelNoRep constructs. A | Total number of enriched strains per treatment. Only strains enriched
2-fold when compared to the Hyg+ control, with more than 10 supporting reads and not present
in the YPAD control, are shown. B | Total number of shared strains enriched in the treated pools
transformed with the DelRep construct. The diagonal shows the total number of strains enriched
per treatment. C | Total number of shared strains enriched in the treated pools transformed with
the DelNoRep construct. The diagonal shows the total number of strains enriched per treatment.
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Figure 3.9: Main GO terms enriched in the strains that acquired deletion between homologous
repeats. The color represents the significance and the size the number of strains in the set that
belong to each term. (The GOSlim Yeast set was used for annotation with Cytoscape [Shannon
et al., 2003]).
They have been previously reported to form discrete foci in the meiotic chromosomes
[Novak et al., 2001].
Based on these results, and given that the meiosis related genes have not previously
been related to the suppression of deletion formation, we selected the deletion mutants
highlighted in Table B.9 to perform experimental validations on their increased rates
of deletion formation (Section 3.7).
3.6 Enriched strains have higher growth rates than a set
of KO strains known to be involved in DNA repair
It was unexpected that among the strains enriched in our experiments, only few be-
longed to the known major pathways of DNA repair and genome maintenance. There-
fore, I assessed whether genome maintenance genes have comparably lower growth rates
and higher vulnerability to the drug stressors than the strains that were enriched in
our screen. For this analysis, I used previously published growth rate values in rich
medium for the strains enriched with and without stressors [Steinmetz et al., 2002]. As
a comparison, I used 44 (excluding the wild type and the control strains) mutant strains
from the mutation accumulation assay described in Chapter 2 (Table B.1). These mu-
tant strains were selected specifically due to their involvement in pathways required for
genome stability.
Indeed, the genes identified in this screen had overall higher growth rates than those
involved in genome maintenance pathways (Wilcoxon rank-sum test, P<0.0001). Sim-
ilarly, the strains enriched without stress, had also higher growth rates than genome
maintenance related strains (Wilcoxon rank-sum test, P<0.0001). There were no dif-
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Figure 3.10: Growth rates in rich medium for the strains in different groups. “Bottleneck strains”
correspond to the mutation accumulation assay, including the strains shown in Table B.1 with known
defects in genome maintenance pathway. “Enriched under stressor” correspond the top ten strains
that acquired deletions between direct repeats (DelRep construct) and that were enriched after drug
treatment. “Enriched under no stressor” are the strains carrying the DelRep construct that were
detected after growth without drug treatment. (*:P<0.0001).
ferences in the growth rates between the treated and untreated strains (Wilcoxon rank-
sum test, P=0.674). This suggests that in our enrichment assay we were mainly able to
recover strains that had no strong growth deficiencies compared to strains with known
defects in genome maintenance (Figure 3.10).
3.7 Experimental validation of candidate genes
3.7.1 The KO strains were tested individually for increased rates of
deletion formation
Due to reported concerns about the original strains in the Yeast Deletion Collection,
including the existence of aneuploidies in several strains or additional mutations other
than the specific KO genes [Hughes et al., 2000; Lehner et al., 2007; Ben-Shitrit et al.,
2012], we decided to newly generate the individual KO strains for the candidate genes.
Starting from the wild type strains of both mating types (BY4341 and BY4342) I cre-
ated haploid and diploid KO strains using the PCR deletion strategy used to create the
original deletion mutants (Detailed methods are described in Section A.2.11). Given the
less direct connection between meiosis genes and the suppression of deletion formation,
we chose to perform experimental validations initially for the KO mutants msh4, zip2,
eno1 and apn2. As mentioned before, these strains were identified as having increased
rates of deletion formation between direct homologous repeats and after the treatment
with different drugs.
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In addition to generating KO strains for the candidate genes, I also created the KO
strain trp5 as a negative control, and rad52 as a positive control. The former is a
gene coding for the tryptophan synthetase, which is not related to DNA repair or
recombination pathways, and the latter is known to be important for DNA repair by
homologous recombination [Lisby et al., 2001]. Each newly generated KO strain, in the
haploid and diploid stages, was additionally transformed with the DelRep construct
and subjected to the same experimental workflow as described in Figure 3.4. A wild
type haploid (MATa) and a diploid strains, untransformed, were also included in the
experiments.
The KO strains have higher deletion formation than the control strains
The formation of deletions in the construct was again monitored by selecting for, and
quantifying, hygromycin resistant colonies. The newly generated KO strains exhibited
significantly higher levels of deletion formation when compared to the wild type strain
and to the negative control for both the diploid and the haploid strains (Figure 3.11A).
The msh4 deletion mutant showed the highest increase in the number of resistant
colonies, in both the haploid and diploid stages, when compared to the other KO
strains, even higher than the rad52 positive control (Figure 3.11B). On the other hand,
even though apn2 and zip2 showed an increase in deletions compared to the trp5
negative control and to the wild type, it was not significantly higher than for the rad52
positive control (Figure 3.11B and Supplementary Table B.11).
Interestingly, no significant differences were found between rates of deletion forma-
tion among the different drug treatments, except for the msh4 deletion mutant (Fig-
ure 3.11B). Furthermore, most KO strains also acquired deletions when grown in a rich
medium (YPAD) in the absence of any drug stress. In fact, for some knockout strains
we could see similar fold increases in the number of strains that acquired deletions in
the presence and absence of a drug (Figure 3.11B). These results suggest that the KO
strains themselves had higher rates of deletion formation independent of the treatment
used, indicating a stronger genotype effect compared to the influence of the chemical
agent.
KO diploids have higher rates of deletion formation than their correspond-
ing haploids.
Furthermore, the diploid KO strains showed higher deletion levels than their haploid
stages (Figure 3.11A). In both growth conditions, with and without drug stress, the
difference between diploid and haploid strains was significant. No difference between
diploids and haploids was observed for the wild type and negative control strains (Fig-
ure 3.11A).
66
Experimental validation of candidate genes
●●
●
●
●
●
●
0
200
400
600
0
25
50
75
100
125
Treatm
ent
Y
PA
D
KO KOcontrol WT KO KOcontrol WT
Diploid Haploid
N
um
be
r o
r H
yg
+ 
co
lo
ni
es
**
**
*
*
*
*
N
um
be
r o
r H
yg
+ 
co
lo
ni
es
A
B
0
20
40
60
Fo
ld
 c
ha
ng
e
co
m
pa
re
d 
to
 W
T
Condition
Campt
Doxo
HU
MMS
YPAD
msh4 eno1 zip2 apn2 rad52 trp5
H** D** H D
MATa
MATa/α
H:
D:
DH DHDH DH
●
●
●
Figure 3.11: Number of KO colonies that acquired deletions between direct repeats in the DelRep
construct after growth under different drug treatments or under no stress (YPAD). A | Comparison
between the number of strains with deletions between direct repeats in the DelRep construct (hy-
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increase in the number of colonies that gained deletions in the KO strains compared to the WT
control. (*:P<0.01; **:P<0.001).
67
Genome-wide screen for genes that suppress deletion formation
The difference between diploids and haploids was less pronounced in the msh4 mutant,
where the haploid strains had also a significant increase in the formation of deletions
(Supplementary Table B.11).
3.8 Discussion
I presented here a genome-wide screen for strains that have an increased tendency to
acquire deletions. With the use of specifically designed constructs inserted into a non-
essential region in chromosome V, we were able to identify strains that are more prone
to acquire deletions in the presence of direct homologous repeats and in the absence of
them. Several of these strains represent mutants that have not previously been linked
with the suppression of deletion formation.
Homologous repeats are often involved in the formation of deletions. DNA
double-strand breaks can occur due to the natural metabolism of the cells or as a
consequence of external factors, such as chemical agents or irradiation. When DSBs
occur, their repair is achieved by different mechanisms, some of which involve homol-
ogous recombination (HR) [Pâques and Haber, 1999]. However, defects in DSB repair
pathways can lead to the formation of genomic rearrangements. Homologous recombi-
nation between repeated sequences has long been recognized as a mechanism of deletion
formation [Eichler, 1998]. For example, in humans, Alu-rich regions show increased ge-
nomic instability [Calabretta et al., 1982], and several diseases are caused by deletions
mediated by flanking repetitive elements [Ledbetter et al., 1981; Yen et al., 1990].
The majority of the identified candidate strains acquired deletions surrounded by direct
repeats. Some of the strains had increased deletion formation even under no stress. In
yeast, naturally occurring repeats can be found at recombination hotspots [St. Charles
and Petes, 2013; Song et al., 2014]. In addition, solo-LTRs (the long terminal repeats at
the ends of LTR-retrotransposons) in the yeast genome are associated with regions of
slow replication fork progression, and these sites are more susceptible to recombinogenic
lesions that can result in the formation of rearrangements [Song et al., 2014]. These
results support our observation that without the influence of drug treatment, a higher
number of deletions were formed between the direct repeats.
Solo-LTRs represent sequences that are reminiscent of older retrotransposition events
[Carr et al., 2012; Neuvéglise et al., 2002]. Even though their sequences are not 100%
identical, there is high homology between them. In budding yeast it has been shown
that recombination between non identical sequences, homeologous recombination, can
occur even between sequences that share only 70% identity [Mézard et al., 1992]. The
recombination between homeologous sequences depends on the existence of shorter
stretches of high identity within them that allow the pairing of the DNA sequences
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[Mézard et al., 1992]. The homologous sequences that are found in the designed con-
struct are 100% identical, but given that they derive from a human sequence, they do
not show high stretches of identity with other loci in the yeast genome.
The sequence configuration of the DelRep construct used in this screen, with direct
repeats separated by 1kb, is not completely uncommon in the yeast genome. For
example, there are 383 long terminal repeats (LTR) annotated in the yeast genome
(Saccharomyces Genome Database). From these LTRs, more than 15% have sequences
around 300bp long and are separated from each other between 1kb and 500bp, mimick-
ing the genomic conformation that the constructs have. Therefore, the results obtained
with our constructs are a good model for processes that can occur in yeast.
Furthermore, our results suggest that deficiencies caused by the knockout of a gene
may be enough to give rise to such deletions. Spontaneous HR events can be initiated
by DSBs, but additionally by other processes inherent to replication, such as single
strand breaks (SSBs), fork stalling and collapse [Lettier et al., 2006; St. Charles and
Petes, 2013]. In fact, different DNA lesions can trigger HR, such as pyrimidine dimers
produced by UV irradiation [Lettier et al., 2006]. If left unrepaired, for example in the
case of defects in nucleotide excision repair pathways, these lesions can lead to replica-
tion fork stalling exposing regions of ssDNA and resulting in genomic rearrangements.
These findings support the presence of genes involved in recombination or base exci-
sion repair (e.g. RAD34 and RDH54 ) in our top candidate lists. The deletion mutant
shu2 has also been identified in a genome-wide screen for genes that suppress gross
chromosomal rearrangements Smith et al. [2004].
Mutation of chromatin remodeling proteins may increase the rates of dele-
tion formations. Among the strains that acquired deletion without treatment, a
particularly interesting one is ioc4. Remarkably, Ioc4 belongs to the chromatin remod-
eling complex Isw1p, which is additionally composed of Ioc2 and Isw1 [Vary et al.,
2003; Maltby et al., 2012]. Consistently, in the mutation accumulation assay described
in Chapter 2, the mutant strain isw1 showed the highest number of deletions after
msh2. These results, derived from independent experiments, support the role of this
complex in the suppression of deletion formation.
Isw1p belongs to the ISWI family of remodeling enzymes that is conserved from yeast
to humans [Clapier and Cairns, 2009; Smolle et al., 2012]. Growing evidence indicates
that chromatin remodeling complexes are implicated in the DNA damage response
[Klochendler-Yeivin et al., 2006; Wilson and Roberts, 2011] particularly for oncogenic
mutations in the SWI/SNF family [Wilson and Roberts, 2011; Shain and Pollack, 2013;
Hohmann and Vakoc, 2014]. Additionally, the ISWI family is also emerging as a player
in the DNA damage response. The human homolog of Isw1, SNF2H, has been recently
shown to accumulate at sites of DNA breaks and prevents genomic instability by pro-
moting correct HR repair [Toiber et al., 2013; Vidi et al., 2014]. The mechanisms by
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which mutations in these chromatin remodeling families lead to genomic instability are
not clear yet. However, one possibility is the recent finding that SNF2H can reduce the
barriers imposed by heterochromatin during the repair of heterochromatic DSBs. Its
interaction with ACF1 induces heterochromatic relaxation by respacing nucleosomes
[Klement et al., 2014].
Treatment with different drug stressors can result in similar outcomes. The
induction of replication stress or direct DNA DSBs by environmental pressures, such
as treatment with chemical compounds, is also known to increase the recombination
between homologous repeats [Bishop and Schiestl, 2000; Iraqui et al., 2012]. However,
it was unexpected to observe overlaps between strains enriched after the different drug
treatments used in our screen. Each of the stressors used has potentially a different
effect on the cells, via diverse mechanisms. Therefore, the mutant strains that were
prone to form deletions under each growth condition were expected to differ as well.
Nonetheless, all these stressors can impede the progression of the replication fork.
For instance, MMS is a DNA alkylating agent that methylates N3-deoxyadenine, a le-
sion that can inhibit DNA synthesis and reduces the rate of fork progression [Chang
et al., 2002]. On the other hand, camptothecin acts differently, by inhibiting DNA
topoisomerase I [Liu et al., 2006]. However, interestingly, camptothecin has also been
shown to cause stalling and collapsing of replication forks in yeast [Regairaz et al.,
2011] and mammalian cells [Saleh-Gohari et al., 2005]. Furthermore, hydroxyurea can
similarly lead to the stalling of replication forks by inhibiting the ribonucleotide reduc-
tase. This leads to replication stress by limiting the pools of nucleotides available and
this way preventing the progression of the replication fork [Saintigny and Lopez, 2002;
Petermann et al., 2010; Arlt et al., 2011]. Consequently, and as explained above, the
defects in replication caused by different drug treatments could be responsible for an
increase formation of deletions in similar mutant strains, especially if these strains have
already deficiencies in the suppression of mutations due to their genotypes.
Defects in meiosis related genes may also lead to the formation of deletions
during vegetative growth. I identified several yeast strains with deficiencies in
meiosis related pathways that showed increased deletion formation. Yeast cells can
enter meiosis only when the environmental conditions meet very specific criteria. The
lack of at least one essential growth nutrient, such as nitrogen, and the absence of a
fermentable carbon source, such as glucose, are required to arrest the cells in G1. Even
very low concentrations of glucose can inhibit the initiation of sporulation [Honigberg
and Purnapatre, 2003]. Furthermore, a non-fermentable carbon source should become
available, to be metabolized by respiration, which in turn act as a signal for sporulation
[Hirschberg and Simchen, 1977; Jambhekar and Amon, 2009; Piekarska et al., 2010].
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All media and cultures used in this study contained all required nutrients and enough
glucose to ensure their vegetative growth.
Non allelic homologous recombination was itself initially regarded as a meiosis specific
process [Carr and Lambert, 2013]. Nevertheless, HR can also play a role in fork protec-
tion and fork restart after replication is blocked, making HR a pathway ensuring DNA
replication at the expense of genomic rearrangements [Lambert et al., 2010; Lambert
and Carr, 2013]. Similarly, proteins that have been characterized for their functions
during meiosis may act in other processes related to the DNA damage response in veg-
etative growth as well. In agreement with this, Tkach et al. [2012] identified several
meiotic processes involved in the processing of DNA DSBs, significantly enriched in
the class of proteins that re-localizes to nuclear foci upon DNA replication stress. This
suggests that some meiosis proteins may be involved in DNA repair pathways outside of
meiosis. Furthermore, it is interesting to point out that the human homolog of MSH4
(whose mutant strain gained deletion between direct repeats only after treatment with
several stressors), hMSH4, has recently been implicated in other functions in mitotic
cells, including double strand break repair [Her et al., 2003; Chu et al., 2013]. This is
in agreement with our validation experiments, where msh4 was the KO strain with the
highest formation of deletions.
Diploid strains tend to acquire more deletions than their corresponding
haploids. An additional finding derived from the validation experiments was that
the KO strains tend to have more deletions in their diploid state than in the haploid.
In mammals, hyperploid cells have higher frequencies of chromosome missegregation
and chromosomal rearrangements [Fujiwara et al., 2005]. Furthermore, in yeast diploids
have been shown to be more resistant to UV irradiation [Snow, 1967], EMS (an alky-
lating agent) [Mable and Otto, 2001] and fluconazole (an antifungal agent) [Anderson
et al., 2004] than the corresponding haploids, meaning that they can tolerate a larger
number of mutations. Perhaps this is a consequence of diploids still having a functional
copy of the damaged gene, providing them with an advantage to survive in spite of
genomic rearrangements.
In fact, some yeast KO mutants are lethal in a haploid state and can only exist in
a heterozygous state. Interestingly, Lada et al. [2013] induced mutations in yeast by
the base analog 6-hydroxylaminopurine (HAP) and by an ectopic DNA editing cytosine
deaminase, resulting in a significant increase in the number of mutations accumulated in
the diploid strains. In contrast, haploids acquired an order of magnitude less mutations.
Most of the mutations found in the diploids were recessive and did not have fitness
effects when heterozygous. [Lada et al., 2013]. Taken together, these results support
the fact that diploids may be able to cope better with mutations and were therefore
found to acquire more deletions in our screen.
Although this experiment monitors the occurrence of mutations at one specific locus,
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this may reflect processes influencing other parts of the genome as well. By using pools
of deletion mutants, we were able to perform a genome-wide screen for genes that, when
mutated, increase deletion formation. Similar experiments could be also implemented
to study the formation of other structural variants, since the mechanisms that give rise
to different types of mutation are also distinct. Further studies will be necessary to
fully understand the functional impact of each candidate gene at a genome-wide level
and the precise mechanisms by which they preserve genomic stability.
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Chapter 4
Detection and validation of structural
variants in cancer genomes
4.1 Motivation
As part of my PhD, in addition to the experiments and analyses of genomic variants
in Saccharomyces cerevisiae presented in the previous chapters, I was involved in mul-
tiple side projects. By performing the data analyses of the yeast related projects I got
acquainted with the tools and pipelines for the analysis of next-generation sequencing
DNA data, especially those involving the calling, filtering and annotation of structural
variants. For this reason, and to further extend my knowledge in this field, I par-
ticipated in additional projects on human data, specifically on cancer samples, some
resulting in co-authorships as described below. This chapter collects the analyses in
these projects and it therefore contains information on different topics, not necessarily
highly related to each other, but with several technical procedures in common.
4.1.1 Contribution
My main contributions in these projects were mostly on technical aspects of the data
analyses. I performed all analyses and results presented in each section of this chapter.
4.2 Validation of structural variants identified by the ref-
erence free Somatic MUtation FINder (SMUFIN)
My contribution to this project is part of the following published paper:
Moncunill V., Gonzalez S., Beà S., Andrieux L. O., Salaverria I., Royo C., Martinez L.,
Puiggròs M., Segura-Wang M., Stütz A. M. et al. Comprehensive characterization of com-
plex structural variations in cancer by directly comparing genome sequence reads. Nature
Biotechnology, 32(11), October 2014.
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As it was mentioned in the introduction, the comprehensive identification and charac-
terization of structural variants still faces several difficulties. One of these limitations
is the need to compare the sequence of a sample against a reference genome. How-
ever, the reference genome is still incomplete, in particular in highly repetitive regions.
Additionally, it is known that sequencing reads derived from rearranged loci are of-
ten not properly aligned to the reference genome and are discarded, leading to loss
of information about the variants. Furthermore, since the tumor sample is aligned to
the reference genome independently from the control sample, further filtering steps are
needed to remove germline variants and to keep the somatic ones. Additional advan-
tages of reference-free based SV detection methods are that the variants are identified
at nucleotide resolution and that non-reference insertions can also be detected.
As part of a collaborative project, I performed validations for SVs detected using
SMUFIN, a reference-free variant detection tool that identifies rearrangements by di-
rect comparison of tumor and normal sequencing reads [Moncunill et al., 2014]. An
initial set of 60 SVs detected with SMUFIN in a medulloblastoma sample affected
by chromothripsis [Rausch et al., 2012a] was randomly selected for PCR and Sanger
sequencing validations. The results of this first assessment were key to identifying
some issues with the detection algorithm, in particular affecting the identification of
interchromosomal events. Therefore, modifications in the tool were implemented that
improved its specificity.
I then performed further validations on new sets of predicted breakpoints. Several vari-
ants identified by SMUFIN were previously called by other reference based methods
but not at nucleotide resolution. Of these, a set of 39 SVs were tested, of which 36
(92%) were positively confirmed. Additionally, another set of 27 variants not previously
identified in the same sample were also assessed by PCR and Sanger Sequencing. Of
these, 25 (92.5%) were validated. With these results we were able to confirm the detec-
tion capabilities of SMUFIN and its ability to identify variants at nucleotide resolution,
even in highly rearranged tumor samples.
4.3 Identification and characterization of structural vari-
ants in a large cohort of medulloblastoma patients
Medulloblastoma constitutes the most common malignant brain tumor in children
[Dolecek et al., 2012] and is the major cause of cancer-related mortality in childhood.
Based on transcriptional profiling with microarrays and genetic data, different subtypes
of medulloblastoma have been defined. The current consensus is the classification into
4 distinct subgroups [Kool et al., 2008; Northcott et al., 2011; Taylor et al., 2012;
Northcott et al., 2012a]. Apart from their different clinical characteristics, they also
exhibit specific cytogenetic traits, mutations and gene expression profiles [Northcott
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et al., 2011, 2012a].
Several next-generation sequencing studies of medulloblastomas have been carried out
in the last years, revealing a large number of previously unknown mutations, includ-
ing structural variants, with several of these alterations being subgroup-specific [Jones
et al., 2012; Northcott et al., 2012b, 2014]. More complex rearrangements, like chro-
mothripsis have also been observed among these tumors [Rausch et al., 2012a]. How-
ever, for medulloblastomas, there is still a lack of integration of the different types of
data available. For example, there is not a complete understanding of the contribution
of point mutations and structural variants, especially in terms of defining driver and
passenger variants. Additionally, the roles of the epigenome and transcriptome in the
development of the tumors are yet to be further characterized.
With the goal of further understanding and integrating different types of data, cur-
rently we are analyzing the largest cohort of medulloblastoma samples for which whole-
genome, exome, expression and methylation data is available. My role in this project
is the detection and characterization of the SVs in paired-end WGS, which currently
comprises a total of 454 tumor-control sample pairs.
I am analyzing all samples with a uniform computational pipeline for the discovery,
annotation and filtering of variants. This workflow is being developed in the frame
of the Pan-Cancer Analysis of Whole Genomes initiative by Joachim Weischenfeldt of
the Korbel Lab. It involves the calling of SVs with DELLY [Rausch et al., 2012b], the
filtering and functional annotation of somatic variants and the removal of low confidence
calls by comparing to the 1000GP and other cancer sample sets.
I have analyzed 360 tumor-control pairs, and continue to call SVs in the remaining sam-
ples. Currently we are able to identify the main known SVs that have been described
in medulloblastoma, in addition to other variants that are not recurrent or occur only
in less than 5 samples. Given that the data set is large, once I finish the SV detection
for all samples, I will assess the existence of new recurrent variants, especially for the
subgroups 3 and 4, for which only few clear oncogenic drivers have been identified.
Additional analyses will include the identification of breakpoint clusters and potential
fusion genes. This data will be then integrated with the other types of genomic in-
formation available for these samples, in collaboration with researchers at the German
Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), with the aim of
generating a comprehensive mutational landscape for medulloblastomas. Studying the
underlying genetic basis of these tumors will eventually help improve patient stratifi-
cation, treatment and prognosis [Northcott et al., 2012a].
Additionally, some of these medulloblastoma samples exhibit chromothripsis, massive
genomic rearrangements that result from a single catastrophic event [Stephens et al.,
2011; Rausch et al., 2012a]. The structural variants that I identified in these samples
have been used in a study that describes a reproducible experimental approach for
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the generation of complex rearrangements and that links these shattering events to
hyperploidy.
My contribution to this project is included in the following manuscript:
Mardin, B., Drainas, A., Waszak, S., Weischenfeldt, J., Isokane, M., Stütz, A., Buccitelli,
C., Segura-Wang, M., Northcott, P., Pfister, S. et al. A novel cell-based model system
links chromothripsis with hyperploidy. (in review in Nature Methods).
4.4 Identification of structural variants at specific loci in
small cell lung cancer
My results of this project have been included in the following manuscript:
George, J., Peifer, M., Cun, Y., Leenders, F., Müller, C., Dahmen, I., Schaub, P., Bosco, G.,
Pinther, B., Lu, X., Seidel, D., Fernandez-Cuesta, L., Sage, J., Lim, J., Jahchan, N., Park,
K., Yang, D., Vaka, D., Torres, A., Karnezis, A., Korbel, J., Segura-Wang, M., Menon,
R. et al. Comprehensive genomic characterization of small cell lung cancer. (in review in
Nature).
I analyzed mate pair WGS data for 7 samples of small cell lung cancer (SCLC) from
a study that included a total of 110 samples. The main variants observed in this large
set of samples were universal inactivating mutations in both TP53 and RB1 detected
in all samples except for 2 that exhibited chromothripsis. Additionally, 20% of the
samples had mutations in genes from the NOTCH family.
However, for these 7 samples there was no clear structural variant detected in NOTCH
genes or RB1. Therefore, mate pair sequencing was used to assess the presence of
larger rearrangements, particularly at these loci. Although with the data available I
was not able to confirm the presence of variants in these specific regions, I identified 2
samples with rearrangements in CREBBP, one with a deletion and another one with a
translocation. This histone acetyl transferase is involved in the coactivation of several
transcription factors, and has been also found mutated in other cancers [Mullighan
et al., 2011]. Based on further analyses performed by our collaborators, it was possible
to find that mutations in CREBBP and NOTCH family genes were mainly mutually
exclusive in SCLC.
4.5 Identification of structural variants in embryonal tu-
mors with abundant neuropil and true rosettes
Embryonal tumors with abundant neuropil and true rosettes (ETANTRs), named for
their histological characteristics, are rare neoplasms of the central nervous system
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Figure 4.1: Focal amplifications in chromosomes 11 and 13 from an ETANTR sample form a
double minute chromosome. A | Read depth profiles for chromosome 11 and chromosome 13 in
one ETANTR sample. High level amplifications are marked with circles. B | The amplified regions
in chromosome 11 and 13 are joined together forming a double minute chromosome. The detected
SVs are shown by colored arches: grey: translocations, red: tandem duplication, yellow: inversion
5’-5’, green: inversions 3’-3’. (Circular plot created using Circos [Krzywinski et al., 2009]).
(CNS) [Korshunov et al., 2014]. ETANTRs typically carry known amplifications in
chromosome 19q13.42. Additionally, they show high expression of LIN28, which leads
to the repression of the let-7 miRNA family and consequently to an upregulation of the
targets of let-7, including MYC, MYCN, RAS and CDK6 [Korshunov et al., 2012].
It has been recently discovered that the amplification in chromosome 19 in ETMR
(a broader classification of embryonal tumors with multilayered rosettes that likely
includes ETANTRs) causes the fusion of the TTYH1 gene with the C19MC miRNA
cluster, leading to the overexpression of these miRNAs. As a consequence, the gene
DNMT3B is also overexpressed [Kleinman et al., 2014]. This gene is normally active
only during early stages of the neural tube development. Its overexpression at later
ages makes it an oncogene involved in ETMR, and probably ETANTR, tumorigenesis
[Kleinman et al., 2014].
As part of a collaboration with researchers at the DKFZ, I analyzed mate-pair whole-
genome sequencing data of 13 ETANTR tumor-normal pairs with the aim of confirming
the high frequency of the chromosome 19 amplification and to identify other potential
rearrangements in these tumors.
Out of the 13 samples, 8 carried the know amplification with support for the fusion
of TTYH1 and C19MC. However, many more rearrangements in this region of chro-
mosome 19 were detected in addition to the amplification. Several samples showed
deletions and inversions in the same locus.
Interestingly, from the other 5 samples where no amplification in 19q13.42 was de-
tected, two samples had rearrangements involving additional miRNA clusters. One
sample showed a high level amplifications in chr11 and chr13 (Figure 4.1A). Based on
paired-end mapping I was able to infer that the amplified regions form a double minute
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chromosome containing the miR-17/92 cluster (Figure 4.1B). This cluster comprises
at least 6 miRNAs involved in cell cycle and proliferation and has been shown to be
amplified in other tumors [Mogilyansky and Rigoutsos, 2013].
An additional sample without the typical amplification contained a translocation be-
tween chromosomes 22 and 19, creating a fusion between the known C19MC miRNA
cluster and MIRLET7BHG. The latter has been also shown to be associated with the
development of other cancers [Peter, 2009; Saleh et al., 2011]. Interestingly, this miRNA
belongs to the let-7 family, which acts as tumor suppressors [Viswanathan et al., 2008].
Although we have not yet found the direct link between these additional rearrange-
ments, it is interesting that in both cases they involve miRNAs that have been linked
to cell proliferation and tumor progression. At the moment, further research on ex-
pression and methylation data for these samples is being conducted by investigators at
the DKFZ to further characterize and understand if these or other variants have some
functional impact on the development of ETANTRs.
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Chapter 5
Conclusions and future perspectives
In this thesis I described two complementary approaches for studying genomic vari-
ants in Saccharomyces cerevisiae and for identifying genes that prevent the formation
of chromosome rearrangements. Using knockout strains I could identify specific genes
related to the maintenance of genomic stability that when deleted, increase the occur-
rence of different types of mutations. Together, these approaches allowed us to have a
broader overview of genomic features that lead to the formation of mutations, such as
the presence of homologous repeats. The results from this work suggest a connection
between chromatin remodeling the maintenance of genomic stability. Additionally, we
found support for the involvement of meiosis related genes in the suppression of deletion
formation.
In Chapter 2 I presented the results of a neutral mutation accumulation (MA) assay in
a set of 47 selected yeast knockout strains with defects in known genome maintenance
pathways. These strains were propagated through single-cell-to-colony bottlenecks and
their whole genome was sequenced at different time points. I generated a comprehensive
catalog of mutations acquired in these strains and analyzed their frequency, distribution
along the genome as well as the genomic features that were related to the formation of
mutations.
Chapter 3 described a genome-wide screen for genes involved in the suppression of
deletion formation. I used a pooled collection of more than 5000 different KO strains to
assess their tendency to acquire deletions with and without different chemical stressors.
I designed specific constructs tailored to monitor the occurrence of deletions, in the
presence and absence of homologous repeats, and integrated them in the genome of the
KO strains. Additionally, through experimental validations, I was able to confirm the
frequent generation of deletions in candidate strains, including two with KO of meiosis
related genes, even in the absence of additional external stressors and especially in their
diploid stages.
In the following sections I summarize the most important conclusions derived from
these approaches. I further discuss limitations and additional experiments that can be
carried out to pursue a better understanding of the processes that maintain genomic
stability.
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Under neutral mutation accumulation, yeast KO strains acquired more
short deletions and insertions (1-5bp long) compared to large rearrange-
ments. Some strains gained more deletions while others tend to have more short
insertions, supporting that there are different processes involved in the formation of
mutations. The msh2 deletion strain became hypermutable and acquired the highest
number of mutations compared to the other strains studied. MSH2 is known to be
involved in mismatch repair and mutations in this gene increase the predisposition to
cancer significantly [Dowty et al., 2013]. It also plays a role in DNA recombination
between homologous sequences, making cells with mutations in this gene more prone
to acquire SNVs and further rearrangements.
Given that the fraction of the genome that is changed by an SV is larger than that
accounted for by an SNV, SVs may have stronger phenotypic consequences [Conrad
et al., 2010; Mills et al., 2011]. Even though no selection process was implemented in
the MA assay, mutations with effects on growth or survival, likely including large SVs,
were not highly represented in the sequenced strains.
Short deletions and insertions occur more frequently in repetitive regions
and between homologous repeats. By performing functional annotation of the
variants detected in the MA strains, I could confirm their frequent occurrence in repet-
itive regions. These results suggest that replication slippage and homologous recombi-
nation are important processes in the formation of mutations.
Repetitive sequences have been shown to be involved in genomic instability [Calabretta
et al., 1982; Bzymek and Lovett, 2001]. Repeat instability is also the basis of several
diseases, exemplifying the importance of studying repetitive DNA and the mechanisms
behind its mutagenic role [López Castel et al., 2010]. Homologous sequences can act
as sources for homologous recombination, causing deletions or duplications of the se-
quence between the repeats. Additionally, highly repetitive regions can adopt different
secondary structures, inducing problems during replication and consequently giving rise
to repeat expansions, chromosomal fragility and gross chromosomal rearrangements
[Voineagu et al., 2009].
My results from the genome-wide screen described in Chapter 3 further support the
role of homologous sequences in the formation of deletions. I identified a larger number
of yeast KO strains that acquired deletions between repeats than in the absence of
them.
Certain KO strains are more prone to acquire deletions, even in the absence
of external stress. Using constructs designed to monitor the occurrence of deletions,
I identified strains with increased deletion formation in the presence and absence of ex-
ternal stress factors. Interestingly, there were more than 200 KO strains that acquired
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deletions in the absence of additional external stress. This suggests that the KO of
these genes may have a strong negative effect on the suppression of mutations. Indeed
in this group we found mutant strains for genes involved in DNA recombination and
repair, synthesis-dependent strand annealing and mismatch repair. Under the pres-
ence of drug stressors causing replication stalling or direct DNA damage, these strains
showed a higher fold enrichment compared to strains that gained deletions only after
stress. In this latter group, the strains are likely functional under normal environmental
conditions, but may have defects in coping with stressful growth situations. The use
of designed constructs proved a useful method for screening for mutant strains that
suppress the formation of deletions.
Chromatin remodeling proteins may be involved in suppressing the forma-
tion of deletions. In addition to mismatch repair genes, I found that the knockout
of chromatin remodeling genes, namely ISW1 and SWR1 may also play a role in pre-
venting the formation of rearrangements, in particular of deletions. In the neutral MA
assay isw1 and swr1 were found among the knockout strains with the highest numbers
of deletions. Isw1 and Swr1 are both part of protein complexes involved in chromatin
remodeling [Mizuguchi et al., 2004; Smolle et al., 2012].
Chromatin architecture plays an important role in the control of gene expression by
regulating the access of proteins to DNA [Cairns, 2009; Clapier and Cairns, 2009].
There is increasing evidence that chromatin remodelers are also important for DNA
repair. For example, they are required for the phosphorylation of serine 129 of histone
H2A in yeast (and serine 139 of histone H2A.X in vertebrates) upon DNA damage.
This phosphorylation step leads to the recruitment of other chromatin remodelers that
facilitate the access of repair proteins to the broken DNA ends [Redon et al., 2003;
Clapier and Cairns, 2009; Xu et al., 2012].
Additionally, the exchange of H2A to H2A.Z (Htz1 in yeast) on nucleosomes at DSBs
is required for the loading of DNA repair proteins [Xu et al., 2012]. The exchange is
mediated by the SWR1 complex. Consistently, the high number of deletions that accu-
mulated in the swr1 KO strain in the MA assay supports its importance in preventing
rearrangements, in line with previous reports demonstrating the involvement of H2A in
the DNA damage response [Morillo-Huesca et al., 2010; Papamichos-Chronakis et al.,
2011].
The ISWI complex also belongs to a family of chromatin remodelers with different
subunit composition and biochemical activities than the SWR1 family [Clapier and
Cairns, 2009; Wilson and Roberts, 2011]. Much less is known of its role in maintaining
genomic instability compared to the SWR1 and SWI/SNF families. Interestingly, our
results from the genome-wide screen, where the ioc4 strain was enriched for deletions
without any additional stress, further support the involvement of the ISWI complex in
maintaining genomic stability. This complex is composed of three proteins, including
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Isw1 and Ioc4 and acts in the repositioning of nucleosomes during transcription. Addi-
tionally, isw1 mutants show strong defects in the chromatin organization [Gkikopoulos
et al., 2011].
Taken together, these results suggest a potential role of the ISWI complex in the sup-
pression of deletion formation. The detailed molecular mechanisms that cause genome
rearrangements in strains having defects or a lack of proteins from the ISWI complex
are, to my knowledge, yet to be characterized.
Meiosis related genes may also play a role in the prevention of deletion
formation during vegetative growth. Among the strains that gained deletions
after the treatment with different stressors I found a significant enrichment for genes
involved in meiosis. The roles of these genes during vegetative growth are not fully
described and their role in genome maintenance is not known. However, there are
proteins that are important components of the meiotic machinery, but have further
been implicated in the DNA damage response in other stages of the cell cycle, such
as the Mre11 complex [Haber, 1998]. Given that meiotic proteins are involved in the
creation and repair of DSBs, it is possible that these functions are also used in additional
processes. Initial evidence exists for the involvement of hMSH4 in DSB repair in mitotic
cells [Her et al., 2003; Chu et al., 2013]. Consistently, as discussed in Chapter 3, its
yeast homolog mutant strain msh4, currently known to be involved in meiosis related
processes, showed high number of deletions.
Limitations. The detection and study of genomic rearrangements faces some limita-
tions despite the recent advances in sequencing technologies and computational tools.
Some types of variants are particularly difficult to ascertain. We are aware that the
detection of indels in the genome is still hampered by the difficulties of mapping reads
in repetitive regions. Furthermore, repeated sequences create ambiguities in the align-
ments that can lead to false positive calls [Treangen and Salzberg, 2012]. We used
stringent filtering criteria to reduce false positives caused by alignment artifacts, such
as removing variant predictions that were present in 90% of the strains. Additionally,
we performed experimental validations to confirm the computational calls. However,
with this filtering process we cannot rule out that some real mutations were removed
from the final catalog, or that a few false positives still remained.
Another important consideration is that the identification of mutations leading to a
certain phenotype is not always a simple task. In the MA approach, each KO strain
carried a deletion of a particular ORF. However, through the accumulation of muta-
tions, other important genes for the maintenance of genomic stability may have been
altered. This complicates the assignment of a phenotype only to the gene initially
deleted. Therefore, the results derived from our approach could also be caused by
multiple factors influencing DNA repair and recombination processes.
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Through the MA assay, I identified mainly short deletions and insertions. Because of
their smaller size and their occurrence in repetitive regions, where there are commonly
less genes, they tend to cause less phenotypic impact. In the MA approach no selection
method was used. However, only mutations not affecting survival or growth can be
recovered. Therefore, we cannot discard the possibility that we were not able to observe
a higher number of larger variants because they may have caused larger fitness defects
compared to the smaller variants.
Furthermore, in the genome-wide screen for genes that suppress deletion formation, we
scored deletions occurring at a specific locus in the genome by using designed constructs
inserted by homologous recombination. Even though a large number of strains was
transformed, strains with strong defects in this process were likely not represented in
the final pools. Additionally, given the differences in the growth rates of the KO strains,
several of them may have been absent from the final pools due to their slower growth
rate and not related to their propensity to formation of deletions.
Since the distribution of genetic variants varies along the genome [Nachman, 2001; Mills
et al., 2006], the results from one locus may not reflect the formation of deletions in
the entire genome. However, since we compare the formation of deletions in all strains
based on this locus, our results can be used as a starting point to carry out further
experiments on the strains with increased levels of deletions. Such experiments can be,
for example, the sequencing of the whole genomes to confirm the increased frequency
of deletions in other loci.
Future perspectives. Even though the budding yeast has been extensively studied,
the phenotypic consequences of different types of mutations are not fully understood.
Systematic analyses of the deletion collection to identify genes that prevent the for-
mation of mutations is still of interest given the diverse pathways involved in these
processes [Huang et al., 2003]. The advances in sequencing technologies will continue
to improve the characterization of genomic variants and their formation mechanisms.
However, further improvements in these technologies, especially in read lengths, are
needed to increase our ability to identify more complex rearrangements and variants at
repeated sequences.
Further studies can be performed using similar techniques as the ones described in this
thesis. For example, the constructs can be modified to test for the formation of other
types of rearrangements, such as inversions and duplications. Other modifications to
the constructs can include the substitution of the direct repeats with inverted repeats.
Moreover, the understanding of the mechanisms of how genomic variants arise is im-
proved by analyzing the sequences around their breakpoints. Therefore, it is of interest
to investigate the resulting sequences in the constructs, after acquiring rearrangements,
to assess for differences between strains that may provide insights into the formation
mechanisms. The use of additional strains from other Yeast Deletion Collections may
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be also beneficial. For example, using a heterozygous collection allows the screening of
essential genes, not included in the homozygous collection used in this study.
Additionally, the identification of genes involved in genomic stability is the first step
into understanding the molecular processes that operate in the cells. In this regard,
further experiments are required to determine the underlying mechanisms involved and
the specific roles that each protein plays. In order to test for potential indirect effects
of the candidate KO genes in our screen, one possibility is to assess transcriptional
changes (for example, through an RNAseq experiment) in the strains before and af-
ter stress with drugs. This may reveal protein changes associated with higher levels
of deletion formation. Due to the high evolutionary conservation of genome mainte-
nance mechanisms, further studies in the budding yeast such as the ones presented
in this thesis, will contribute to the global understanding of these processes in higher
eukaryotes.
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Appendix A
Methods
A.1 General protocols for Chapter 2
A.1.1 Mutation accumulation assay
In order to study the rates and types of spontaneous mutations in the yeast genome, a
single-cell-to-colony bottleneck mutation accumulation assay was used. For this study
we selected a set of 47 haploid deletion mutants from the yeast deletion collection
(BY4741 MATa his3∆1 leu2∆0 met15∆0 ura3∆0), with a range of defects in DNA
replication, repair and recombination. The complete list of mutant strains used and
their general function is shown in Table B.1.
Two colonies of each deletion strain were passed through a series of colony-to-single-cell
bottlenecks that consisted on selecting individual colonies and streaking them out on
YPAD plates to separate them into individual cells. These cells were grown into colonies
for around 2 days at 30°C after which one colony was selected again for isolation. This
process was repeated for a total of 90 bottlenecks (Figure 2.1). Frozen stocks were
saved after bottlenecks 30, 60 and 90. This process leads to an accumulation of neutral
mutations that can then be related to the effect of the disruption of specific genes that
play a role in the maintenance of genome stability. The saved stocks at bottlenecks 30,
60 and 90, in addition to the original stocks at time point 0, were used for whole-genome
sequencing as described below.
A.1.2 DNA extraction from yeast on 96 well plates
For extracting DNA from the yeast strains for sequencing, the PrepEase Genomic DNA
Isolation Kit (Affymetrix) was used, with some modifications. Specifically, the Sphero-
plast and Enzyme Solutions were replaced by Buffer Y1 (Qiagen’s Yeast Lysis Buffer:
1M Sorbitol, 100mM EDTA, 14mM β-mercaptoethanol) and Zymolyase (Seikagaku
Corporation) treatment.
Two colonies of each strain, i.e. the two lines grown for up to 90 generations, were
subject to paired-end whole-genome sequencing (WGS) at the first generation, and
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then after 30, 60 and 90 generations. For WGS, a small aliquot from the saved stocks
was streaked out for single colonies on YPAD plates. A single colony of each mutation
accumulation line (2 per deletion mutant strain) was inoculated into a single 4ml liquid
YPAD culture in a glass tube, or 4×1ml YPAD cultures in 2ml deep well plates, and
let grow overnight in a rotor or shaker at 200rpm and 30°C.
After 12-14h of growth the cultures were centrifuged for 2min at 3000rpm and the
supernatant was removed. If the cultures were grown in deep well plates, the cells of
all cultures were merged into a single plate after centrifugation. The cells were washed
once with 450µl water. To make spheroplasts, 200µl of Buffer Y1, 10µl of Zymolyase
(1000U/ml) and 0.5µl RNaseA (10mg/ml) were added per well with a multichannel
pipet. The plate was covered with a plastic seal and placed in a shaker at 25rpm, at
37°C for 1-2h. After this, 200µl of water were added and the solutions were mixed
shortly on a vortex.
The spheroplasts were collected by centrifugation at 6000rpm for 5min. The super-
natant was discarded and 120µl of Homogenization Buffer (PrepEase kit) were added
and mixed with a multichannel pipet to resuspend the pellet completely. 120µl of chlo-
roform and 400µl of Protein Precipitation Buffer (PrepEase kit) were added to each
well and mixed with a pipet. The solutions were centrifuged at 4000rpm for 45min.
From the upper aqueous phase, 450µl were transferred to a new halfdeep well plate con-
taining 340µl of isopropanol per well, mixed and let stand for 15min at -21°C. These
solutions were again centrifuged at 4000rpm for 1h. The supernatant was decanted,
500µl of cold 70% ethanol were added to wash the DNA and centrifuged at 6000rpm
for 10min.
After the supernatant was removed, the pellets were dried for 5min at 37°C. The DNA
was resuspended in 200µl of TE and shake at 37°C for 15min to completely disolve the
pellet. Typically, the concentration of at least 10 samples was measured with Qubit
dsDNA BR Assay (Life Technologies).
A.1.3 Whole-genome sequencing of yeast strains
Before preparing the libraries for paired-end WGS, 5µg of yeast genomic DNA from
each strain was sheared using a Covaris S2 system (Covaris Inc.) set to generate 500bp
fragments: 90s, duty cycle of 5%, intensity of 3 and 200 cycles per burst. To purify the
sheared products, the 120µl solution was dried down completely in a vacuum at 45°C
and then resuspended in 30µl of EB. The DNA was then purified with 1.8x Ampure
XP beads (Agencourt) following the default protocol. The final elution was done with
34µl of EB.
Library preparation was carried out using the NEBNext DNA Sample Preparation kit
(New England BioLabs) with 32µl of the sheared and purified DNA and following the
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protocol of the manufacturer. After each step the products were purified using Ampure
XP beads. Size selection was performed by either loading the products on 2% agarose
gels and cutting the respective products at around 500bp, or by one step of Ampure XP
bead purification adapting the amount of beads to achieve the desired fragment size.
After the size selection, the products were quantified using Qubit dsDNA HS Assay (Life
Technologies). A representative set of products was also loaded on a Bioanalyzer DNA
1000 chip (Agilent Technologies, Inc.) to assess the size distribution of the fragments.
All strains were sequenced with 101bp paired-ends using an Illumina HiSeq 2000 and
aiming for a coverage of 20×. The samples were multiplexed using a set of 55 different
molecular barcodes 6pb long (Table B.5), most of them described in Wilkening et al.
[2013]. These barcodes have an equilibrated base composition in the first 2 positions,
allowing for better clustering, and differ from each other by at least 3bp preventing the
confusion of samples by sequencing errors [Wilkening et al., 2013].
A.1.4 Data analysis
This section describes in detail the pipelines depicted in Figures 2.1 and 2.5.
Sequence alignment. For mutation identification, the sequences were aligned against
the S288c Saccharomyces cerevisiae reference genome (sacCer3) using the software
Novoalign version V2.07.06 (http://www.novocraft.com/) with the parameter -r Ran-
dom (random placement of reads that align to multiple locations in the genome).
Identification of the mutational spectrum of each deletion strain. Different
types of mutations were identified with a set of computational tools as follows. To detect
deletions, tandem duplications and inversions, the DELLY tool (v0.0.11) developed by
Tobias Rausch in the Korbel Lab [Rausch et al., 2012b] was used, requiring a minimum
paired-end mapping quality (-q) of 20 and a minimum flanking sequence (-m) of 5.
Deletions and tandem duplications were also detected by Pindel (v0.2.4s) [Ye et al.,
2009] with maximum size set to 7, i.e. a maximum SV length of 517.8kb. The same
type of variants were identified by a third algorithm, BIC-Seq [Xi et al., 2010], with
the advantage that this is a read depth based algorithm and therefore adds a different
way of discovering these types of rearrangements.
Shorter insertions and deletions (indels) were additionally identified by using Dindel
(v1.01) [Albers et al., 2011] and mpileup from Samtools (v0.1.18) [Li et al., 2009].
Dindel was run using in addition the predicted calls from Pindel as candidate regions.
These methods are able to call only variants of around less than 50bp, in contrast to
the tools described before, which can identify longer variants.
Cortex (v1.0.5.3), a tool that uses a de novo assembly approach, which in higher eukary-
otes can be a difficult computational task. However, given the advantage of the small
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yeast genome, this method provides a way of detecting genomic variants without com-
paring to the reference genome. The parameters used were -kmer_size 31 -mem_width
100 and -mem_height 22.
All algorithms described were applied to each individual sample. On the other hand, the
population based method GenomeSTRiP [Handsaker et al., 2011] was run on all samples
simultaneously, with a minimum mapping quality of 20. By using the information of
all the genomes, the quality of the calls and the power to infer them are increased.
The SNVs identification pipeline included calling with Samtools mpileup [Li et al., 2009]
followed by bcftools view, and filtering by using the varFilter tools from vcfutils.pl using
a maximum read depth (-D) of 50,000. To obtain high quality SNVs they were required
to have at least 5 supporting pairs and a mapping quality higher than 40. Since SNV
calling can have artifacts that affect most of the samples at the same positions, only
variants called in less than 10% of the samples were considered for further analyses.
De novo mutations were obtained by removing all variants occurring the the b0 strains
(the original strains before the bottleneck assay).
For the sequence context analyses, 10bp up and downstream of each SNV were extracted
and for each position the number of each nucleotide was counted. Equivalent nucleotide
substitutions, like G>T and C>A, were combined.
Merging of mutation calls. After collecting the variants by applying the tools
described in the previous section, the calls were merged with the goal of reducing the
redundancy in the final set of calls. For merging, first the calls per individual were
combined using the in house tool imerge (developed by Tobias Rausch). For this, a
confidence interval around the predicted breakpoints was defined taking into account
the accuracy of variant identification for each tool. Specifically, intervals for variants
detected a nucleotide resolution were defined as 10bp to each side of the breakpoint.
For DELLY calls without a breakpoint, the intervals were 20bp outside the variant and
50bp into the variant. Given that variant discovery in BIC-seq is based on read depth,
the breakpoint prediction is more inaccurate and therefore the intervals were defined
as 1000bp outwards and 400bp outwards. For Cortex, intervals of only 1bp around the
breakpoints were allowed. For GenomeSTRiP, this step was not necessary. A variant
was consider to be the same as another one if the defined intervals of both start and
end breakpoints overlapped. These events were therefore merged into single variants.
Then the lists of variants detected by each algorithm were filtered for good mapping
quality (>20) and at least 3 supporting read pairs. After this step, confidence intervals
were defined once again for each list, using the same criteria as above and 50bp outwards
and 100bp inwards for GenomeSTRiP. Using these intervals, all variant calls among
tools were merged together using imerge. Only those calls detected by at least two
algorithms were considered. Additionally, given that there are regions where some
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artifacts can happen, or where the reference genome is different from all other samples,
only those variants that were present in less than 10% of the samples were kept. This
set was then called “unique” variants. On the other hand, since in this project there are
strains sequenced at different time points, mutations detected in the later generations
that were already present in previous generations were also removed, resulting in a final
set of “de novo” variants.
Estimation of mutation rates. Estimation of the mutation rates per base per
generation was based on the number of SNVs per strain. The rates were calculated as
N/n×t×bp, with N=total number of SNVs at b60; n=number of mutation accumulation
lines (two in this study); t=mean number of generations; and bp=yeast haploid genome
size (12,162,995bp). The mean number of generations was estimated considering 20
generations per bottleneck (after each single-cell-to-colony bottleneck the cells were
allowed to form colonies for 48h), and 60 bottlenecks, accounting for 1200 generations.
Functional annotation of mutations. The annotation of indels and SNVs was
performed using the ANNOVAR software [Wang et al., 2010]), using sacCer3 as the
reference genome and the Ensemble gene annotations for Saccharomyces cerevisiae.
Additionally, all deletions and insertions independent of size were overlapped with a
set of different genomic features, using published data, to analyze the location of the
variants and their possible functional effects. For this, I compared the overlap of the
variants with genes (ensGene from UCSC), recombination hotspots [Mancera et al.,
2008], crossovers [Mancera et al., 2008], 3’UTR and 5’UTR [Nagalakshmi et al., 2008],
nucleosome positioning based on H2AZ [Albert et al., 2007], origin of replication sites,
DSB hotspots [Pan et al., 2011], TATA elements [Rhee and Pugh, 2012], transposable
elements from the SGD, transcription start sites (TSS) [Zhang and Dietrich, 2005] and
simple repeats from the SGD.
For comparison, a permutation approach was used to assess the significant values of
the overlaps. The set of discovered mutations from out strains was distributed along
the whole yeast genome and the overlap with the mentioned features was assessed as
described in the previous paragraph. This process was iterated 1000 times, and the
percent of random mutations overlapping each of the defined genomic features was
estimated. Wilcoxon rank-sum tests were used to compare the overlaps between the
detected mutations with different features and the randomly positioned mutations.
SNVs and indels were also annotated using ANNOVAR [Wang et al., 2010] with gene an-
notations downloaded from UCSC (ftp://hgdownload.cse.ucsc.edu/goldenPath/
sacCer3/database/). The variants were classified as exonic or intronic. For exonic
variants, their functional consequences were also predicted and classified as nonsynony-
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mous SNV, synonymous SNV, frameshift insertion, frameshift deletion, nonframeshift
insertion, nonframeshift deletion, and frameshift or nonframeshift substitution.
Identification of chromosome aneuploidies. Chromosome aneuploidies were iden-
tified by estimating chromosome copy number based on the read depth. To estimate
the read depth, the yeast genome was divided into non overlapping 10bp windows. For
each strain, the number of reads aligning to a specific window were counted using an
in-house tool “cov” (developed by Tobias Rausch). To infer copy number changes be-
tween the initial wild type (WT-b0) strain and the deletion strains at all time points
(b0, b30, b60, b90), the read counts of each sample were normalized for differences
between the coverages. For this normalization step, the read depth ratio between the
WT-b0 strain and each of the mutant strains was estimated. The median of these ratios
was multiplied by the counts of each time point per strain. Then the log2 ratios of the
normalized read counts were calculated per window and subjected to GC normalization
based on the relation between the GC content and the log2 read depth ratio of each
sample pair (WT-b0 versus any of other generations).
Based on the log2 read depth ratio estimations for each sample pair, chromosome gains
were identified as those having ratios larger than 0.7, instead of the expected log2
ratio of one for a gain of a chromosome (or part of it) in a haploid genome. This was
chosen because there were some cases where the sequenced colony might not have been
completely pure, giving a ratio lower than one, although still sufficiently distinct to
the b0 strain and to other chromosomes, making it possible to identify chromosome
copy changes. An aneuploidy was then scored if the chromosome gain was seen in time
points b30, b60 or b90, but absent in the b0 of the corresponding strain. This means,
that chromosome gains occurred through the mutation accumulation assay.
Plots and statistical tests. All plots and statistical analyses in this section were
done using the software environment R, version 3.1.0 [R Core Team, 2014].
A.1.5 Validation of genetic variants by PCR and Sanger sequencing
To validate the computationally predicted mutation calls, PCRs were performed aiming
to have either a difference in size between a positive and a negative SV call, or a
difference in the ability to produce an amplicon. In the latter, a lack of a PCR product
is indicative of an absence of the SV. To validate SNVs and indels, the primers were
designed to amplify a product where at least one of the primers was close enough to the
prediction that it could be used to perform Sanger sequencing. This way the presence
of the mutation could be validated by looking a the sequence directly. When possible,
the fragments were sequenced from both directions. Considering that some of the SVs
were not predicted at a nucleotide resolution, the primers were placed 500bp away from
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the breakpoints when there were no repetitive sequences in the region. Otherwise the
primers were placed farther away to avoid the amplification of unspecific products.
All primers were designed using the Primer3Plus software [Untergasser et al., 2007], and
amplicons were generated using the SequalPrep Long PCR Kit (Invitrogen). Reactions
were done following the specifications of the manufacturer, with total volumes of 25µl,
annealing temperatures of 56-54°C and adapting the elongation steps depending on
the expected product size. The PCR products were loaded on 1% agarose gels and
visualized with the SYBR Safe Dye (Invitrogen) and using a 100bp or 1kb DNA ladder
(NEB) depending on the expected product size. When required, the products were
cut out of the gel, purified with QIAquick Gel Extraction Kit (Qiagen), and eluted
in 30µl EB buffer. The products were sent to GATC Biotech (Germany) for Sanger
sequencing. All sequences were analyzed with the Sequence Scanner Software (Applied
Biosystems). For these validations, the DNA used was the same as the one used for
the WGS experiments, and obtained as described in Section A.1.2.
A.1.6 Verification of aneuploidies by qPCRs
To confirm the presence of aneuploidies in the deletion strains that arose during the
bottleneck mutation accumulation assay, qPCR assays were designed. Two primer pairs
per aneuploid chromosome were chosen, binding to the left and the right arms of each
chromosome. Some primer sequences were obtained from Pavelka et al. [2010] whereas
others were newly designed following the methods from these same authors and using
the Primer3Plus software [Untergasser et al., 2007] with default qPCR settings (except
reducing the maximum length of mononucleotide repeats to 3). As template sequences,
yeast intergenic regions not overlapping repetitive elements were downloaded from the
Saccharomyces Genome Database (http://downloads.yeastgenome.org/sequence/
S288C_reference/intergenic/NotFeature.fasta.gz, version from the 03-Feb-2011).
The amplicon lengths were chosen to be between 75-200bp. Primer sequences can be
found in the Supplementary Table B.4.
qPCRs experiments were performed using the SYBR Green PCR Master Mix Kit and
following the standard protocol (Applied Biosystems) and 20µl total reaction volumes.
All assays were set up in 96 well plates and included three replicates of each sample,
the standards and non-template controls. For the samples, a total of 0.1ng of DNA was
used for a total concentration of 0.02ng/µl per reaction, and final primer concentrations
of 0.2pM/ul. A master mix with the primers and the SYBR Green mix was prepared
and aliquoted into each well.
To estimate the fold change in chromosome copy number a relative quantification based
on the ∆∆Ct method was used. The Ct (cycle threshold) refers to the number of cycles
at which the fluorescent signal produced by the DNA-binding dye in the SYBR Green
is detectable. In this assay, the relative amount of an amplicon is estimated in relation
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to a reference locus in the same sample and then this is compared to the respective
ratio in a control sample. By doing the normalization to a reference locus, differences
in the amount of sample loaded into the assay can be compensated. In all experiments
the WT-b0 strain was used as the control, and the SPT15 gene was used as the internal
reference locus.
First, the Ct of the target chromosome was normalized to the Ct of the reference lo-
cus for both, the test and control samples: ∆Ct(test) = Ct(testTarget)−Ct(testRef) and
∆Ct(control)= Ct(controlTarget)−Ct(controlRef). Then the ∆Ct of the test sample was nor-
malized against the ∆Ct of the control sample: ∆∆Ct = ∆Ct(test)−∆Ct(control). Finally,
the fold change (or relative copy number) of the target chromosome in the test sample
compared to the same locus in the control sample and normalized by the copy number
of a reference locus was estimated as 2−∆∆Ct .
To estimate the primer efficiencies, standard curves of the Ct values versus the log10 of
the quantities of template were produced using 8 serial two-fold dilutions from 2ng to
0.016ng for the WT-b0 control strain. A regression line was fitted and the amplification
efficiencies were calculated as 10(−1/slope) (Table B.4). Examples of the primer efficien-
cies for both arms of the assessed chromosomes and the reference locus are shown
in Figures 2.8 and B.2. Spearman rank correlation tests were used to calculate the
P-values for the relation between read depth base predictions and qPCR fold change
estimates.
A.2 General protocols for Chapter 3
A.2.1 Construct design
The deletion construct used in this study was design using SnapGene Viewer v2.5
[SnapGene] and the plasmid editing software ApE [Davis, 2012].
A.2.2 Construct synthesis
Due to its complex sequence composition, the deletion construct was synthesized by
GENEWIZ, Inc. Custom Gene Synthesis service and was received in a pUC57-Amp
plasmid. It was then cloned and modified as detailed below.
From the synthesized deletion construct (DelRep), another construct was derived by
removing the direct repeats (DelNoRep) present at the boundaries of the URA3 gene
(Figure 3.1). To remove the direct repeats, restriction digestions with enzymes PsiI
(NEB) and NaeI (NEB) for the left side repeat and enzymes PmeI (NEB) and SnaBI
(NEB) for the right side, were performed, independently for each repeat. For each
restriction digestion, 1µl of the original purified plasmid with the construct was used,
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in addition to 2µl of 10x CutSmart Buffer (NEB) and 1µl of each enzyme. The reaction
was incubated at 37°C for 1h. After the first restriction digestion, the open plasmid
was re-ligated using the Quick Ligation Kit (NEB), with 10µl of restriction digestion
reaction, 10µl of 2x Buffer and 1µl of Ligase enzyme. The mix was incubated for 5min.
at room temperature. Once the left repeat was removed, 2µl of the quick ligation
reaction were used to transform 50µl of JM109 cells for cloning of the plasmid (for
more details about cloning see Section A.2.3). This process was repeated to perform
the deletion of the repeat on the right side of the construct, using as a starting plasmid
the one lacking the left repeat.
Confirmation of the deletion of both left and right homologous repeats in the deletion
construct was performed by looking at the size differences of the products on a 1%
agarose gel (Section A.1.5). Additionally, Sanger sequencing of the area surrounding
the repeats was used to confirm de deletions.
The two deletion constructs, one carrying the direct repeats and the one without it,
were cloned (Section A.2.3) and used to amplify the constructs. The specific deletion
constructs were amplified then by PCR using primers M13FW and M13RV (the se-
quences are displayed in Table B.3). The PCR products were then separated on a 1%
agarose gel (Section A.1.5), purified using the QIAquick Gel Extraction Kit (Qiagen),
and used for the bulk transformation as described below.
Furthermore, a control construct (Hyg+), conferring constitutive hygromycin resistance
was also generated by removing the URA3 gene interrupting the HPH gene allowing its
expression and conferring resistance to the strains. Starting from the DelRep construct
in pUC57-Amp plasmid, a restriction digestion using blunt enzymes PsiI and PmeI
(NEB) was performed to excise the URA3 gene. Then the plasmid was re-ligated using
the Quick Ligation Kit (NEB) as explained before. The size of the new construct was
confirmed in a 1% agarose gel, and its sequence was confirmed by Sanger sequencing.
For transformation into the pool of yeast homozygous deletion mutants, all constructs
were linearized by restriction digestion using enzymes HindIIIHF and SacI (NEB).
A.2.3 Construct cloning
Each plasmid containing the deletion constructs was transformed into JM109 competent
bacteria for cloning. The bacteria were thawed on ice for approximately 5min. mixing
the cells by gentle flicking. For each transformation reaction, 10ng of the plasmid and
50µl of competent bacteria were added to 1.5ml reaction tubes. The mix was incubated
on ice for 20min. The cells were then heat shocked at 42°C for 45s. in a water bath
without shaking. The tubes were then immediately return to ice for 2min. After this,
250µl of S.O.C. medium (Invitrogen) at room temperature were added to each reaction
tube. The cells were then incubated for 1.5h at 37°C with shaking.
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To select for transformants, 100µl of the cells were plated in duplicate on LB + Amp
plates. The plates were incubated overnight at 37°C. The next day, the plates were
screened for colonies and four colonies for each plasmid were selected. These colonies
were then inoculated into 5ml LB + Amp cultures and incubated at 37°C overnight.
The following day, the plasmids were purified using the Mini Prep plasmid Purification
Kit (Qiagen).
A.2.4 Strains used
A homogeneous pool of the homozygous yeast deletion collection was obtained from
the Steinmetz lab at EMBL. All strains were in a S288c background. The distribution
of the strains was assessed by amplification of the uptags and downtags as explained
below.
The pool was composed of 5083 different mutant strains, and the growth rates of
these mutants is known to differ due to their deficiencies in different cellular processes.
Therefore, to avoid an imbalance in strain constitution of the pool due to growth, the
incubation times and the timing of the experiments was always optimized to be as short
as possible.
A.2.5 Yeast bulk transformation
All transformation were done using the high-efficiency Lithium Acetate (LiAc), single
stranded carrier DNA and Polyethylene Glycol 3350 (PEG) method [Gietz and Schiestl,
2007; Knop et al., 1999], with a few modifications. In summary a 50µl aliquot of the
pooled homozygous yeast deletion collection, at an OD600 of 50 was inoculated into a
5ml YPAD culture and incubated overnight on a rotor at 30°C.
The next day, the overnight culture was diluted to get an OD600 between 0.2 and 0.3.
Usually this meant diluting 2ml of the overnight culture in 50ml YPAD. The dilutions
were grown at 30°C at 180rpm for around 2.5h to reach and OD600 of 0.5-0.7. Once this
OD was reached, the cultures were centrifuged at 2500g for 3min and the supernatant
removed. The cells were then washed by resuspending them in 50ml of water and
repeating the centrifugation step using the same conditions. The supernatant was
discarded, and the cells were once again resuspended in 1ml of water.
From these cells, 100µl were transferred to a new tube and used for each transformation.
For each construct to be transformed, 20 independent transformations were done. The
100µl aliquot was centrifuged and the supernatant removed. Then, 34µl of the construct
were added to the cells and mixed by pipetting, corresponding to around 800ng to 1µg
of linearized construct DNA (prepared as explained in Section A.2.2), and incubated
for 10min at room temperature.
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A transformation mix was prepared using 240µl of PEG 50%, 36µl of LiAc 1M and 50µl
of single stranded DNA (salmon testis DNA denatured by heating at 95°C for 10min
and placed immediately on ice). This mix of 326µl was added to each of the 100µl
grown yeast cells. The transformation tubes were incubated for 70min at 42°C. This
time was optimized for high transformation efficiency of the yeast pool by performing
several transformations with varying heat shock times and estimating the transforma-
tion efficiency.
After the heat shock, the mix was centrifuged at 2500g for 30s. The supernatant was
removed and 500µl of YPAD were added to each transformed cells. These cultures
were incubated at 30°C and 550rpm for recovering the strains for 2h before plating in
synthetic complete medium lacking uracil (SC-URA). For the selection of transformed
strains, 250µl of the recovered culture were plated in SC-URA on 10cm petri dishes.
Two plates were done for each transformation experiment. The plates were incubated
at 30°C for 4 days.
After this incubation time, the colonies present on each plate were counted and picked
manually. All transformed strains with the same construct were combined in sets of
around 2000 colonies and stored in YPAD glycerol stock and stored at -80°C. In total,
20,000 colonies were picked for each construct transformation to cover, in theory, each
ORF in the homozygous yeast deletion collection approximately 5 times.
A.2.6 Confirmation of construct insertion
The insertion of the construct into the HXT13 gene in chrV was verified by PCRs,
positioning a primer into the cassette and a primer ouside of the cassette in both sides
of the insertion were verified. Primers LeftOutConstruct, LeftIntConstruct, RightOut-
Construct and RightIntConstruct in Table B.3 were used, yielding products of 531bp
for the left side and 535bp for the right side. The PCRs were performed using the
LongAmp Taq PCR kit (NEB), with an initial denaturation step of 94°C for 1min,
followed by 35 cycles of 20s at 94°C, 30s at 54°C and 1min at 65°C, and a final elonga-
tion step of 10min at 65°C, ending on hold at 10°C. Presence of a PCR product of the
correct size was confirmed in a 1% agarose gel (Section A.1.5).
A.2.7 Inducing replication stress to the pooled deletion collection
To increase mutation rates and to get some insights into the mechanisms that give rise
to a higher mutation formation, the transformed pools were treated with several drugs
that cause different stresses to the cells. The drugs applied were: hydroxyurea (HU),
methyl methanesulfonate (MMS), doxorubicin (Doxo) and camptothecin (Campt) (all
from Sigma) to induce replication stress or DNA damage.
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The induction of replication stress and DNA damage was done in deep well plates of
2ml. Using 100µl of the corresponding transformed pooled strains, a dilution to 200µl
was done with YPAD. These cultures were treated with the drugs and concentrations
depicted in Table B.6 and were grown overnight at 30°C. A non treated control was
always included. For MMS, the treatment time was reduced to 1h because cell viability
is lower in this drug. A non treated control, grown for 1h, was also included while
treating cells with MMS to have a similarly grown culture since the composition of the
pool changes with the growing timings.
After treatment, the cultures were centrifuged and the supernatant removed. The
cells were then washed 2 times by adding 500µl of YPAD, and centrifuged, and the
supernatant was discarded. The cells were then let to recover by resuspending them in
500µl of YPAD and incubating for 2.5h at 30°C.
Selection of the strains that acquired rearrangements in the construct was then done
by plating the cultures in YPAD + Hyg plates (with a hygromycin concentration of
200µg/ml) and letting them grow at 30°C for three days. After this, all the Hyg+
colonies were picked from the plate and stored at -80°C for subsequent experiments.
For confirmation of Hyg resistance, some plates were also replica plated in YPAD
+ 5FOA (5-fluoroorotic acid). The selectable marker URA3 allows for positive and
negative selection. The presence of the URA3 gene makes strains not able to grow
on 5FOA. However, if the strains have lost the expression of this gene, and in this
particular case, if they have deletions in this gene that allow the expression of the Hyg
resistance gene, then they are also able to grow in 5FOA plates. Therefore, this method
was used to double select the strains.
A.2.8 Amplification of the tags from the transformed pooled deletion
collection
For each enrichment and selection experiment, all Hyg+ colonies grown on YPAD +
Hyg plates, i.e. all strains that acquired a rearrangement in the construct and therefore
became hygromycin resistant, were picked from plates, and glycerol stocks were made
for storage at -80°C. From these stocks, 10µl were used for PCR amplification of the
tags. The aliquot was diluted in 20µl of SDS (0.2%) and incubated at 95°C for 5min to
break the cells, after which the cells were centrifuged and 2µl of the supernatant were
used for the PCR.
The PCRs to amplify the uptags and downtags were done for the pooled yeast cultures
using primers U1+KanB and D1+KanC respectively (see Table B.3 for the specific
sequences). PCR amplification using primers U1+KanB yields a product of 299bp
containing the uptags, and D1+KanC yields a 624bp product. Both tags were amplified
in a single 20µl PCR reaction using the SequalPrep Long PCR Kit (Invitrogen), with
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2min at 94°C, 10 cycles of 20s at 94°C, 40s at 56°C, and 1min at 68°C, followed by
another 25 cycles of 20s at 94°C, 40s at 54°C, and 1.5min at 68°C, and a final step of
10min at 72°. 2µl of the PCR products were loaded on a 1% agarose gel for verification
(Section A.1.5), and upon successful amplification, the PCRs were then purified using
1.8µl of AMPure XP beads (Agencourt) per 1µl of PCR product.
A.2.9 Sequencing of tags from the pooled deletion collection
The purified PCR products were used for library preparation and multiplex sequenc-
ing using the procedures and barcodes described in Section A.1.3. The protocol was
slightly modified, skipping the size selection step of the library preparation because the
amplicons had already sizes small enough to reach the barcode sequence from one side.
The sequencing was done on Illumina HiSeq 2000 or MiSeq instruments with paired
ends of 101bp or 150bp respectively.
A.2.10 Data analysis
Identification of strains through the sequences of the barcodes. The sequenc-
ing reads were then used for barcode identification. In theory, each deletion strain
contains one unique 20bp sequence in each of the amplicons. Based on some Sanger se-
quencing experiments, I realized that some of the mutants contain truncated barcodes,
or sequences that extend beyond the theoretical 20bp. The deletion collection has been
shown to have some inconsistencies, and therefore for the identification of the strains
through the barcodes we used strict criteria to perform the correct annotation.
Given that the PCR amplicons containing the uptags and downtags of all deletion
strains have the same sequence except for the mentioned 20bp, for each sequencing
read, we could remove the shared sequences using the trimming tool cutadapt [Martin,
2011]. It finds and removes sequences (adapters) from the 3’ and 5’ ends of the reads.
By using the parameter -a the sequences in the 3’ end of the barcode were removed, and
by using the parameter -g, the sequences at the 5’ end of the barcode were trimmed. As
queries, sequences of 20bp directly up and downstream of the barcode were used. Since
the reads may contain sequencing errors, the allowed maximum error rate (-e) was set
to 0.15. This accounts for up to 3 deletions, insertions or mismatches per adapter. The
resulting sequences were kept for following analyses if they were between 15-21bp long.
The trimmed sequences, that corresponded to the tags, were used to identify the
strains. For this, the list of all matched barcodes and strains was obtained from the
Saccharomyces Genome Deletion Project website (http://www-sequence.stanford.
edu/group/yeast_deletion_project/strain_homozygous_diploid.txt), and used
to search for our sequences allowing up to 3 inconsistencies, including mismatches,
deletions or insertions. Only barcodes that could be assigned uniquely to a strain
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name were used for the analysis. The number of reads per strain were quantified and
only strains supported by at least 10 sequencing reads, and identified by both up and
downtags, were considered to test for enrichments.
Assessing the strain composition of the transformed pools. After performing
the bulk transformation of the constructs, the strain composition of the pooled cultures
transformed with each of the constructs (the deletion construct with and without direct
repeats and the control construct that confers constitutive Hyg resistance) was assessed
by sequencing the barcodes and identifying the strains as described above. Additionally,
the original pool before the transformation was done, was also sequenced as a control to
assess how many strains could be identified by the PCR of the barcodes. The percentage
of strains out of a total of 5083 possible strains was estimated.
Identification of significantly enriched strains. To identify Hyg resistant strains
that were significantly enriched after applying each stressor or after growth in YPAD,
the R package DESeq2 [Love et al., 2014] was used. Differences in sequencing coverage
for each experiment are accounted for in the DESeq package, so that the read count
data can be used directly for analysis. We assessed if there were differences in the
composition of the Hyg resistant strain pools by using the read count data in the form
of a matrix with rows being all strains detected and columns being each treatment. A
significant enrichment of at least 2 fold was required (log2 fold change lfcThreshold=1).
Differential analysis was performed considering the pool of strains with constitutive Hyg
resistance as control.
Strains enriched in the pool without treatment were considered as having a stronger
genotype effect, i.e. the KO of a gene had an influence on the ability to suppress the
formation of deletions. The strains that were enriched only after drug treatment were
considered to have a higher influence from the environment, i.e. the stressor effect had
a stronger impact on the formation of deletions. Strains that were present before and
after treatment had an additive effect of the influence of their genotype and the drug
stressor.
Growth rates comparison. The growth rates in rich medium for all yeast homozy-
gous deletion strains were downloaded from http://www-deletion.stanford.edu/
YDPM/index.html. The results of two time course experiments are available, but are
highly correlated. Therefore the measures of growth base in the first time course were
used for the comparisons. The growth rates were estimated by a linear regression fit to
intensity values obtained from growth experiments [Steinmetz et al., 2002].
The growth rates of the strains from the bottleneck mutation accumulation assay (Ta-
ble B.1) were compared to the growth rates of the top ten strains detected in the
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enrichment assay carrying the DelRep construct and treated with drugs (Table B.9).
Additionally, the growth rates of the strains detected after no stressor were also used
for comparison. Wilcoxon rank-sum tests were used to assess the differences between
the growth rates of these pools of strains.
Pathway analysis of the enriched strains. Gene ontology enrichment analysis
was performed with the AmiGO 2 GO term enrichment tool based on the PANTHER
Classification System [Mi et al., 2013] The PANTHER database maintains up to date
GO annotations. The estimations of significance for the enrichment analysis are com-
puted based on the background number of genes that belong to a specific GO term and
the number of strains belonging to that pathway the sample set.
Additionally, GOSlim terms were used to create Figure 3.9, in which the GO terms are
parental categories, i.e. broader groups that comprise several GO terms. The plot and
the estimation of the significance of enrichment were done using Cytoscape [Shannon
et al., 2003] and the plugin BiNGO [Maere et al., 2005], with a custom reference set
of strains used as background. For this reference set, only the strains detected in the
original pool of deletion mutants were included.
Plots and statistical tests. All plots and statistical analyses in this section were
done using the software environment R, version 3.1.0 [R Core Team, 2014], unless
otherwise specified.
A.2.11 Verification of candidate genes
Creation of KO strains. Due to several issues and concerns about the original yeast
deletion collection, e.g. Ben-Shitrit et al. [2012], the deletion strains for the candidate
genes were generated starting with the BY4341 (MATa) and the BY4342 (MATα)
wildtype haploid strains. For this aim, a PCR deletion strategy was used [Baudin et al.,
1993; Wach et al., 1994], similar to the procedure used to create the original deletion
strains, where each desired ORF is substituted from its start and stop codons with
the KanMX4 cassette. In this case, the unique barcodes incorporated in the original
experiment were not included, as the strains were grown afterwards independently.
Once strains of both mating types were created, homozygous diploid deletion mutants
were also generated as described in the following section.
The KanMX4 cassette was amplified from the pFA6a-KanMX4 plasmid (kindly pro-
vided by the Steinmetz Lab, EMBL) with extended U2 and D2 primers, each including
40bp homologous to the upstream and downstream sequences of the yeast ORFs respec-
tively (full sequences are provided in http://www-sequence.stanford.edu/group/
yeast_deletion_project/strain_homozygous_diploid.txt). The cassette was am-
plified using the SequalPrep Long PCR Kit (Invitrogen) as described in Section A.2.8,
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with extension times of 2:30min for the first 10 cycles and and 2:45min for the remain-
ing 25 cycles. PCR products were loaded on a 1% agarose gel (Section A.1.5) and
the bands were cut out and purified with the QIAquick Gel Extraction Kit (QIAGEN)
following the protocol from the provider. Concentrations of the purified products were
measured with Qubit dsDNA BR Assay (Life Technologies).
The amplified KanMX4 cassette containing the homologous sequences were used in
independent transformation assays, using the Gietz and Schiestl [2007] protocol as
described in Section A.2.5. After the transformation, the strains were plated on YPAD
+ G418 plates (with a geneticin concentration of 200ug/ml). The plates were incubated
at 30°C for 2 days and replica plated to new YPAD + G418 plates to remove false
positives. After plate incubation for 2 more days, three colonies were confirmed by
PCR as described in Section A.2.11, inoculated in a 5ml YPAD and grown overnight.
Glycerol stocks were made for each strain and stored at -80°C.
Strain confirmation. PCRs using primers outside of the KanMX4 cassette 200-
400bp upstream and downstream of each ORF (primers A and D), and a pair of primers
within the cassette (primers KanB and KanC in Table B.3), were done as described by
[Winzeler, 1999]. Therefore, upon successful deletion of the desired ORF by replacing
it with the KanMX4 cassette, the PCRs using primers A for each specific ORF and
KanB, or primers D and KanC, should both give products. PCRs were performed us-
ing the primers listed in the Saccharomyces Genome Deletion Project website (http://
www-sequence.stanford.edu/group/yeast_deletion_project/deletions3.html)
and the LongAmp Taq PCR kit (NEB) as described in Section A.2.6. All products
had sizes of around 500-800bp.
Creating homozygous diploid KO strains. Diploids were created by mating the
KO strains of each mating type. One MATa colony KO was streaked onto a YPAD
plate. On top of the streaked colony, another MATα colony of the same KO was
streaked out. The plates were left to grow at 30°C for two days after which a small
amount of the combined strains was streaked out for single colonies into a new YPAD
plate. From the growing colonies, two were selected for PCR assessment of the mating
type to confirm the ploidy as explained below.
Assessment of yeast mating type by PCR. To verify the mating type of each
newly created strain, a PCR-based assessment method was used following Huxley et al.
[1990]. In summary, it is possible to amplify regions of the MAT locus that clearly
distinguish between three possible mating types, namely a, α, or the a/α diploid. For
the PCR, one single colony was dissolved in 20µl SDS 0.2% and incubated at 95°C
for 5min. Then 1µl of the supernatant was used for each reaction. Three primers
are used in each reaction (Table B.3). Two are forward primers: primer MATa binds
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to a sequences within the a-specific region of the MATa locus. Similarly, the MATα
primer binds to a α-specific sequence. The reverse primer aligns to a sequence directly
downstream of the MAT locus. By using the three primers in a single reaction, the
MATa strains with generate a PCR product of 544bp, the MATα strains with give a
404bp product. The diploid strains will show both bands.
Induction of replication stress in individual KO strains. Once the individual
KO strains containing the constructs were created, they were treated independently
with the same drugs used in the pooled screen to confirm the effect on the formation of
deletions. For this step, one colony of each strain was inoculated to a 2ml YPAD culture
and grown overnight at 30°C. The next day, several aliquots of around 9.25×105 cells of
the grown strain were each diluted to a total of 100µl YPAD culture. Each 100µl culture
was then treated with the appropriate amounts of drug to achieve the concentrations
shown in Table B.6.
Identification and quantification of strains with rearrangements in the con-
struct. The detection of strains with rearrangements in the construct that confer
hygromycin resistance was done by plating around 3×104 of the treated cells on YPAD
+ Hyg plates. The plates were incubated at 30°C for 3 days after which the colonies on
each plate were counted. To be able to quantify the differences between the treatments
and the KO strains, the same amounts of cells were plated.
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Supplementary figures and tables
B.1 Supplementary figures and tables for Chapter 2
Table B.1: Yeast deletion mutant strains used in the neutral mutation accumulation experiment
grouped into broad functional categories.
Deleted yeast gene General functions Main functional category
MRE11 DSB repair by recombination Recombination
RAD52 DSB repair by recombination
SGS1 Illegitimate recombination suppression
RAD59 Recombination, single-strand annealing
ESC2 Transcriptional Silencing, Recombination, DNA Dam-
age Checkpoint
MSH2 Mismatch repair DNA Repair
LIF1 Non-homologous end-joining
SAE2 Hairpin DNA processing
RTT107 Replication fork repair
SRS2 DNA repair, genome stability
RAD50 DSB repair, NHEJ
MMS4 Recombination and repair
RAD6 Histone Modifying, DSB repair, Checkpoint Control
PMS1 Mismatch Repair
RAD10 NER (Nucleotide Excision Repair), DSB repair
MUS81 Replication fork restart, DNA repair
RAD18 Postreplication repair, Ubiquitin ligase Chromosome segregation
CHK1 Chromosome Segregation (DNA damage checkpoint)
SGO1 Chromosome Segregation, Spindle Checkpoint
CTF19 Chromosome Segregation
CIN8 Chromosome Segregation
NUP170 Chromosome Segregation, Nuclear Pore Complex
RSC1 Chromatin Remodeling Chromatin remodeling
ASF1 Chromatin Remodeling, Ty1 Transposition
ISW1 Chromatin Remodeling
SPT2 Chromatin Remodeling
SWR1 Chromatin Remodeling
continued on next page
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Table B.1: continued from previous page
Deleted yeast gene General function Main functional category
CTF8 DNA damage replication checkpoint, Sister Chromatid
Cohesion
Replication
CSM3 DNA damage replication checkpoint, meiotic chromo-
some segregation
TOF1 DNA replication checkpoint
RAD27 Okazaki fragment processing
POL32 Error-prone DNA synthesis
RRM3 Ty1 Transposition, Replication Fork Stalling
CTF4 DNA Replication, Sister Chromatid Cohesion
SLX1 Replication fork restart
DUN1 DNA damage replication checkpoint, post-replicative
DNA repair
HST3 Transcriptional Silencing Other functions
ARD1 Transcriptional Silencing, N-terminal acetylation
RAD24 DNA damage checkpoint signaling
DOT1 Histone Modifying, DNA damage response
SET1 Histone Modifying
PMR1 Protein sorting
YKU70 Telomere maintenance and NHEJ
YOL086W-A Genome stability maintenance, homolog of Fanconi Ane-
mia Complex
GCN5 Transcription regulation
BY4741 Parental strain wild type
HIS1 Histidine biosynthesis - control
TRP5 Tryptophan biosynthesis - control
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Table B.2: Total number of de novo mutations accumulated in different yeast deletion mutants.
Two replicates are shown, corresponding to the two MA lines per deletion strain analyzed. (SI: short
insertions, Tandem dup: tandem duplications).
Deleted yeast gene Replicate Deletions SI Tandem dup. SNVs
ARD1 1 15 5 0 48
ARD1 2 18 8 0 33
ASF1 1 10 7 0 81
ASF1 2 13 6 1 47
BY4741 1 17 4 0 41
BY4741 2 15 5 0 77
CHK1 1 29 17 0 17
CHK1 2 53 11 1 12
CSM3 1 12 4 0 91
CSM3 2 91 25 2 10
CTF4 1 36 10 0 97
CTF4 2 31 13 1 77
CTF8 1 11 0 0 30
CTF8 2 113 21 10 20
CTF9 1 32 10 0 30
CTF9 2 6 2 0 52
DOT1 1 35 16 1 23
DOT1 2 30 6 1 15
DUN1 1 16 5 1 11
DUN1 2 6 2 1 49
ESC2 1 8 1 0 30
ESC2 2 11 8 0 40
GCN5 1 14 4 3 83
GCN5 2 30 14 1 23
HIS1 1 195 16 2 48
HIS1 2 26 12 4 29
HST3 1 17 5 1 42
HST3 2 81 24 4 32
HTZ1 1 39 12 2 59
HTZ1 2 47 13 1 29
ISW1 1 86 18 0 31
ISW1 2 110 23 2 22
LIF1 1 87 13 2 82
LIF1 2 26 4 1 74
MMS4 1 55 18 6 20
MMS4 2 76 32 3 26
MRE11 1 117 26 6 51
MRE11 2 38 12 2 67
MSH2 1 1002 146 0 175
MSH2 2 418 38 0 174
MUS81 1 31 12 1 21
MUS81 2 1 2 0 26
NUP170 1 73 11 4 10
NUP170 2 20 4 0 25
PMR1 1 18 17 0 91
PMR1 2 26 11 3 104
continued on next page
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Table B.2: continued from previous page
Deleted yeast gene Replicate Deletions SI Tandem dup. SNVs
PMS1 1 9 10 1 65
PMS1 2 17 10 3 48
POL32 1 57 4 1 37
POL32 2 58 9 3 37
RAD10 1 26 14 3 39
RAD10 2 12 6 4 66
RAD18 1 21 6 1 18
RAD18 2 15 2 3 46
RAD24 1 28 10 2 31
RAD24 2 28 11 0 37
RAD27 1 123 67 2 76
RAD27 2 84 85 6 60
RAD50 1 104 24 7 87
RAD50 2 14 8 2 46
RAD52 1 169 29 5 91
RAD52 2 88 19 13 75
RAD59 1 74 17 1 76
RAD59 2 30 6 0 67
RAD6 1 7 3 0 36
RAD6 2 17 2 2 54
RRM3 1 27 7 0 48
RRM3 2 19 4 1 61
RSC1 1 38 10 3 53
RSC1 2 40 12 5 70
RTT107 1 96 19 3 48
RTT107 2 75 20 3 104
SAE2 1 122 13 1 68
SAE2 2 23 8 0 66
SGO1 1 107 27 1 11
SGO1 2 54 10 2 20
SGS1 1 42 5 0 32
SGS1 2 24 8 4 52
SLX1 1 118 26 2 11
SLX1 2 7 1 0 35
SRS2 1 31 12 8 31
SRS2 2 65 22 3 7
SWR1 1 77 9 1 21
SWR1 2 85 14 1 30
TOF1 1 73 14 5 61
TOF1 2 76 14 3 52
TRP5 1 100 9 0 99
TRP5 2 128 21 3 42
YKU70 1 51 20 10 38
YKU70 2 31 5 1 66
YOL086-A 1 22 14 4 68
YOL086-A 2 18 4 0 41
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Figure B.1: Number of A | deletions, B | short insertions and C | SNVs in each yeast deletion
mutant classified into broad functional categories. For comparison, the strains are ordered by the
number of deletions they acquired, and the same order is preserved in the other plots. It is noticeable
that strains with the highest number of deletions are not necessarily the ones with the highest number
of short insertions or SNVs. The total number of de novo mutations occurring in less than 10% of
the strains is shown.
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Table
B
.3:
Prim
ersused
in
thisstudy.
Nam
e
Sequence
5’-3’
Function
Source
M
13FW
TGTAAAACGACGGCCAGT
Am
plify
constructfrom
plasm
id
Universalplasm
id
prim
er
M
13RV
CAGGAAACAGCTATGACC
Am
plify
constructfrom
plasm
id
Universalplasm
id
prim
er
ConstructSeqPrim
erFW
CGTTGTTCCAGAGCTGATGA
Testforrearrangem
ents
in
construct
This
study
ConstructSeqPrim
erRV
ATAGGTCAGGCTCTCGCTGA
Testforrearrangem
ents
in
construct
This
study
LeftO
utConstruct
ACGGATATTCAGAACCCAATGA
Confirm
ation
ofconstructtransform
ation
This
study
LeftIntConstruct
GTAACTGGAAGGAAGGCCGT
Confirm
ation
ofconstructtransform
ation
This
study
RightIntConstruct
CATCCGGAGCTTGCAGGATC
Confirm
ation
ofconstructtransform
ation
This
study
RightO
utConstruct
TTCACTCCACCCCGCTTTAC
Confirm
ation
ofconstructtransform
ation
This
study
U1
GATGTCCACGAGGTCTCT
Am
plify
the
uptag
[Giaeveretal.,2002]
D
1
CGGTGTCGGTCTCGTAG
Am
plify
the
downtag
[Giaeveretal.,2002]
KanB
CTGCAGCGAGGAGCCGTAAT
Am
plify
the
uptag
[Giaeveretal.,2002]
KanC
TGATTTTGATGACGAGCGTAAT
Am
plify
the
downtag
[Giaeveretal.,2002]
M
AT
a
AGTCACATCAAGATCGTTTATGG
M
ating
type
assessm
ent
[Huxley
etal.,1990]
M
AT
α
GCACGGAATATGGGACTACTTCG
M
ating
type
assessm
ent
[Huxley
etal.,1990]
M
AT
a/
α
ACTCCACTTCAAGTAAGAGTTTG
M
ating
type
assessm
ent
[Huxley
etal.,1990]
GFPinternalRV
CGTTCTTCTGCTTGTCGGCCATGA
GFP
tagging
confirm
ation
This
study
GFPinternalFW
TATGCTGTTATCGATTTGGGAT
GFP
tagging
confirm
ation
This
study
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Figure B.2: Primer efficiencies for qPCR validation of aneuploidies. A, B | Standard curves for
primer efficiency estimation for regions in the left and right arms of chrII respectively. C,D | Standard
curves for primer efficiency estimation for regions in the left and right arms of chrVI respectively.
E | Standard curves for primer efficiency estimation for SPT15, the internal reference locus used for
calibration.
110
Supplementary figures and tables for Chapter 2
Table B.5: List of barcodes for multiplexed paired-end sequencing used in this study (WW barcodes
were previously described in [Wilkening et al., 2013]).
Name codePE2 codePE1
WWmp1 AGCGCT AGCGCT
WWmp2 AGTCTT AAGACT
WWmp3 TCGCTT AAGCGA
WWmp4 TGACAT ATGTCA
WWmp5 CACTGT ACAGTG
WWmp6 GAGAGT ACTCTC
WWmp7 GATGCT AGCATC
WWmp8 CAAGTT AACTTG
WWmp9 GGAACT AGTTCC
WWmp10 CCGTAT ATACGG
WWmp11 ATAGAT ATCTAT
WWmp12 GCTCAT ATGAGC
WWmp13 ATCGTG CACGAT
WWmp14 TGAGTG CACTCA
WWmp15 CGCCTG CAGGCG
WWmp16 GCGTGG CCACGC
WWmp17 TTGCGG CCGCAA
WWmp18 CTAAGG CCTTAG
WWmp19 ATTCCG CGGAAT
WWmp20 CGTACG CGTACG
WWmp21 AGCTAG CTAGCT
WWmp22 GTATAG CTATAC
WWmp23 TCTGAG CTCAGA
WWmp24 TACAAG CTTGTA
WWmp25 TCCGTC GACGGA
WWmp26 CCACTC GAGTGG
WWmp27 TATATC GATATA
WWmp28 CTGATC GATCAG
WWmp29 CCTTGC GCAAGG
Name codePE2 codePE1
WWmp30 AAGTGC GCACTT
WWmp31 TGGAGC GCTCCA
WWmp32 TGTGCC GGCACA
WWmp33 CAGGCC GGCCTG
WWmp34 GCTACC GGTAGC
WWmp35 CTCTAC GTAGAG
WWmp36 GGCCAC GTGGCC
WWmp37 CGAAAC GTTTCG
WWmp38 GCTGTA TACAGC
WWmp39 ATTATA TATAAT
WWmp40 GAATGA TCATTC
WWmp41 TCGGGA TCCCGA
WWmp42 TGCCGA TCGGCA
WWmp43 CATTCA TGAATG
WWmp44 ATGGCA TGCCAT
WWmp45 CCAGCA TGCTGG
WWmp46 GCCTAA TTAGGC
WWmp47 TTCGAA TTCGAA
WWmp48 GGAGAA TTCTCC
mp13 GGGGTT AACCCC
mp19 GTTTGT ACAAAC
mp21 AAAATG CATTTT
mp5 ACATCG CGATGT
mp49 AAACCT AGGTTT
mp50 CTTTTG CAAAAG
mp51 GGACGG CCGTCC
mp52 GGTTTC GAAACC
mp53 TTTCAC GTGAAA
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B.2 Supplementary figures and tables for Chapter 3
Table B.6: Drug concentrations used to induce mutations in the transformed pooled deletion
collection.
Drug Working Concentration
Hydroxyurea (HU) 50µM
Doxorubicin (Doxo) 25µM
Camptothecin (Campt) 10µM
Methyl methanesulfonate (MMS) 0.10%
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Table B.7: Total number of reads sequenced for the original pool of homozygous yeast deletion
mutant strains (before the transformation of any construct), and the pools after transformation of
the DelRep, DelNoRep and Hyg+ constructs. The percentage of strains in each transformed pool
compared to the original pool was calculated taken into account the strains that are shared between
replicates.
Pool Replicate
Total number of
reads
Total number of
strains identified
Percentage of strains
in the original pool
Original pool 1 871666 5143
2 626098 4562
DelRep construct 1 643728 3713 76.76%
2 781458 3959
3 792034 3503
DelNoRep construct 1 901580 3759 74.54%
2 906772 3951
3 861048 3141
Hyg+ construct 1 763190 3802 76.00%
2 972044 3826
3 891776 3436
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Figure B.3: Correlation between the number of reads per strain detected with the uptags and
downtags in the original pool of yeast KO strains (r : Pearson correlation coefficient).
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Figure B.4: Correlation between replicate experiments of the pools transformed with the DelRep
construct, after the treatment with drugs (r : Pearson correlation coefficient).
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Figure B.5: Correlation between replicate experiments of the pools transformed with the DelNoRep
construct after the treatment with drugs (r : Pearson correlation coefficient).
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Figure B.6: Strains enriched after different treatments in the pools transformed with the Del-
Rep and DelNoRep constructs. The blue lines delimit the 2-fold change threshold. A | Del-
NoRep+camptothecin (Campt). B | DelNoRep+doxorubicin (Doxo). C | DelNoRep+hydroxyurea
(HU). D | DelNoRep+methyl methanesulfonate (MMS). E | DelRep+camptothecin. F | Del-
Rep+doxorubicin. G | DelRep+hydroxyurea. H | DelRep+methyl methanesulfonate.
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Table B.8: Significantly enriched strains in the pools transformed with the DelNoRep construct after
different drug treatments. Highlighted are the strains selected for experimental validations (Gene
Name indicates the particular genes that are deleted in these strains. padj: Benjamini-Hochberg
adjusted p-value).
Strain Fold
Change
padj Gene Name Description
Campt
YDR252W 6.92 6.14E-05 BTT1 Heterotrimeric nascent polypeptide-associated
complex beta3 subunit
YKL047W 6.66 0.046 ANR2 Putative protein of unknown function
YDR316W 6.22 0.036 OMS1 Protein integral to the mitochondrial membrane
YFL027C 6.14 0.055 GYP8 GTPase-activating protein for yeast Rab family
members
YJR128W 4.22 0.092 - Dubious open reading frame
YOR374W 3.56 0.091 ALD4 Mitochondrial aldehyde dehydrogenase
Doxo
YKL047W 6.78 0.027 ANR2 Putative protein of unknown function
YDR252W 4.88 0.001 BTT1 Heterotrimeric nascent polypeptide-associated
complex beta3 subunit
YBL002W 3.80 0.005 HTB2 Histone H2B
YOR374W 3.50 0.077 ALD4 Mitochondrial aldehyde dehydrogenase
HU
YDR252W 4.17 0.021 BTT1 Heterotrimeric nascent polypeptide-associated
complex beta3 subunit
MMS
YJR021C 5.94 0.056 REC107 Protein involved in early stages of meiotic recom-
bination
YER005W 5.68 0.086 YND1 Apyrase with wide substrate specificity
YLR285W 5.36 0.005 NNT1 S-adenosylmethionine-dependent methyltrans-
ferase
YDR336W 5.34 0.017 - Putative protein of unknown function
YKL205W 5.03 0.025 LOS1 Nuclear pore protein
YBR116C 4.73 0.030 - Dubious open reading frame
YDL121C 4.70 0.082 - Putative protein of unknown function
YDL233W 3.91 0.081 MFG1 Regulator of filamentous growth
YHR155W 3.35 0.093 YSP1 Mitochondrial protein
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Table B.9: Top ten significantly enriched strains in the pools transformed with the DelRep construct
after different drug treatments. Highlighted are the strains selected for experimental validations
(Gene Name indicates the particular genes that are deleted in these strains. padj: Benjamini-
Hochberg adjusted P-value. 11 strains are shown for HU to include REC114).
Strain Fold
Change
padj Gene Name Description
Campt
YFL003C 7.86 0.001 MSH4 Protein involved in meiotic recombination; re-
quired for normal levels of crossing over, colo-
calizes with Zip2p to discrete foci on meiotic
chromosomes
YGL226C-A 7.28 0.004 OST5 Zeta subunit of the oligosaccharyltransferase
complex of the ER lumen
YGL248W 7.05 0.006 PDE1 Low-affinity cyclic AMP phosphodiesterase
YGR254W 6.64 0.018 ENO1 Enolase I, a phosphopyruvate hydratase
YDR370C 6.51 0.013 DXO1 mRNA 5’-end-capping quality-control protein
YER046W 6.44 0.020 SPO73 Meiosis-specific protein of unknown function
YGL249W 6.41 0.028 ZIP2 Meiosis-specific protein; involved in normal
synaptonemal complex formation and pairing be-
tween homologous chromosomes during meiosis
YBR169C 6.30 0.025 SSE2 Member of the heat shock protein 70 (HSP70)
family
YGR100W 6.21 0.049 MDR1 Cytoplasmic GTPase-activating protein
YLR131C 6.20 0.062 ACE2 Transcription factor required for septum destruc-
tion after cytokinesis
Doxo
YBR217W 8.62 1.27E-04 ATG12 Ubiquitin-like modifier involved in autophagy
and the Cvt pathway
YER046W 7.67 0.002 SPO73 Meiosis-specific protein of unknown function
YGR015C 7.54 0.002 - Putative protein of unknown function
YBR169C 7.39 0.005 SSE2 Member of the heat shock protein 70 (HSP70)
family
YDL093W 7.15 0.005 PMT5 Protein O-mannosyltransferase
YDR312W 7.12 0.008 SSF2 Protein required for ribosomal large subunit mat-
uration
YDR503C 7.06 0.009 LPP1 Lipid phosphate phosphatase
YGR100W 7.02 0.009 MDR1 Cytoplasmic GTPase-activating protein
YOL158C 7.00 0.007 ENB1 Endosomal ferric enterobactin transporter
YBL055C 6.90 0.011 - 3’-5’ exonuclease and endonuclease with a pos-
sible role in apoptosis
HU
YDR314C 8.60 2.70E-05 RAD34 Protein involved in nucleotide excision repair
(NER)
YJR082C 8.30 4.49E-05 EAF6 Subunit of the NuA4 acetyltransferase complex
YJL171C 7.80 0.001 - GPI-anchored cell wall protein of unknown func-
tion
YGL249W 7.48 0.003 ZIP2 Meiosis-specific protein; involved in normal
synaptonemal complex formation and pairing be-
tween homologous chromosomes during meiosis
continued on next page
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Table B.9: continued from previous page
Strain Fold
Change
padj Gene Name Description
YBL019W 7.19 0.003 APN2 Class II abasic (AP) endonuclease involved in re-
pair of DNA damage
YBR233W 7.17 0.004 PBP2 RNA binding protein; involved in the regulation
of telomere position effect and telomere length
YDL110C 7.04 0.004 TMA17 ATPase dedicated chaperone that adapts protea-
some assembly to stress
YDR078C 6.98 0.006 SHU2 Component of the Shu complex, which promotes
error-free DNA repair
YDR421W 6.97 0.014 ARO80 Zinc finger transcriptional activator of the
Zn2Cys6 family
YGR238C 6.96 0.010 KEL2 Protein that negatively regulates mitotic exit
YMR133W 6.94 0.013 REC114 Protein involved in early stages of meiotic recom-
bination
MMS
YDR497C 14.13 0.001 ITR1 Myo-inositol transporter; member of the sugar
transporter superfamily
YLR047C 17.61 0.002 FRE8 Protein with sequence similarity to iron/copper
reductase
YLR131C 4.46 0.015 ACE2 Transcription factor required for septum destruc-
tion after cytokinesis
YJL083W 3.30 0.028 TAX4 EH domain-containing protein
YKL061W 3.90 0.037 BLI1 Subunit of the BLOC-1 complex involved in en-
dosomal maturation
YBR169C 2.62 0.025 SSE2 Member of the heat shock protein 70 (HSP70)
family
YBL052C 4.13 0.029 SAS3 Histone acetyltransferase catalytic subunit of
NuA3 complex
YGL257C 5.74 0.025 MNT2 Mannosyltransferase
YLR246W 3.21 0.051 ERF2 Subunit of a palmitoyltransferase
YLR456W 7.83 0.025 - Putative pyridoxal 5’-phosphate synthase
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Table B.10: Strains with the highest fold enrichments detected under both stress and no stress
growth conditions. In bold, genes that are related to DNA repair and genome maintenance pathways.
Underlined are genes uniquely detected in each drug.
Strain Gene Name Fold enrich.
Drug
Fold enrich.
YPAD
Description
Campt
YBR222C PCS60 11.4 5.5 Oxalyl-CoA synthetase
YBR073W RDH54 11.0 5.2 DNA-dependent ATPase; DNA recombination/repair
translocase, supercoils DNA and promotes DNA
strand opening
YGR121C MEP1 10.0 7.8 Ammonium permease
YIR013C GAT4 9.9 6.3 Protein containing GATA family zinc finger motifs
YMR186W HSC82 9.8 8.8 Cytoplasmic chaperone of the Hsp90 famil
YKL174C TPO5 9.7 7.0 Protein involved in excretion of putrescine and sper-
midine
YBR066C NRG2 9.6 5.2 Transcriptional repressor
YGL087C MMS2 9.6 7.5 Ubiquitin-conjugating enzyme variant; involved in
error-free postreplication repair
YOL136C PFK27 9.5 9.2 6-PhosphoFructo-2-Kinase
YIL038C NOT3 9.4 6.0 Subunit of CCR4-NOT global transcriptional regula-
tor
YDR034C LYS14 9.3 7.1 Transcriptional activator involved in regulating lysine
biosynthesis
YLR247C IRC20 9.3 8.1 E3 ubiquitin ligase and putative helicase; involved in
synthesis-dependent strand annealing-mediated ho-
mologous recombination
YMR038C CCS1 9.3 8.6 Copper chaperone for superoxide dismutase Sod1p;
protein abundance increases in response to DNA
replication stress
YAR042W SWH1 9.2 3.6 Protein similar to mammalian oxysterol-binding pro-
tein
YDL230W PTP1 9.2 7.1 Phosphotyrosine-specific protein phosphatase
YML074C FPR3 9.2 8.6 Nucleolar peptidyl-prolyl cis-trans isomerase (PPI-
ase)
YBL002W HTB2 9.1 3.7 Histone H2B; core histone protein required for chro-
matin assembly and chromosome function
YDL182W LYS20 9.1 7.0 Homocitrate synthase isozyme
YIL120W QDR1 9.0 6.2 Multidrug transporter of the major facilitator super-
family
YLR445W GMC2 8.9 8.4 Protein involved in meiotic crossing over
YJR001W AVT1 8.8 7.8 Vacuolar transporter
YDR465C RMT2 8.8 7.3 Arginine N5 methyltransferase; relative distribution
to the nucleus increases upon DNA replication stress
YGL032C AGA2 8.7 7.3 Adhesion subunit of a-agglutinin of a-cells
YHR155W YSP1 8.7 5.8 Mitochondrial protein
YPL103C FMP30 8.7 9.7 Protein with a role in maintaining mitochondrial mor-
phology
YGL255W ZRT1 8.7 7.6 High-affinity zinc transporter of the plasma mem-
brane
YBR057C MUM2 8.5 5.0 Protein essential for meiotic DNA replication and
sporulation
YNL253W TEX1 8.4 9.2 Protein involved in mRNA export
YMR044W IOC4 8.4 8.7 Member of a complex (Isw1b) with Isw1p and Ioc2p
Doxo
YOL136C PFK27 14.1 9.2 6-phosphofructo-2-kinase; catalyzes synthesis of
fructose-2,6-bisphosphate
YBR222C PCS60 13.8 5.5 Oxalyl-CoA synthetase
YBR057C MUM2 13.1 5.0 Protein essential for meiotic DNA replication and
sporulation
continued on next page
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Table B.10: continued from previous page
Strain Gene Name Fold enrich.
Drug
Fold enrich.
YPAD
Description
YDL182W LYS20 12.8 6.6 Homocitrate synthase isozyme; catalyzes the conden-
sation of acetyl-CoA and alpha-ketoglutarate to form
homocitrate
YMR038C CCS1 12.7 8.6 Copper chaperone for superoxide dismutase Sod1p;
protein abundance increases in response to DNA
replication stress
YDR465C RMT2 12.2 7.3 Arginine N5 methyltransferase; relative distribution
to the nucleus increases upon DNA replication stress
YBR216C YBP1 12.2 5.4 Protein involved in cellular response to oxidative
stress
YLR445W GMC2 12.1 8.3 Protein involved in meiotic crossing over; component
of the Synaptonemal Complex (SC)
YEL012W UBC8 11.9 5.9 Ubiquitin-conjugating enzyme that regulates gluco-
neogenesis
YDR345C HXT3 11.8 7.2 Low affinity glucose transporter of the major facilita-
tor superfamily
YOR371C GPB1 11.5 9.6 Multistep regulator of cAMP-PKA signaling
YMR186W HSC82 11.4 8.7 Cytoplasmic chaperone of the Hsp90 family
YBR066C NRG2 11.4 5.1 Transcriptional repressor
YBR258C SHG1 11.3 5.5 Subunit of the COMPASS (Set1C) complex; COM-
PASS methylates histone H3
YGR121C MEP1 11.2 7.5 Ammonium permease
YBL002W HTB2 11.1 3.6 Histone H2B; core histone protein required for chro-
matin assembly and chromosome function
YAR042W SWH1 11.0 11.1 Protein similar to mammalian oxysterol-binding pro-
tein
YGL087C MMS2 10.8 7.3 Ubiquitin-conjugating enzyme variant; involved in
error-free postreplication repair
YGR260W TNA1 10.8 7.6 High affinity nicotinic acid plasma membrane perme-
ase
YBR073W RDH54 10.8 5.2 DNA-dependent ATPase; DNA recombination/repair
translocase, supercoils DNA and promotes DNA
strand opening
YPL103C FMP30 10.7 9.7 Protein with a role in maintaining mitochondrial mor-
phology
YER037W PHM8 10.5 6.0 Lysophosphatidic acid (LPA) phosphatase, nucleoti-
dase
YKL137W CMC1 10.5 6.6 Copper-binding protein of the mitochondrial inter-
membrane space
YDR357C CNL1 10.5 7.3 Subunit of the BLOC-1 complex involved in endoso-
mal maturation
YGR068C ART5 10.4 7.3 Protein proposed to regulate endocytosis of plasma
membrane proteins
YDR034C LYS14 10.4 7.2 Transcriptional activator involved in regulating lysine
biosynthesis
YCL026C-A FRM2 10.4 5.6 Type II nitroreductase, using NADH as reductant;
involved in the oxidative stress response
YMR101C SRT1 10.4 8.6 Cis-prenyltransferase
YDL230W PTP1 10.3 7.0 Phosphotyrosine-specific protein phosphatase
HU
YMR038C CCS1 13.5 8.6 Copper chaperone for superoxide dismutase Sod1p;
protein abundance increases in response to DNA
replication stress
YOL136C PFK27 13.0 9.2 6-PhosphoFructo-2-Kinase
YMR186W HSC82 13.0 8.8 Cytoplasmic chaperone of the Hsp90 family
YNL253W TEX1 12.9 9.2 Protein involved in mRNA export
YJR004C SAG1 12.2 7.8 Alpha-agglutinin of alpha-cells
YBR057C MUM2 12.1 5.0 Protein essential for meiotic DNA replication and
sporulation
YBR222C PCS60 11.7 5.5 Oxalyl-CoA synthetase
continued on next page
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Table B.10: continued from previous page
Strain Gene Name Fold enrich.
Drug
Fold enrich.
YPAD
Description
YIR013C GAT4 11.6 6.5 Protein containing GATA family zinc finger motifs
YDR163W CWC15 11.6 7.3 Non-essential protein involved in pre-mRNA splicing
YBR066C NRG2 11.5 5.1 Transcriptional repressor
YDL188C PPH22 11.5 7.3 Catalytic subunit of protein phosphatase 2A
YML100W TSL1 11.4 8.6 Large subunit of trehalose 6-phosphate syn-
thase/phosphatase complex; mutant has aneuploidy
tolerance; protein abundance increases in response to
DNA replication stress
YGR121C MEP1 11.3 7.5 Ammonium permease
YDR345C HXT3 11.0 7.3 Low affinity glucose transporter of the major facilita-
tor superfamily
YAR042W SWH1 10.9 3.6 Protein similar to mammalian oxysterol-binding pro-
tein
YLR247C IRC20 10.8 8.1 E3 ubiquitin ligase and putative helicase; involved in
synthesis-dependent strand annealing-mediated ho-
mologous recombination
YPL103C FMP30 10.8 9.7 Protein with a role in maintaining mitochondrial mor-
phology
YDL230W PTP1 10.8 7.3 Phosphotyrosine-specific protein phosphatase
YOR371C GPB1 10.7 9.6 Multistep regulator of cAMP-PKA signaling
YCL026C-A FRM2 10.7 5.6 Type II nitroreductase, using NADH as reductant;
involved in the oxidative stress response
YGR260W TNA1 10.6 7.6 High affinity nicotinic acid plasma membrane perme-
ase
YGL087C MMS2 10.6 7.4 Ubiquitin-conjugating enzyme variant; involved in
error-free postreplication repair
YIL038C NOT3 10.5 6.2 Subunit of CCR4-NOT global transcriptional regula-
tor
YPR129W SCD6 10.5 9.9 Repressor of translation initiation
YDR357C CNL1 10.5 7.4 Subunit of the BLOC-1 complex involved in endoso-
mal maturation
YPL070W MUK1 10.4 9.7 Guanine nucleotide exchange factor (GEF)
YGL234W ADE5,7 10.4 7.5 Enzyme of the de novo purine nucleotide biosynthetic
pathway
YNL082W PMS1 10.4 8.8 ATP-binding protein required for mismatch repair;
required for both mitosis and meiosis
YKL137W CMC1 10.1 7.2 Copper-binding protein of the mitochondrial inter-
membrane space
YIL120W QDR1 10.1 6.4 Multidrug transporter of the major facilitator super-
family
YHR155W YSP1 10.1 6.0 Mitochondrial protein
MMS
YBR066C NRG2 12.9 5.4 Transcriptional repressor
YMR186W HSC82 12.2 9.0 Cytoplasmic chaperone of the Hsp90 family
YAR042W SWH1 12.1 11.1 Protein similar to mammalian oxysterol-binding pro-
tein
YIL038C NOT3 11.9 7.0 Subunit of CCR4-NOT global transcriptional regula-
tor
YKL137W CMC1 11.3 7.6 Copper-binding protein of the mitochondrial inter-
membrane space
YOR371C GPB1 11.3 9.7 Multistep regulator of cAMP-PKA signaling
YLR028C ADE16 11.0 8.3 Enzyme of de novo purine biosynthesis
YCL026C-A FRM2 11.0 5.9 Type II nitroreductase, using NADH as reductant;
involved in the oxidative stress response
YBR258C SHG1 10.8 5.8 Subunit of the COMPASS (Set1C) complex
YBR222C PCS60 10.8 5.6 Oxalyl-CoA synthetase
YNL082W PMS1 10.7 9.1 ATP-binding protein required for mismatch repair;
required for both mitosis and meiosis
YLR247C IRC20 10.6 8.3 E3 ubiquitin ligase and putative helicase; involved in
synthesis-dependent strand annealing-mediated ho-
mologous recombination
continued on next page
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Table B.10: continued from previous page
Strain Gene Name Fold enrich.
Drug
Fold enrich.
YPAD
Description
YER037W PHM8 10.6 6.5 Lysophosphatidic acid (LPA) phosphatase, nucleoti-
dase
YDR465C RMT2 10.4 7.9 Arginine N5 methyltransferase; relative distribution
to the nucleus increases upon DNA replication stress
YBR057C MUM2 10.2 5.1 Protein essential for meiotic DNA replication and
sporulation
YDR357C CNL1 10.2 7.8 Subunit of the BLOC-1 complex involved in endoso-
mal maturation
YIR013C GAT4 10.2 7.3 Protein containing GATA family zinc finger motifs
YOL136C PFK27 10.1 9.2 6-PhosphoFructo-2-Kinase
YKL174C TPO5 10.1 7.6 Protein involved in excretion of putrescine and sper-
midine
YML100W TSL1 10.1 8.7 Large subunit of trehalose 6-phosphate syn-
thase/phosphatase complex; mutant has aneuploidy
tolerance; protein abundance increases in response to
DNA replication stress
YDR345C HXT3 9.9 7.7 Low affinity glucose transporter of the major facilita-
tor superfamily
YHR044C DOG1 9.9 6.6 2-deoxyglucose-6-phosphate phosphatase
YMR101C SRT1 9.8 8.8 Cis-prenyltransferase
YMR038C CCS1 9.6 8.7 Copper chaperone for superoxide dismutase Sod1p;
protein abundance increases in response to DNA
replication stress
YDR163W CWC15 9.3 7.6 Non-essential protein involved in pre-mRNA splicing
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Figure B.7: PCR validations of mating type for newly generated KO strains for the validation
experiments (M: 100bp marker). The PCRs were done using three primers in the same reaction:
two primers that anneal to a specific region of MATα and MATa respectively and one that anneals
in a common region of both mating types and it is directed towards the MAT locus [Huxley et al.,
1990].
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